No,PMID,title,year,journal,age_grp,interven,interven_type,blind_all,source_cont_required,source_cont_done,cond_specific,cond_cat,sterile_site,n_randomised,setting,country,income,short_protocol,long_protocol,short_actual,long_actual,rand_process,hypothesis,margin,pri_analysis_population,sec_analysis_pop,diffshown_ITT,diffshown_PP,arm_clinicalsuperior,outcome_measure,sample_size_calculated,didnotmeetcalculatedsamplesize,RoB2,n_short_randomised,n_long_randomised,n_analysed,n_adherent_short,n_adherent_long,shortXlong,longXshort,adhere_monitor,excl_prianalysis_reason,funding,diagnosis,abx_specific,abx_short,abx_long,culture_directed_insome,fu_period,fu_period_note,primary_outcome,combined_outcome,obj_outcome,abxpresc_outcome,outcome_clinical,outcome_microb_clinical,outcome_microb_colonising,abx_se,outcome_economic,per_priclinicaloutcome_short,per_priclinicaloutcome_long,per_mortality,note
1,34313686,Effect of 7 vs 14 Days of Antibiotic Therapy on Resolution of Symptoms Among Afebrile Men With Urinary Tract Infection: A Randomized Clinical Trial,2021,JAMA,adult,7 days of treatment and were randomized to receive continued antibiotic therapy (n = 136) or placebo (n = 136) for days 8 to 14 of treatment.,arbitruary durations,1,0,0,afebrile men with presumed symptomatic UTI,Urinary tract infection,0,272,outpatient,USA,high,7,14,not reported,not reported,stratified randomisation,non-inferiority,10,as treated,ITT,0,NA,NA,absolute difference,1,1,0,136,136,272,131,123,0,13,Self reporting,0,investigator initiated,clinical syndrome,,"ciprofloxacin, bactrim","ciprofloxacin, bactrim",0,14,14 days after initiation of treatment,resolution of UTI symptoms by 14 days after completion of active antibiotic treatment,0,0,0,1,1,0,1,0,7,10,0,
2,33773631,"Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial",2021,Lancet,adult,who met prespecified clinical stability criteria after 3 days of treatment with β-lactam therapy were randomly assigned (1:1) to receive β-lactam therapy (oral amoxicillin 1 g plus clavulanate 125 mg three times a day) or matched placebo for 5 extra days,arbitruary durations,1,0,0,moderately severe CAP,Lower respiratory tract infection,0,310,inpatient,France,high,3,8,not reported,not reported,stratified randomisation,non-inferiority,10,ITT,PP,0,0,NA,absolute difference,1,0,1,157,153,303,145,146,5,1,Self reporting,withdrew consent,investigator initiated,clinical syndrome,,amoxicillin/clav,amoxicillin/clav,0,15,"cure 15 days after first antibiotic intake, defined by apyrexia (temperature ≤37·8°C), resolution or improvement of respiratory symptoms, and no additional antibiotic treatment for any cause","cure 15 days after first antibiotic intake, defined by apyrexia (temperature ≤37·8°C), resolution or improvement of respiratory symptoms, and no additional antibiotic treatment for any cause",0,0,0,1,1,0,1,hospital los,23,32,2,"in our sample size calculations we anticipated a 90% cure rate; however, our actual cure rate was much lower. This difference might be due to the high variability in definitions of cure between studies leading to overestimation in our calculations"
3,33683325,"Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia
The SAFER Randomized Clinical Trial",2021,JAMA Paeds,children,5 days of high-dose amoxicillin for CAP was associated with noninferior rates of clinical cure compared with 10 days of high-dose amoxicillin,arbitruary durations,1,0,0,CAP,Lower respiratory tract infection,0,281,outpatient,Canada,high,5,10,not reported,not reported,simple randomization,non-inferiority,7.5,PP,ITT,0,0,NA,absolute difference,1,0,1,140,141,252,109,114,Not reported,not reported,Self reporting,"withdrew consent, protocol deviation",investigator initiated,clinical syndrome,,amoxicillin,amoxicillin,0,21,Clinical cure at 14 to 21 days,Clinical cure at 14 to 21 days,0,0,0,1,0,0,1,0,14,16,0,"per-protocol (PP) analysis including those participants adherent to medications (ie, >80% of antimicrobial doses taken and no additional antibiotics taken for nonpneumonia infections), and strict PP analysis including only those in the PP group whose radiographs had radiologist-confirmed pneumonia"
4,32537711,"Early Discontinuation versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients with Febrile Neutropenia, Before Recovery of Counts: A Randomized Controlled Trial (DALFEN Study)",2021,The Indian Journal of Pediatrics,children,"After an afebrile period of at least 24 h, and confirmation of a negative blood culture report, patients with persisting neutropenia (ANC <500) were randomized between two arms
 (Arm A: stoppage of antibiotics and Arm B: oral antibiotics)",treatment protocol,0,0,NA,Febrile neutropenia,Prophylaxis (immunocompromised),0,75,outpatient,India,lower middle,NA,NA,60,Not reported (at least 60),simple randomization,non-inferiority,15,ITT,none,0,NA,NA,absolute difference,1,1,0,38,37,75,Not reported,Not reported,Not reported,Not reported,Self reporting,NA,investigator initiated,clinical syndrome,"amoxcillin, levofloxacin continued in long arm",various,various,0,Not reported,"not specified, but mean recovery of ANC in both arms were 4 days",proportion of patients remaining afebrile until ANC>500,0,1,0,1,0,0,0,0,5,5,0,"antibiotics were upgraded in those
 patients whose fever persisted/ progressed after 96 h or they
 developed signs of clinical deterioration. These patients were
 excluded from the study"
5,33904295,Comparison of Short Course Versus Long Course Antibiotic Prophylaxis for Caesarean Section: A Randomised Controlled Trial,2021,West African Journal of Medicine,adult,"The study group received intravenous dose of 1g of ceftriaxone with 500mg of metronidazole stat post umbilical cord clamping. While the control group received post-operative doses of intravenous ceftriaxone 1g 12 hourly with 500mg of metronidazole eight hourly for 24 hours, then oral cefuroxime 500mg twice daily and metronidazole 400mg thrice daily for five days.",arbitrary durations,0,0,NA,prophylaxis post caesarian section,Prophylaxis (post-surgery),0,166,inpatient,Nigeria,low,1 dose,5,Not known,Not known,Not known,non-inferiority,Not known,ITT,none,0,NA,NA,absolute difference,Not known,Not known,0,83,83,166,Not known,Not known,Not known,Not known,Medical chart,NA,Not known,NA,"study group received intravenous dose of 1g of ceftriaxone with 500mg of metronidazole stat post umbilical cord clamping. While the control group received post-operative doses of intravenous ceftriaxone 1g 12 hourly with 500mg of metronidazole eight hourly for 24 hours, then oral cefuroxime 500mg twice daily and metronidazole 400mg thrice daily for five days.","ceftriaxone, metronidazole","ceftriaxone, metronidazole, oral cefuroxime, metronidazole",0,Not reported,Not found in abstract,"proportion of patients with febrile morbidity, wound infection and clinical endometritis",0,0,0,1,0,0,0,direct cost,12,14,0,full article not found
6,34042388,Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection,2020,NEJM,adult,The patients were randomly assigned to receive 6 weeks or 12 weeks of antibiotic therapy as soon as possible after surgical debridement,arbitrary durations,0,1,1,prosthetic joint infection (hip or knee),Bone and prosthetics infection,1,410,inpatient,France,high,42,84,42,84,stratified randomisation,non-inferiority,10,mITT,PP,1,1,long,absolute difference,1,0,1,205,205,404,165,160,22,22,Self reporting,"withdrew consent, died",investigator initiated,culture of sterile site,"Among the 380 patients who received at least one oral antibiotic agent, the most frequently used agents were rifampin (267 patients [70.3%]) and fluoroquinolone (260 [68.4%]); a total of 194 patients (51.1%) received both.",various,various,1,730,"Results of clinical assessments and patient-reported outcome measures were recorded at enrollment and at 6, 12, 24, and 52 weeks after day 0 and at 104 weeks after the planned completion date of antibiotic therapy.",persistent infection within 2 years after the end of antibiotic therapy,0,0,0,1,1,0,1,hospital los,18,9,0,most of the treatment failures in the 6-week group occurred among the patients who had undergone débridement with implant retention
7,32857331,Seven versus Ten Days Antibiotics Course for Acute Pyogenic Meningitis in Children: A Randomized Controlled Trial,2021,The Indian Journal of Pediatrics,children,"A treatment comprising of ceftriaxone (100 mg/kg/d in 2
 divided doses administered every 12 h) and vancomycin
 (60 mg/kg/d in 4 divided doses administered every 6 h) as
 per the unit protocol based on recent guidelines on management of acute bacterial meningitis was initiated in all the study
 participants",arbitrary durations,0,0,NA,Meningitis,Meningitis,1,104,inpatient,India,lower middle,7,10,Not reported,Not reported,simple randomization,non-inferiority,15,mITT,none,0,NA,NA,absolute difference,1,1,0,52,52,91,45,46,Not reported,Not reported,Medical chart,loss to follow up,investigator initiated,clinical syndrome with laboratory test,"empirical ceftriaxone, vancomycin","ceftriaxone, vancomycin","ceftriaxone, vancomycin",0,14,2 weeks from discharge,"treatment failure rate, defined as lack of
 clinical improvement indicated by the presence of anyone of the
 following: fever along with meningeal signs, seizures and altered
 sensorium at the end of the therapy or relapse of meningitis,
 defined as the recurrence of signs and symptoms of meningitis
 within 2 wk of discharge from hospital.",0,0,0,1,0,0,0,none,15,13,0,"None of the cases had positive blood culture (>50% has antibiotics prior to admission)
 or CSF culture."
8,33904798,"The Duration of Antibiotics Prophylaxis at the Time of Catheter Removal after Radical Prostatectomy: Clinically-Integrated, Cluster, Randomized Trial",2021,J Uro,adult,"prescribe 1-day vs 3-day regimen of prophylactic antibiotics at the time
 of catheter removal.",arbitrary durations,0,1,1,"Antibiotics Prophylaxis at the Time of Catheter
 Removal after Radical Prostatectomy",Prophylaxis (post-surgery),0,824,outpatient,USA,high,1,3,Not reported,Not reported,cluster randomisation,non-inferiority,0.35,ITT,PP,0,0,NA,absolute difference,1,0,1,389,435,800,336,406,33,15,Self reporting,NA,investigator initiated,NA,,Ciprofloxacin,Ciprofloxacin,0,Not reported,Not mentioned in the paper,UTI,0,0,0,1,0,0,0,0,0,0.7,0,Nested in a prostate CA study
9,34006044,Efficacy and safety of the point-of-care procalcitonin test for determining the antibiotic treatment duration in patients with ventilator-associated pneumonia in the intensive care unit: a randomised controlled trial,2021,Anaesthesiology Intensive Therapy,adult,"Patients ventilated
 for > 48 hours who had CPISs > 5 were enrolled in
 the study. The patients were randomised to PCT
 and control groups. For the PCT group, 2 mL blood
 samples were withdrawn from each patient and
 kept in an ethylene diamine tetraacetic acid bottle.
 The sample was immediately analysed by the investigator using the Finecare Plus analyser (Wondfo,
 Guangzhou, China), and the results were available
 after 15 minutes. The serial PCT levels were monitored on days 1, 3, 7 and 9. In the control group, serial CRP levels were monitored in accordance with
 the physician’s decision",inflammatory markers,0,0,NA,VAP,Lower respiratory tract infection,0,100,ICU,Malaysia,upper middle,NA,NA,10.28,11.52,simple randomization,superiority,NA,PP,none,NA,0,NA,duration of antibiotic,0,Not known,0,50,50,85,31,42,12,Not reported,Medical chart,"MDRO, loss to follow up",investigator initiated,clinical syndrome,"No specific antibiotics were allocated to both
groups. The antibiotic selection was entirely at the
attending physician’s discretion based on either
the sensitivity of the organism or as empirical treatment.",various,various,0,NA,during admission,antibiotic duration,0,1,1,0,0,0,0,hospital los,not reported,not reported,12,
10,34097231,"Ten Versus 14 Days of Antibiotic Therapy in Culture-Proven Neonatal Sepsis: A Randomized, Controlled Trial",2021,The Indian Journal of Pediatrics,neonate,All the eligible neonates who met all the inclusion criteria and none of the exclusion criteria were randomized at the end of 10th day of antibiotics.,arbitrary durations,0,0,NA,culture-positive sepsis,Bloodstream infection,1,70,ICU,India,lower middle,10,14,10,14,simple randomization,non-inferiority,not reported,ITT,NA,0,NA,NA,not reported,0,NA,0,35,35,68,34,34,0,0,Medical chart,loss to follow up,investigator initiated,culture of sterile site,,various,various,1,28,readmission to the NICU within 4 wk of discharge with blood culture growing same organism with similar antibiogram or any readmission with signs of sepsis with negative blood culture.,readmission to the NICU within 4 wk of discharge with blood culture growing same organism with similar antibiogram or any readmission with signs of sepsis with negative blood culture.,0,0,0,1,1,0,0,hospital los,3,0,0,pilot study
11,33242083,"Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: A prospective, randomized, non-inferiority pilot trial",2020,CID,adult,"Treating clinicians were allowed to perform any needed wound debridement procedures, to choose the method of weight off-loading the affected foot and the appropriate diagnostic imaging methods [15], to decide on the need for angioplasty, and to use negative-pressure vacuum therapy or hyperbaric oxygen for wound healing. While full resection of all infected bone was an exclusion, we permitted partial surgical amputation for necrotic bone. Our definition for “partial amputation” was purposely loose, including an amputation in 1 toe but leaving the DFO of another toe for conservative therapy, or a planned limited resection, such as during a partial calcanectomy [16, 17]. If there was a partial amputation, we determined the presence of residual DFO by previous radiological and/or intraoperative assessments, and the decision to treat remaining DFO with antibiotic therapy. To limit the number of antibiotic drugs investigators might select, we provided a list of permitted agents, from which the clinician could select the most appropriate",arbitrary durations,0,1,1,Diabetic foot osteomyelitis,Bone and prosthetics infection,1,93,inpatient,Switzerland,high,21,42,Not reported,Not reported,simple randomization,non-inferiority,25,ITT,PP,0,0,NA,absolute difference,1,1,0,44,49,93,39,43,0,0,Self reporting,clinical complications,investigator initiated,clinical syndrome with laboratory test,"We used 47 different antibiotic regimens, among which the most frequent agents were co-amoxiclav (63%), levofloxacin (22%), clindamycin (17%), co-trimoxazole (9%), and doxycycline (9%); rifampicin was administered in only 1 case",various,various,1,330,"median of 11 months, minimum 2 months","complete absence of clinical and radiologic findings of infection after a minimum follow-up of 2 months after EOT. We defined clinical failure as either recurrent, persistent, or new infection at the original site [21], or secondary amputation for progressive infection, ischemia, or necrosis. We defined microbiological failure as a microbiologically confirmed recurrence or persistence at the same localization with the same pathogen (or at least 1 of the same pathogens in case of polymicrobial infection).",0,0,0,1,1,0,0,hospital los,16,27,0,pilot study
12,32609979,Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children,2020,NEJM,children,"children with chest-indrawing pneumonia (cough lasting <14 days or difficulty breathing, along with visible indrawing of the chest wall with or without fast breathing for age). Children not infected with human immunodeficiency virus (HIV) who were 2 to 59 months of age and had chest-indrawing pneumonia were randomly assigned to receive amoxicillin twice daily for either 3 days or 5 days",arbitrary durations,1,0,NA,Fast-breathing Pneumonia,Lower respiratory tract infection,0,3000,outpatient,Malawi,low,3,5,Not reported,Not reported,stratified randomisation,non-inferiority,5.2,mITT,NA,0,NA,NA,relative difference,1,0,1,1497,1503,2898,1442,1456,0,0,Self reporting,loss to follow up,investigator initiated,clinical syndrome,High-dose oral amoxicillin was provided in 250-mg dispersible tablets (tablets dissolved in liquid) in two divided doses daily. Children in the 3-day group received amoxicillin tablets for 3 days and placebo tablets for 2 days. Children in the 5-day group received amoxicillin tablets for 5 days.,amoxicillin,amoxicillin,0,6,"total follow up 14 days, outcome determined on day 6",treatment failure,0,0,0,1,0,0,0,none,13,11,0,
13,32484534,"Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial",2020,JAMA,adult,"individualized CRP-guided antibiotic treatment duration (discontinuation once CRP declined by 75% from peak; n = 170), fixed 7-day treatment duration (n = 169), or fixed 14-day treatment duration (n = 165).",treatment protocol,0,0,NA,Uncomplicated Gram-Negative Bacteremia,Bloodstream infection,1,504,inpatient,Switzerland,high,NA,NA,7,Not reported,stratified randomisation,non-inferiority,10,mITT,PP,0,0,NA,absolute difference,1,0,1,170,165,334,130,143,13,13,Medical chart,withdrew consent,investigator initiated,culture of sterile site,Inpatient physicians followed local guidelines for antibiotic choice and administration route; a switch from intravenous to oral administration was allowed per routine practice.,various,various,1,30,"total follow up 90 days, primary outcome determined on day 30","clinical failure rate at day 30, defined as the presence of at least 1 of the following, with a non-inferiority margin of 10%: recurrent bacteremia, local suppurative complication, distant complication (growth of the same organism causing the initial bacteremia), restarting gram-negative–directed antibiotic therapy due to clinical worsening suspected to be due to the initial organism, or death due to any cause.",0,0,0,1,1,0,1,hospital los,2,4,2,"interpretation is limited by the large noninferiority margin compared with the low observed event rate, as well as low adherence and wide range of treatment durations in the CRP-guided group."
13,32484534,"Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial",2020,JAMA,adult,"individualized CRP-guided antibiotic treatment duration (discontinuation once CRP declined by 75% from peak; n = 170), fixed 7-day treatment duration (n = 169), or fixed 14-day treatment duration (n = 165).",arbitrary durations,0,0,NA,Uncomplicated Gram-Negative Bacteremia,Bloodstream infection,1,504,inpatient,Switzerland,high,7,14,Not reported,Not reported,simple randomization,non-inferiority,10,mITT,PP,0,0,NA,absolute difference,1,0,1,169,165,334,141,143,24,13,Medical chart,withdrew consent,investigator initiated,culture of sterile site,Inpatient physicians followed local guidelines for antibiotic choice and administration route; a switch from intravenous to oral administration was allowed per routine practice.,various,various,1,30,"total follow up 90 days, primary outcome determined on day 30","clinical failure rate at day 30, defined as the presence of at least 1 of the following, with a non-inferiority margin of 10%: recurrent bacteremia, local suppurative complication, distant complication (growth of the same organism causing the initial bacteremia), restarting gram-negative–directed antibiotic therapy due to clinical worsening suspected to be due to the initial organism, or death due to any cause.",0,0,0,1,1,0,1,hospital los,6,2,2,
14,31618678,"Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial",2020,Clin Microbiol Infect,adult,symptom improvement who were afebrile were randomized between an additional 6 days of oral flucloxacillin or placebo,arbitrary durations,1,0,NA,Severe cellulitis,Skin and soft tissue infection,0,151,inpatient,Netherland,high,6,12,Not reported,Not reported,simple randomization,non-inferiority,10,ITT,PP,NA,NA,NA,absolute difference,1,1,0,73,76,149,66,66,1,5,Medical chart,NA,investigator initiated,clinical syndrome,,flucloxacillin,flucloxacillin,0,28,"The primary outcome was cure by day 14 without relapse by day 28 in the intention-to-treat (ITT) population, which included all participants who were correctly randomized. Cure by day 14 was defined as the absence of pain and warmth and a reduction in erythema and oedema. Relapse was defined as the initiation of new antibiotics for cellulitis by non-trial physicians.
 Secondary outcomes included a per-protocol analysis (PPA), (time to) relapse within 90 days, sequential visual analogue scores (VASs) of pain and oedema, the CSS over time, and cure without relapse using a modified cure assessment.",cure by day 14 without relapse by day 28,0,0,0,1,0,0,0,0,50,49,1,could not make conclusion because under powered
15,30992295,"Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial",2019,Ann Rheum Dis,adult,"eligible hospitalised patients, following a specified randomisation procedure (1:1, by computer-generated random numbers) to therapy with systemic antibiotic agents for either 2 weeks (±3 days) or 4 weeks (±3 days).",arbitrary durations,0,1,1,native joint bacterial arthritis:,Bone and prosthesis infection,1,154,inpatient,Switzerland,high,14,28,14,28,simple randomization,non-inferiority,10,ITT,PP,0,0,NA,absolute difference,1,0,1,77,77,85,not reported,not reported,not reported,not reported,Medical chart,not reported,investigator initiated,NA,"The most frequently administered parenteral antibiotics were co-amoxiclav (n=71), ceftriaxone (n=3) and vancomycin (n=4). Overall, we administered parenteral β-lactam antibiotics in 107 (69%) cases. The oral antibiotics prescribed were co-amoxiclav (74), quinolones (26), clindamycin (19), doxycycline (2), co-trimoxazole (3) or a combination of above.",various,various,0,60,"Remission was defined as the complete absence of clinical, laboratory or radiological findings after a minimal follow-up of 2 months after treatment.","rates of remission of infection. Remission was defined as the complete absence of clinical, laboratory or radiological findings after a minimal follow-up of 2 months after treatment.",0,0,0,1,1,0,1,hospital los,4,5,0,
16,30596964,Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2-59 Months in Pakistan: A Cluster-randomized Trial,2019,CID,children,"treated fast-breathing pneumonia as per the LHW program standard of care [15], using oral co-trimoxazole at 40 mg sulphamethoxazole/8mg trimethoprim/kg/day (200mg sulphamethoxazole/40mg trimethoprim/5 ml), given twice daily for 5 days. In the intervention clusters, LHWs treated fast-breathing pneumonia for 3 days with oral amoxicillin at 50mg/kg/day (250mg/5ml), given twice daily.",arbitrary durations,0,0,NA,Fast-breathing Pneumonia,Lower respiratory tract infection,0,19291,outpatient,Pakistan,low,3,5,Not reported,Not reported,cluster randomisation,equivalency,plus minus 5,PP,ITT,1,0,short,absolute difference,1,0,1,11230,8061,15662,9153,6509,47,1418,"Self reporting, check medication",protocol deviation,investigator initiated,clinical syndrome,,Amoxicillin,Bactrim,0,6,Day 4 (Primary Outcome Intervention) and Day 6 (Primary Outcome Control),treatment failure,0,0,0,1,0,0,1,0,4,9,0,
17,31585944,"Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: randomised controlled, open label, non-inferiority study",2019,BMJ,children,"Patients aged 6 years and over with pharyngotonsillitis caused by group A streptococci and three or four Centor criteria (fever ≥38.5°C, tender lymph nodes, coatings of the tonsils, and absence of cough).
 
 Interventions
 Penicillin V 800 mg four times daily for five days (total 16 g) compared with the current recommended dose of 1000 mg three times daily for 10 days (total 30 g)",arbitrary durations,0,0,NA,pharyngotonsillitis,Upper respiratory tract infection,0,433,outpatient,Sweden,high,5,10,Not reported,Not reported,stratified randomisation,non-inferiority,10,PP,mITT,0,0,NA,absolute difference,1,0,1,215,218,422,202,195,Reported in proportions of doses taken,Reported in proportions of doses taken,Self reporting,"withdrew consent, did not satisfy inclusion criteria",investigator initiated,"clinical syndrome, culture",,penicillin,penicillin,1,6,clinical cure five to seven days after the end of antibiotic treatment,clinical cure,0,0,0,1,1,0,1,0,10,7,0,
18,30982631,Guideline-Based Clinical Assessment Versus Procalcitonin-Guided Antibiotic Use in Pneumonia: A Pragmatic Randomized Trial,2019,Ann Emerg Med,adult,procalcitonin-guided or clinical assessment group,inflammatory markers,0,0,NA,CAP,Lower respiratory tract infection,0,285,inpatient,France,high,NA,NA,9,10,simple randomization,superiority,NA,ITT,mITT,0,NA,NA,duration of antibiotic,1,0,1,142,143,262,108,143,34,0,Medical chart,"enrolment error, other diagnosis",investigator initiated,clinical syndrome,"Antibiotics administered in the ED included amoxicillin (clinical assessment group 32 [22%], procalcitonin group 26 [18%]), amoxicillin-clavulanate (clinical assessment group 62 [43%], procalcitonin group 57 [40%]), a fluoroquinolone (clinical assessment group 7 [5%], procalcitonin group 5 [3%]), ceftriaxone (clinical assessment group 42 [29%], procalcitonin group 38 [27%]), and others (clinical assessment group 18 [13%], procalcitonin group 26 [18%]).",various,various,0,30,total days of antibiotic exposure within 30 days after ED admission in the intention-to-treat population,total days of antibiotic exposure within 30 days after ED admission in the intention-to-treat population,0,1,1,1,0,0,0,hospital los,8,8,2,
19,31030266,Antimicrobial prophylaxis for 1 day versus 3 days in liver cancer surgery: a randomized controlled non-inferiority trial,2019,surg today,adult,"hepatocellular carcinoma scheduled to undergo resection were randomly assigned to receive either a 1-day regimen for antimicrobial prophylaxis, or a 3-day regimen",arbitrary durations,0,0,NA,SSI in liver cancer surgery,Prophylaxis (post-surgery),0,480,inpatient,Japan,high,1,3,Not reported,Not reported,simple randomization,non-inferiority,8,mITT,none,0,NA,NA,absolute difference,1,0,1,240,240,467,232,235,Not reported,Not reported,Medical chart,"elderly, other procedures, withdrew consent",investigator initiated,NA,,flomoxef,flomoxef,0,30,30 days after operation,SSI,0,0,0,1,1,0,0,0,10,10,0,
20,30535100,Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial,2019,CID,adult,"Inpatients with gram-negative bacteremia, who were afebrile and hemodynamically stable for at least 48 hours, were randomized to receive 7 days (intervention) or 14 days (control) of covering antibiotic therapy.",arbitrary durations,0,0,NA,Gram-negative bacteremia,Bloodstream infection,1,604,inpatient,Israel and Italy,high,7,14,10,16,simple randomization,non-inferiority,10,ITT,PP,0,0,NA,absolute difference,1,0,1,306,298,604,280,276,26,13,Medical chart,NA,investigator initiated,culture of sterile site,The type of empirical or directed antibiotic treatment was chosen by the treating physicians.,various,various,1,90,"primary outcome at 90 days from randomization was a composite of all-cause mortality; clinical failure, including either relapse of the bacteremia, local suppurative complications, or distant complications; and readmission or extended hospital stay (>14 days)","composite of all-cause mortality; clinical failure, including either relapse of the bacteremia, local suppurative complications, or distant complications; and readmission or extended hospital stay (>14 days)",1,0,0,1,1,0,1,hospital los,46,48,11,
21,31106353,Four versus six weeks of antibiotic therapy for osteoarticular infections after implant removal: a randomized trial,2019,JAC,adult,"4 or 6 weeks of systemic, pathogen-targeted antibiotic therapy",arbitrary durations,0,1,1,treating orthopaedic implant infections after surgical drainage and complete implant removal,Bone and prosthetics infection,1,123,inpatient,Switzerland,high,28,42,28,42,simple randomization,non-inferiority,10,ITT,PP,0,0,NA,absolute difference,1,0,1,62,61,123,60,57,Not reported,Not reported,Self reporting,did not remove implant,investigator initiated,culture of sterile site,"The most frequently prescribed parenteral antibiotics were vancomycin (n = 23), amoxicillin/clavulanic acid (30) and cefuroxime (17). Among oral antibiotics, the most commonly prescribed were fluoroquinolones (n = 32), clindamycin (24), doxycycline (21), amoxicillin/clavulanic acid (30) and co-trimoxazole (13).",various,various,1,805.2,median follow-up period of 2.2 years,remission of infection at the operative site,0,0,0,1,1,0,1,0,6,5,0,
22,29484469,Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial,2018,Intensive care med,adult,8-day versus 15-day antibiotic therapy in critically ill patients with PIAI,arbitrary durations,0,1,1,postoperative intra-abdominal infection,Abdominal infection,1,249,ICU,France,high,8,15,Not reported,Not reported,stratified randomisation,superiority,NA,mITT,PP,0,0,NA,number of antibiotic-free days,1,0,1,126,123,236,77,66,21,10,Medical chart,"loss to follow up, death",investigator initiated,culture of sterile site,"Empirical ABT was recommended according to the French Guidelines for PIAI (Methods-ESM) [5]. However, ABT and management were left to the discretion of the attending physicians, including drug plasma monitoring and any adaptation considered necessary.",various,various,1,28,"number of antibiotic-free days (i.e. number of days alive and antibiotic-free) from day 8 to day 28
 (analysis of superiority)","number of antibiotic-free days (i.e. number of days alive and antibiotic-free) from day 8 to day 28
 (analysis of superiority)",0,1,1,1,1,1,0,hospital los,8,11,13,mortality day 8-18 used as clinical outcome
23,30318069,"Re: Angela Huttner, Arina Kowalczyk, Adi Turjeman, et al. Effect of 5-Day Nitrofurantoin vs Single-dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. JAMA 2018;319:1781–9",2018,JAMA,adult,"100 mg 3 times a day for 5 days (n = 255), or a single 3-g dose of oral fosfomycin (n = 258)",arbitrary durations,0,0,NA,Uncomplicated Lower Urinary Tract Infection,Urinary tract infection,0,513,outpatient,"Switzerland; Lodz, Poland; and Petah-Tiqva, Israel",high,1,5,Not reported,Not reported,simple randomization,superiority,NA,mITT,PP,0,0,NA,"clinical response in the 28 (±7) days following completion of therapy, defined as clinical resolution (complete resolution of symptoms and signs of UTI without prior failure), failure (need for additional or change in antibiotic treatment due to a UTI or discontinuation due to lack of efficacy), or indeterminate (either persistence of symptoms without objective evidence of infection or any extenuating circumstances precluding a classification of clinical resolution or failure). Clinical resolution was thus a lack of prior failure with complete resolution of symptoms at the date of the examination, indeterminate response was a lack of prior failure yet with persistence of symptoms without objective evidence of infection, and clinical failure at any time point was carried through to the end of the study.",1,0,1,258,255,485,237,237,Not reported,Not reported,Self reporting,missing data,investigator initiated,clinical syndrome with laboratory test,,fosfomycin,nitrofurantoin,0,28,attended 2 follow-up visits at 14 (±2) and 28 (±7) days after completion of antibiotic therapy; urine cultures were collected at all scheduled and unscheduled visits,"clinical response in the 28 (±7) days following completion of therapy, defined as clinical resolution (complete resolution of symptoms and signs of UTI without prior failure), failure (need for additional or change in antibiotic treatment due to a UTI or discontinuation due to lack of efficacy), or indeterminate (either persistence of symptoms without objective evidence of infection or any extenuating circumstances precluding a classification of clinical resolution or failure). Clinical resolution was thus a lack of prior failure with complete resolution of symptoms at the date of the examination, indeterminate response was a lack of prior failure yet with persistence of symptoms without objective evidence of infection, and clinical failure at any time point was carried through to the end of the study.",0,0,0,1,1,1,0,0,42,30,0,
24,29781043,Comparison of Four Days Versus Seven Days Duration of Antibiotic Therapy for Neonatal Pneumonia: A Randomized Controlled Trial,2018,Indian J Paed,neonate,total of 4 d (Study group) or 7 d (Control group) of antibiotic therapy (intravenous Ceftriaxone 100 mg/kg in two divided doses plus Amikacin 15 mg/kg once daily),arbitrary durations,0,0,NA,Neonatal pneumonia,Lower respiratory tract infection,0,70,inpatient,India,lower middle,4,7,Not reported,Not reported,simple randomization,non-inferiority,6,ITT,none,0,NA,NA,absolute difference,1,1,0,35,35,70,Not reported,Not reported,Not reported,Not reported,Medical chart,NA,investigator initiated,clinical syndrome,,"ceftriaxone, amikacin","ceftriaxone, amikacin",0,3,"3 d after discharge and then weekly for up to 28 d after enrollment to look for any recurrence of symptoms, namely fast breathing, nasal flaring, grunting, chest retractions, poor feeding, lethargy, fever or cold to touch, abdominal distention, or any other morbidity (danger signs)",treatment failure in each group within 3 d of discharge,0,0,0,1,0,0,1,"hospital los, direct costs",0,0,0,sample size calculated based on 6% NI margin but only 35 per group?
25,29781385,Procalcitonin-guided use of antibiotics for lower respiratory tract infection,2018,NEJM,adult,"patients who presented to the emergency department with a suspected lower respiratory tract infection and for whom the treating physician was uncertain whether antibiotic therapy was indicated to one of two groups: the procalcitonin group, in which the treating clinicians were provided with real-time initial (and serial, if the patient was hospitalized) procalcitonin assay results and an antibiotic use guideline with graded recommendations based on four tiers of procalcitonin levels, or the usual-care group",inflammatory markers,0,0,NA,Clinical suspicion of pneumonia,Lower respiratory tract infection,0,1664,inpatient,USA,high,NA,NA,4,4,simple randomization,non-inferiority,4.5,ITT,PP,0,0,NA,absolute difference,1,0,1,830,834,1656,696,830,134,0,Medical chart,withdrew consent,bioMérieux,clinical syndrome,,various,various,0,30,30 days after enrolment,"adverse outcomes that could be attributable to withholding antibiotics in lower respiratory tract infection, within 30 days after enrollment",0,0,0,1,0,0,0,0,12,13,2,
26,27759623,Duration of Antimicrobial Prophylaxis in Patients Undergoing Major Hepatectomy With Extrahepatic Bile Duct Resection: A Randomized Controlled Trial,2018,Ann surg,adult,Patients with suspected hilar obstruction scheduled to undergo complicated hepatectomy after biliary drainage were randomized to 2-day (antibiotic treatment on days 1 and 2) or 4-day (on days 1 to 4) groups. Antibiotics were selected based on preoperative bile culture.,arbitrary durations,0,0,NA,Prophylaxis in Patients Undergoing Major Hepatectomy With Extrahepatic Bile Duct Resection,Prophylaxis (post-surgery),1,86,inpatient,Japan,high,2,4,Not reported,Not reported,simple randomization,non-inferiority,20,ITT,none,0,NA,NA,absolute difference,1,1,0,43,43,86,43,43,0,0,Medical chart,NA,investigator initiated,NA,"Cefazolin (CEZ) was the most frequently used, followed by sulbactum/ampicillin (SBT/ABPC), ceftriaxone (CTRX), and cefepime (CFPM)",various,various,1,30,30 days after operation,postoperative infectious complications,0,0,0,1,0,0,0,hospital los,30,33,0,
27,29663044,Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study,2018,Intensive care med,adult,"Circulating PCT levels were sequentially assessed at inclusion (PCT-H0), at 6 h after inclusion (PCT-H6), and on days 1, 3 and 5 after inclusion. PCT levels were measured by Elecsys BRAHMS PCT immunoassay (Roche Diagnostics, Mannheim, Germany) using a cobas e411 analyzer, according to the manufacturer’s instructions.
 
 In the PCT group, the antibiotic treatment was guided by serum procalcitonin levels. The patients were classified into the following three groups based on the probability of bacterial infection, according to the PCT level, which was measured as described in previous reports [4–7] and our prospective pilot studies in the indicated setting [12, 13]: group 1, PCT < 0.1 μg/L, which indicated that no bacterial infection was present, and the initiation or continuation of antibiotics was strongly discouraged; group 2, PCT > 0.1 and < 0.25 μg/L, which indicated that bacterial infection was possible [12, 13], and the initiation or continuation of antibiotics was encouraged; and group 3, PCT > 0.25 μg/L, which indicated that bacterial infection was present, and the initiation or continuation of antibiotics was strongly encouraged. In addition, the investigators were encouraged to discontinue antibiotics when the PCT concentration was less than 90% of the peak concentration or an absolute concentration less than 0.1 μg/L was noted.",inflammatory markers,0,0,NA,acute exacerbations of COPD admitted to the ICU,Lower respiratory tract infection,0,302,ICU,France,high,NA,NA,5,5,stratified randomisation,non-inferiority,12,ITT,none,0,NA,NA,absolute difference,1,0,1,151,151,302,Not reported,Not reported,Not reported,Not reported,Not reported,NA,investigator initiated,clinical syndrome with laboratory test,"Antibiotic therapy during the first 48 h after inclusion included: cephalosporins (31%), macrolides (25%), antipseudomonal penicillins (19%), aminopenicillins (18%), and fluoroquinolones (5%). Patients with pneumonia received combination therapy in 88% of cases (52/64 in PCT group and 58/61 in control group, p = 0.013).",various,various,0,90,3 months after randomisation,all cause mortality,0,0,0,1,0,0,0,0,20,14,17,mortality not really a direct effect??
28,30264119,Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial,2018,JAMA,adult,algorithm-based therapy vs usual practice,treatment protocol,0,0,NA,Staph BSI,Bloodstream infection,1,509,inpatient,USA,high,NA,NA,4,6,simple randomization,non-inferiority,15,ITT,PP,0,0,NA,absolute difference,1,0,1,255,254,509,207,203,Not reported,Not reported,Not reported,NA,investigator initiated,culture of sterile site,The choice and duration of antibiotics in the usual practice group was determined by the treating physician,various,various,1,42,42 days beyond end of therapy for those with Staphylococcus aureus and 28 days for those with coagulase-negative staphylococcal bacteremia,clinical success,0,0,0,1,0,0,0,0,18,19,6,
29,28283830,Is 5 days of oral fluoroquinolone enough for acute uncomplicated pyelonephritis? The DTP randomized trial,2017,Eur J Clin Microbiol Infect Dis,adult,omparing 5 days to 10 days of fluoroquinolone treatment,arbitrary durations,0,0,NA,uncomplicated pyelonephritis,Urinary tract infection,0,100,outpatient,France,high,5,10,Not reported,Not reported,simple randomization,non-inferiority,not reported,ITT,none,0,NA,NA,absolute difference,1,1,0,49,51,88,23,20,Not reported,Not reported,Not reported,NA,investigator initiated,clinical syndrome,,Fluoroquinolone,Fluoroquinolone,1,30,30 days after end of treatment,clinical cure,0,0,0,1,1,0,0,0,7,5,0,
30,29153975,"Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial",2017,Lancet Haematology,adult,"For the experimental group, EAT was withdrawn after 72 h or more of apyrexia plus clinical recovery; for the control group, treatment was withdrawn when the neutrophil count was also 0·5 × 109 cells per L or higher.",treatment protocol,0,0,NA,febrile neutropenia,Prophylaxis (immunocompromised),0,157,inpatient,Spain,high,NA,NA,Not reported,Not reported,simple randomization,superiority,NA,ITT,PP,0,0,NA,duration of antibiotic free days,1,0,1,78,79,157,66,66,Not reported,Not reported,Not reported,NA,investigator initiated,clinical syndrome,antipseudomonal β-lactam drug as monotherapy or as combination therapy,various,various,0,30,median 30 days,duration of antibiotic free days,0,1,1,1,0,0,1,0,NA,NA,3,clinical outcomes reported were side effects of antibiotics 
31,28711318,"Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns)",2017,Lancet,neonate,"Using score to risk stratify for probability of infection (included population of patients with low risk of infection), then use procalcitonin",inflammatory markers,0,0,NA,early-onset sepsis,Lower respiratory tract infection,0,1710,ICU,"Netherlands, Switzerland, Canada, Czech",high,NA,NA,2,3,simple randomization,non-inferiority,2,ITT,mITT,1,1,long,absolute difference,1,0,1,866,844,1710,565,435,180,198,Medical chart,NA,investigator initiated,clinical syndrome,,various,various,1,30,first month of life,re-infection or death in the first month of life,1,0,0,1,0,0,0,hospital los,1,1,1,PP population analysed included those not adherent to the protocol. I have subtracted those numbers from the PP population (really should be mITT). Infection deemed unlikely in 42%
32,28666965,Individualizing duration of antibiotic therapy in community-acquired pneumonia,2017,Pulmonary Pharmacology & Therapeutics,adult,patients with CAP reaching clinical stability within 5 days after hospitalization were randomized to a standard vs. individualized antibiotic duration,treatment protocol,0,0,NA,CAP,Lower respiratory tract infection,0,260,inpatient,Italy,high,NA,NA,Not reported,Not reported,stratified randomisation,non-inferiority,5,ITT,PP,1,1,long,absolute difference,1,1,0,125,135,260,81,135,Not reported,Not reported,Not reported,NA,investigator initiated,clinical syndrome,,various,various,0,30,30 days following CAP diagnosis and including any of the following conditions: (1) pneumonia-related complications,"composite study outcome occurring within 30 days following CAP diagnosis and including any of the following conditions: (1) pneumonia-related complications (e.g., lung abscess, empyema); (2) clinical failure during hospitalization (definition in the online data supplement); (3) a new antibiotic course after discontinuation of antibiotic therapy prescribed for the pneumonia, (4) re-hospitalization from any reason; (5) death from any reason",1,0,0,1,0,0,1,hospital los,11,7,2,
33,28219190,Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment of sepsis patients,2017,Zhonghua Yi Xue Za Zhi,adult,"In the procalcitonin-guided group, a non-binding advice to discontinue antibiotics was provided if procalcitonin concentration had decreased by 90% or more of its peak value or to 0.25 μg/L or lower.In the regular antibiotic group, patients were treated according to principle of antimicrobial usage.",inflammatory markers,0,0,0,non-specific,Sepsis,0,156,ICU,China,high middle,NA,NA,8,10,missing,difference,NA,ITT,none,0,NA,NA,absolute difference,missing,missing,0,79,77,156,missing,misisng,misisng,misisng,misisng,NA,missing,clinical syndrome,Patients who received antibiotics for presumed infection according to principle of antimicrobial usage.,various,various,1,during hospitalisation,missing,missing,0,0,0,1,missing,missing,missing,hospital los,missing,missing,missing,only abstract available
34,28366170,"Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women",2017,BMC medicine,adult,receive antibiotic treatment for 7 or 14 days (the second week being ciprofloxacin 500 mg or placebo orally twice daily),arbitrary durations,1,0,NA,febrile UTI in man and women,Urinary tract infection,0,200,outpatient,Netherland,high,7,14,Not reported,Not reported,stratified randomisation,non-inferiority,10,ITT,PP,0,0,NA,absolute difference,1,1,0,97,103,194,92,93,Not reported,Not reported,Not reported,"loss to follow up, protocol deviation",investigator initiated,clinical syndrome with laboratory test,"The first week of treatment was open label. In the second week, treatment was continued double-blinded, with either ciprofloxacin 500 mg or placebo orally twice daily (identical capsules for placebo and ciprofloxacin were used), according to randomization code.. In inpatients, the treating physician could administer discretionary empirical intravenous antibiotics at the start of treatment according to local guidelines (in all participating centers: a β-lactam antibiotic ± aminoglycoside). These patients were switched as soon as deemed possible to open label oral ciprofloxacin (non-blinded) up to the seventh day after inclusion (equal to day of presentation with febrile UTI and start of antibiotic treatment).",ciprofloxacin,ciprofloxacin,1,18,primary endpoint was the clinical cure rate through the 10- to 18-day post-treatment visit with preset subgroup analysis including sex,clinical cure rate through the 10- to 18-day post-treatment visit with preset subgroup analysis including sex,0,0,0,1,1,0,1,0,6,7,0,"Women with fUTI can be treated successfully with antibiotics for 7 days. In men, 7 days of antibiotic treatment for fUTI is inferior to 14 days during short-term follow-up but it is non-inferior when looking at longer follow-up."
35,28398692,Seven versus 10 days antibiotic therapy for culture-proven neonatal sepsis: A randomised controlled trial,2017,J Paediatr Child Health,neonate,"Neonates, who had completed 5 days of appropriate antibiotic therapy (based on in vitro antibiotic sensitivity testing), were randomised at the end of day 5 to receive either 7 or 10 days duration of antibiotics, provided they were in clinical remission, not requiring FiO2 > 0.4, not requiring any inotropic support, without active bleeding and tolerating enteral feeds",arbitrary durations,0,0,NA,simple BSI with no source,Bloodstream infection,1,132,ICU,India,lower middle,7,10,Not reported,Not reported,simple randomization,non-inferiority,16,mITT,none,0,NA,NA,absolute difference,1,0,1,66,66,128,64,64,Not reported,Not reported,Not reported,loss to follow up,investigator initiated,culture of sterile site,Neonates with suspected sepsis were started on empirical antibiotic treatment (intravenous ceftriaxone and amikacin) as per the neonatal intensive care unit (NICU) protocol based on the culture-sensitivity patterns of bacterial isolates in our NICU from previous 2-year records. Antibiotics were revised according to the sensitivity pattern obtained between 48 and 72 h.,various,various,1,28,28 days of stopping antibiotics,"Treatment failure defined by the reappearance of signs and symptoms of sepsis within 28 days of stopping antibiotics, supported by the presence of a positive blood culture growing the same organism (with similar antibiogram) as cultured earlier. Any symptomatic sepsis episode within 28 days of stopping antibiotics with a reactive CRP (≥0.6 mg/dL) but a sterile blood culture was regarded as treatment failure if deemed so by the expert committee.",0,0,0,1,1,0,0,hospital los,2,2,0,
36,27455166,Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial,2016,JAMA Intern Med,adult,"treated with antibiotics for a minimum of 5 days, and the antibiotic treatment was stopped at this point if their body temperature was 37.8°C or less for 48 hours and they had no more than 1 CAP-associated sign of clinical instability, defined as systolic blood pressure less than 90 mm Hg, heart rate greater than 100/min, respiratory rate greater than 24 /min, arterial oxygen saturation less than 90%, or Pao2 less than 60 mm Hg in room air",treatment protocol,0,0,NA,CAP,Lower respiratory tract infection,0,312,inpatient,Spain,high,NA,NA,5,10,simple randomization,non-inferiority,3,ITT,PP,0,0,NA,absolute difference,1,0,1,162,150,312,146,137,6,Not reported,Medical chart,NA,investigator initiated,clinical syndrome,"In both groups, antibiotic type was chosen empirically by physicians according to local guidelines. ",various,various,0,10,day 10 and late follow-up (day 30) since admission,CAP symptom questionnaire mean score,0,0,0,1,0,0,1,0,8,11,2,clinical success at day 30 taken as clinical outcome
37,27524103,Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial,2016,Int J Antimicrob Agents,adult,"randomised to receive 8 weeks of treatment (short schedule) versus a long schedule (3 months or 6 months for hip or knee prostheses, respectively).",arbitrary durations,0,1,0,early post-surgical or haematogenous staphylococcal PJI - hip,Bone and prosthetics infection,1,29,inpatient,Spain,high,56,90,Not reported,Not reported,simple randomization,non-inferiority,15,ITT,PP,0,0,NA,absolute difference,1,1,0,18,11,29,not reported,not reported,not reported,not reported,Not reported,NA,investigator initiated,"clinical syndrome, culture","Treatment consisted of the combination of rifampicin (600 mg once daily, after fasting) [10] and levofloxacin (750 mg once daily). The oral route was preferred as soon as the patient could tolerate it. In the case of polymicrobial infections, other antibiotics could also be used provided they had no antistaphylococcal activity (i.e. aztreonam, ceftazidime).","Levofloxacin, rifampicin","Levofloxacin, rifampicin",1,540,Median follow-up was 540 days,cure rate.,0,0,0,1,0,0,0,0,18,44,0,hip prosthesis
37,27524103,Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial,2016,Int J Antimicrob Agents,adult,"randomised to receive 8 weeks of treatment (short schedule) versus a long schedule (3 months or 6 months for hip or knee prostheses, respectively).",arbitrary durations,0,1,0,early post-surgical or haematogenous staphylococcal PJI - knee,Bone and prosthetics infection,1,34,inpatient,Spain,high,56,180,Not reported,Not reported,simple randomization,non-inferiority,15,ITT,PP,0,0,NA,absolute difference,1,1,0,15,19,34,not reported,not reported,not reported,not reported,Not reported,NA,investigator initiated,"clinical syndrome, culture","Treatment consisted of the combination of rifampicin (600 mg once daily, after fasting) [10] and levofloxacin (750 mg once daily). The oral route was preferred as soon as the patient could tolerate it. In the case of polymicrobial infections, other antibiotics could also be used provided they had no antistaphylococcal activity (i.e. aztreonam, ceftazidime).","Levofloxacin, rifampicin","Levofloxacin, rifampicin",1,540,Median follow-up was 540 days,cure rate.,0,0,0,1,0,0,0,0,32,40,0,knee prosthesis
38,26947523,"Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial",2016,Lancet infectious disease,adult,receive either procalcitonin-guided or standard-of-care antibiotic discontinuation,inflammatory markers,0,0,NA,"Critically ill patients aged at least 18 years, admitted to the ICU, and who received their first dose of antibiotics no longer than 24 h before inclusion in the study for an assumed or proven infection were eligible to participate.",Sepsis,0,1575,ICU,Netherland,high,NA,NA,5,7,stratified randomisation,non-inferiority,8,mITT,PP,0,0,NA,absolute difference,1,0,1,776,799,1546,538,457,NA,NA,Medical chart,"loss to follow up, protocol deviation",Thermo Fisher Scientific,"clinical syndrome, culture",,various,various,1,28,"Patients were followed up for 1 year after entering the study, allowing assessment of 28-day and 1-year mortality.",consumption of antibiotics (expressed as defined daily doses) and duration of antibiotic treatment (defined as the number of 24 h periods between start and end of antibiotic treatment) in in the two groups for all randomised patients who were not excluded (the modified intention-to-treat population).,0,1,1,1,0,0,0,"hospital los, direct costs",20,25,23,56% did not stop abx in the PCT arm within 24 hours. mortality at day 28 taken as clinical outcome
39,28002709,Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children,2016,NEJM,children,"10-day course of amoxicillin–clavulanate at a total daily dose of 90 mg of amoxicillin and 6.4 mg of clavulanate per kilogram of body weight, provided in two bottles (for days 1 to 5 and days 6 to 10), or a 5-day course of amoxicillin–clavulanate (provided in one bottle) followed by a 5-day course of placebo (provided in a second bottle)",arbitrary durations,0,0,NA,Otitis media,Upper respiratory tract infection,0,520,outpatient,USA,high,5,10,Not reported,Not reported,stratified randomisation,non-inferiority,10,ITT,PP,1,1,long,absolute difference,1,0,1,258,257,515,Not reported,Not reported,Not reported,Not reported,Self reporting,did not fulfill inclusion criteria,investigator initiated,clinical syndrome,"either a 10-day course of amoxicillin–clavulanate at a total daily dose of 90 mg of amoxicillin and 6.4 mg of clavulanate per kilogram of body weight, provided in two bottles (for days 1 to 5 and days 6 to 10), or a 5-day course of amoxicillin–clavulanate (provided in one bottle) followed by a 5-day course of placebo (provided in a second bottle).",Amxocillin/clav,Amxocillin/clav,0,14,"We assessed children on day 4, 5, or 6 by means of telephone conversations with the parents and at an end-of-treatment office visit, usually on day 12, 13, or 14",the percentage of children who had clinical failure after treatment of the index infection,0,0,0,1,1,1,1,0,34,16,0,"Of 470 children for whom medication data for the index episode were available, 435 (93%) reportedly received all scheduled medication doses during the first 3 days of treatment, and 418 (89%) also received at least 80% of doses overall."
40,26611777,A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection,2016,CID,adult,a single intravenous infusion of 1500 mg of dalbavancin over 30 minutes or in 2 doses as 1000 mg intravenously over 30 minutes followed 1 week later by 500 mg intravenously,arbitrary durations,1,0,NA,Acute bacterial skin and skin structure infections,Skin and soft tissue infection,0,698,inpatient,"United States, Eastern Europe, Russia, and South Africa","high, high middle, low middle",1,7,NA,NA,stratified randomisation,non-inferiority,10,ITT,PP,0,0,NA,absolute difference,1,0,1,349,349,698,271,267,0,2,Medical chart,NA,Durata Therapeutics and Allergan plc,clinical syndrome,,dalbavancin,dalbavancin,1,3,The primary endpoint was a ≥20% reduction in the area of erythema at 48–72 hours in the intent-to-treat population.,≥20% reduction in the area of erythema at 48–72 hours in the intent-to-treat population,0,0,0,1,1,0,1,hospital los,19,16,0,"Dalbavancin is a lipoglycopeptide antibiotic with activity against the gram-positive pathogens responsible for ABSSSI, including MRSA. Its pharmacokinetic/pharmacodynamic properties would predict that larger doses given early in the course of therapy would be most beneficial [6, 7]. Currently approved therapy is given as 2 doses 1 week apart, a regimen made possible by its terminal half-life of 15.5 days."
41,27382274,Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD,2016,Int J Chron Obstruct Pulmon Dis,adult,initiation or continuation of antibiotics was strongly discouraged if PCT was 0.15 ng/mL or lower and discouraged if levels were between 0.15 ng/mL and 0.25 ng/mL. Initiation or continuation of antibiotics was encouraged if PCT was >0.25 ng/mL,inflammatory markers,0,0,NA,acute exacerbations of COPD,Lower respiratory tract infection,0,120,inpatient,Denmark,high,NA,NA,4,9,simple randomization,difference,NA,ITT,PP,0,0,NA,absolute difference,1,0,1,62,58,120,38,46,24,0,Medical chart,NA,bioMérieux,clinical syndrome,"The empiric first choice of antibiotic drug followed local guidelines in both groups, namely oral amoxicillin clavulanate in clinically stable patients and intravenous piperacillin/tazobactam in unstable patients",various,various,0,28,28 days after inclusion,"fraction of patients using antibiotics for ≥5 days within 28 days after inclusion, which was evaluated by overall antibiotic exposure",0,1,1,1,0,0,1,hospital los,35,26,3,Composite adverse events taken as clinical outcome
42,25468170,"Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial",2015,Lancet,adult,6 weeks or 12 weeks of antibiotic treatment (encompassing any parenteral and oral periods of treatment).,arbitrary durations,0,0,NA,pyogenic vertebral osteomyelitis,Bone and prosthetics infection,1,359,inpatient,France,high,42,84,42,84,stratified randomisation,non-inferiority,10,mITT,PP,0,0,NA,absolute difference,1,0,1,176,175,351,146,137,0,16,Medical chart,"loss to follow up, protocol deviation",investigator initiated,culture of sterile site,"The most frequently used antibiotics were oral fluoroquinolones or rifampicin or a combination of both in 253 (72%) patients, followed by oral aminopenicillin (98 [28%] patients; table 4). Parenteral meticillin (133 [38%] patients) and aminoglycosides (213 [61%]) were used during the initial intravenous phase of treatment",various,various,1,365,cured at 1 year by a masked independent validation committee,"proportion of patients who were classified as cured at 1 year by a masked independent validation committee, analysed by intention to treat",0,0,0,1,0,0,1,0,9,9,7,
43,25658564,Postprescription review improves in-hospital antibiotic use: a multicenter randomized controlled trial,2015,Clin Microbiol Infect,adult,"postprescription review and
 advice from the ASP IDP experts",ASP (ID physician or electronic programmes),0,0,NA,non-specific,non-specific,0,246,inpatient,France,high,NA,NA,7,10,stratified randomisation,difference,NA,ITT,none,0,NA,NA,absolute difference,1,0,1,123,123,246,116,123,7,0,Medical chart,NA,investigator initiated,"clinical syndrome, culture",,various,various,1,NA,"appropriateness of antimicrobial therapy, a composite score of appropriateness of
 antibiotic use at days 3 to 4 and appropriate treatment duration, adjudicated by a blinded committee","appropriateness of antimicrobial therapy, a composite score of appropriateness of
 antibiotic use at days 3 to 4 and appropriate treatment duration, adjudicated by a blinded committee",1,1,1,1,0,0,0,direct and indirect costs,19,23,1,clinical improvement at day 3 taken as clinical outcome
44,25934044,Procalcitonin and pyuria-based algorithm reduces antibiotic use in urinary tract infections: a randomized controlled trial,2015,BMC medicine,adult,antibiotic duration was based on absolute PCT-values and relative decreases of PCT-levels,inflammatory markers,0,0,NA,community-acquired non-catheter-related UTI,Urinary tract infection,0,143,inpatient,Switzerland,high,NA,NA,7,10,simple randomization,non-inferiority,not reported,ITT,PP,0,0,NA,absolute difference,1,1,0,63,55,118,61,54,Not reported,Not reported,Not reported,"loss to follow up, protocol deviation",investigator initiated,clinical syndrome with laboratory test,Procalcitonin and pyuria-based algorithm reduces antibiotic use in urinary tract infections: a randomized controlled trial,various,various,1,90,All endpoints were assessed at discharge from hospital and 30 and 90 days after enrollment through standardized telephone interviews by blinded members of the study team.,overall antibiotic exposure within 90 days,0,1,1,1,1,0,0,0,25,22,4,feasibility study. Recurrence taken as clinical end point
45,25992746,Trial of short-course antimicrobial therapy for intraabdominal infection,2015,NEJM,adult,"receive antibiotics until 2 days after the resolution of fever, leukocytosis, and ileus, with a maximum of 10 days of therapy (control group), or to receive a fixed course of antibiotics (experimental group) for 4±1 calendar days",arbitrary durations,0,1,1,complicated intraabdominal infection and adequate source control,Abdominal infection,1,518,inpatient,USA,high,4,NA,4,8,simple randomization,difference,10,ITT,PP,0,0,NA,absolute difference,1,0,1,258,260,518,211,189,47,36,Medical chart,withdrew consent,investigator initiated,"clinical syndrome, culture",,various,various,1,30,NA,a surgical-site infection or recurrent intraabdominal infection developed or in whom death occurred within 30 days after the index source-control procedure,1,0,0,1,1,0,1,hospital los,22,22,1,
46,25760346,Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial,2015,Plos One,adult,"Patients randomized to the standard group continued antibiotic therapy for 10 days, whereas patients randomized to the PCT group either continued treatment for 10 days or stopped on Day 3, depending on their PCT levels, according to previously recommended cut-off values",inflammatory markers,0,0,NA,Severe Exacerbations of Chronic Obstructive Pulmonary Disease,Lower respiratory tract infection,0,183,inpatient,Italy,high,NA,NA,3,10,stratified randomisation,non-inferiority,15,ITT,none,1,1,long,absolute difference,1,1,0,93,90,178,45,90,43,0,Medical chart,loss to follow up,investigator initiated,clinical syndrome,all patients received a 3-day course of antibiotics (either amoxicillin plus clavulanate or quinolones),"amoxicillin plus clavulanate, quinolones","amoxicillin plus clavulanate, quinolones",0,180,"Follow-up visits were scheduled on Day 1, Day 3, and 6 months after discharge; telephone interviews were conducted at 2, 4, and 5 months after discharge.",rate of ECOPD at 6 months,0,0,0,1,0,0,1,hospital los,32,28,3,
47,25681965,Evaluation of duration of antibiotic therapy in neonatal bacterial meningitis: a randomized controlled trial,2015,J Tropical Paed,neonate,10 days (study group) or 14 days (control group) of antibiotics,arbitrary durations,0,0,NA,Meningitis,Meningitis,1,70,inpatient,India,lower middle,10,14,not reported,not reported,simple randomization,not reported,NA,ITT,none,0,NA,NA,absolute difference,0,1,0,35,35,70,35,35,Not reported,Not reported,Not reported,NA,investigator initiated,"clinical syndrome, culture",,various,various,1,28,treatment failure in each group within 28 days of enrolment,treatment failure in each group within 28 days of enrolment,0,0,0,1,0,0,0,0,0,0,0,
48,26248828,Can We Stop Antibiotic Therapy When Signs and Symptoms Have Resolved in Diabetic Foot Infection Patients?,2015,Int J Low Extrem Wounds,adult,continuing antibiotics group (CAG) and discontinuing antibiotics group,treatment protocol,0,1,1,Diabetic Foot Infection,Bone and prosthetics infection,1,375,inpatient,China,high middle,NA,NA,not reported,not reported,simple randomization,not reported,NA,ITT,none,0,NA,NA,absolute difference,0,NA,0,191,184,375,Not reported,Not reported,Not reported,Not reported,Not reported,NA,investigator initiated,"clinical syndrome, culture",,various,various,1,120,"Patients were followed-up as outpatients after discharge
 at 1week, 1 month, and 3 months, and the clinical outcomes",Not reported,0,0,0,1,0,0,0,0,29,16,0,Recurrence taken as clinical outcome
49,26288467,Comparative evaluation of 2 g single dose versus conventional dose azithromycin in uncomplicated skin and skin structure infections,2015,Indian J Pharmacol,adult,One group (n = 146) received 2 g single supervised dose while the other (n = 146) received conventional dose of 500 mg once daily for 5 days.,arbitrary durations,0,0,NA,Uncomplicated skin and skin structure infections,Skin and soft tissue infection,0,294,outpatient,India,lower middle,1,5,not reported,not reported,simple randomization,difference,NA,mITT,none,0,NA,NA,absolute difference,1,0,1,148,146,294,148,126,0,20,Direct observation,loss to follow up,investigator initiated,clinical syndrome,,Azithromycin,Azithromycin,0,7,Subjects were followed up on day 4 and day 8.,"Complete clinical cure implied complete healing of lesions, without residual signs or symptoms, within 7 days",0,0,0,1,0,0,1,0,2,1,0,
50,26695667,[Value of serum procalcitonin for the guidance of antibiotic therapy in children with lower respiratory tract infection],2015,Chin J Contemp Pediatr,children,antibiotic therapy was guided by serum PCT level,inflammatory markers,0,0,NA,LRTI,Lower respiratory tract infection,0,396,inpatient,China,high middle,NA,NA,4,6,simple randomization,not reported,NA,ITT,none,0,NA,NA,absolute difference,0,NA,0,198,198,396,Not reported,Not reported,Not reported,Not reported,Not reported,NA,investigator initiated,clinical syndrome,,various,various,0,14,,Not reported,0,0,0,1,0,0,1,hospital los,62,60,0,Hospitalisation taken as clinical end point
51,25294250,Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study,2015,CID,adult,single intravenous 1200-mg dose of oritavancin or 7–10 days of twice-daily vancomycin,arbitrary durations,1,0,NA,acute bacterial skin and skin structure infections,Skin and soft tissue infection,0,1019,inpatient,"India, Russia, Argentina, USA, Romania, Ukraine, Spain,Mexico, Israel (but majority from USA)","high, high middle, lower middle",1,8,1,8,stratified randomisation,non-inferiority,10,ITT,PP,0,0,NA,absolute difference,1,0,1,509,510,1005,427,408,0,35,Medical chart,loss to follow up,The Medicines Company,clinical syndrome,,oritavancin,vancomycin,0,3,"primary composite endpoint at 48–72 hours (cessation of spreading or reduction in lesion size, absence of fever, and no rescue antibiotic)","primary composite endpoint at 48–72 hours (cessation of spreading or reduction in lesion size, absence of fever, and no rescue antibiotic)",1,0,0,1,0,0,1,0,20,17,0,
52,25414157,Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study,2015,Diabetes care,adult,comparing 6- versus 12-week duration of antibiotic treatment,arbitrary durations,0,0,NA,Nonsurgically Treated Diabetic Foot Osteomyelitis,Bone and prosthetics infection,1,40,inpatient,France,high,42,84,Not reported,Not reported,simple randomization,difference,NA,ITT,none,0,NA,NA,absolute difference,0,NA,0,20,20,40,Not reported,Not reported,Not reported,Not reported,Not reported,NA,investigator initiated,"clinical syndrome, culture","Rifampin was the antibiotic agent most frequently used (27 patients; 67.5%), followed by fluoroquinolone (especially levofloxacin) in 28 patients (70%).",various,various,1,365,"Remission of osteomyelitis during the monitoring period was defined as complete and persistent (>4 weeks) healing of the wound (if present initially), absence of recurrent infection at the initial site or that of adjacent rays, and no need for surgical bone resection or amputation at the end of a follow-up period of at least 12 months after completion of antibiotic treatment.","Remission of osteomyelitis during the monitoring period was defined as complete and persistent (>4 weeks) healing of the wound (if present initially), absence of recurrent infection at the initial site or that of adjacent rays, and no need for surgical bone resection or amputation at the end of a follow-up period of at least 12 months after completion of antibiotic treatment.",0,0,0,1,0,0,1,hospital los,40,30,0,
53,25263498,"Single-dose compared with multiple day antibiotic prophylaxis for cesarean section in low-resource settings, a randomized controlled, noninferiority trial",2015,Obs and Gynae,adult,single prophylactic dose of ampicillin combined with metronidazole to prevent postcesarean section infections compared with a multiple day regimen,arbitrary durations,0,0,NA,postcesarean section,Prophylaxis (post-surgery),0,181,inpatient,Tazania,lower middle,1 dose,5,Not reported,Not reported,simple randomization,non-inferiority,10,ITT,none,0,NA,NA,absolute difference,1,0,1,89,87,176,Not reported,Not reported,Not reported,Not reported,Not reported,NA,investigator initiated,NA,,ampicillin and metronidazole,ampicillin and metronidazole,0,during hospitalisation,,maternal postcesarean infection,0,0,0,1,0,0,0,hospital los,7,10,0,
54,23989106,"Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial",2014,Pediatric Infectious Disease Journal,children,clinical and laboratory outcomes of a 3-day or a 5-day to a 10-day treatment in young children with community-acquired alveolar pneumonia.,arbitrary durations,1,0,NA,CAP,Lower respiratory tract infection,0,22,outpatient,Israel,high,3,10,Not reported,Not reported,simple randomization,non-inferiority,10,PP,none,NA,1,Long,absolute difference,1,1,0,13,12,22,Not reported,Not reported,Not reported,Not reported,Not reported,"loss to follow up, protocol deviation",investigator initiated,clinical syndrome,,Amxocillin,Amxocillin,0,30,Scheduled visits were on days 4–5 and 10–14 with daily telephone interviews for 30 days.,need for a rescue treatment or hospitalization,1,0,0,1,0,0,0,0,40,0,0,
54,23989106,"Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial",2014,Pediatric Infectious Disease Journal,children,clinical and laboratory outcomes of a 3-day or a 5-day to a 10-day treatment in young children with community-acquired alveolar pneumonia.,arbitrary durations,1,0,NA,CAP,Lower respiratory tract infection,0,115,outpatient,Israel,high,5,10,Not reported,Not reported,simple randomization,non-inferiority,10,PP,none,NA,0,NA,absolute difference,1,0,1,56,59,115,Not reported,Not reported,Not reported,Not reported,Not reported,"loss to follow up, protocol deviation",investigator initiated,clinical syndrome,,Amxocillin,Amxocillin,0,30,Scheduled visits were on days 4–5 and 10–14 with daily telephone interviews for 30 days.,need for a rescue treatment or hospitalization,1,0,0,1,0,0,0,0,0,0,0,
55,24035770,Short versus long course of antibiotics for catheter-associated urinary tract infections in patients with spinal cord injury: A randomized controlled noninferiority trial,2014,Archives of physical medicine and rehab,adult,5-day regimen of antibiotics after catheter exchange (experimental group) or a 10-day regimen of antibiotics with catheter retention (control group),arbitrary durations,0,1,0,catheter-associated urinary tract infection (CA-UTI) in patients with spinal cord injury,Urinary tract infection,0,61,inpatient,USA,high,5,10,Not reported,Not reported,simple randomization,non-inferiority,10,PP,none,NA,0,NA,absolute difference,1,0,1,28,27,55,Not reported,Not reported,Not reported,Not reported,Not reported,protocol deviation,investigator initiated,"clinical syndrome, culture","We standardized the choice of empirical antibiotics to include an oral fluoroquinolone (for gram-negative bacteria) and amoxicillin (for gram-positive bacteria, namely the enterococci). Patients who either were allergic to fluoroquinolone and penicillin or could not take oral antibiotics received intravenous aztreonam (for gram-negative bacteria) and vancomycin (for gram-positive bacteria). In selected patients with previous history of UTI caused by antibiotic-resistant organisms, empirical antibiotic regimens were chosen according to the previous culture results.",various,various,1,10,end of treatment,Clinical cure at the end of therapy,0,0,0,1,1,0,1,0,18,11,0,Comparing catheter removal in short arm and with retention in long arm
56,25331236,Antibiotic prophylaxis for transrectal prostate biopsy: a comparison of one-day and five-day regimen,2014,Niger Postgrad Med J,adult,"oral ciprofloxacin (500mg, 12 hourly) and oral metronidazole (400mg, 8 hourly) for 1 day while those in group II (N=45) received same antibiotic combination for 5 days.",arbitrary durations,0,0,NA,prostate transection,Prophylaxis (post-surgery),0,87,inpatient,Benin,lower middle,1,5,missing,missing,simple randomization,difference,NA,ITT,none,0,NA,NA,absolute difference,missing,missing,0,42,45,87,missing,missing,missing,missing,missing,missing,investigator initiated,NA,,"ciprofloxacin, metronidazole","ciprofloxacin, metronidazole",0,5,5 days after procedure,Post biopsy fever and positive urine cultures were indicative of infection.,0,0,0,1,1,0,0,0,21,18,0,only abstract available
57,24636266,Procalcitonin-guided antibiotic therapy in aspiration pneumonia and an assessment of the continuation of oral intake,2014,Respiratory invest,adult,different durations of antibiotic therapy based on the procalcitonin levels upon admission (procalcitonin group) or according to the standard guidelines (control group),inflammatory markers,0,0,NA,aspiration pneumonia,Lower respiratory tract infection,0,105,inpatient,Japan,high,NA,NA,5,8,simple randomization,non-inferiority,10,ITT,none,0,NA,NA,absolute difference,1,0,1,53,52,96,Not reported,Not reported,Not reported,Not reported,Not reported,"withdrew consent, protocol deviation",investigator initiated,clinical syndrome,"In both groups, the choice of antibiotic regimen was left to the discretion of the treating physician.",various,various,0,30,relapse of aspiration pneumonia and death within 30 days,relapse of aspiration pneumonia and death within 30 days,0,0,0,1,0,0,0,0,25,38,16,
58,24909499,"Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial",2014,Lancet infectious disease,adult,"intravenous once-daily tedizolid (200 mg for 6 days) or twice-daily linezolid (600 mg for 10 days), with optional oral step-down",arbitrary durations,1,0,NA,acute bacterial skin and skin-structure infections,Skin and soft tissue infection,0,666,inpatient,"Argentina, Australia, Germany, New Zealand, Poland, Russia, South Africa, Spain, and the USA","high, high middle",6,10,Not reported,Not reported,stratified randomisation,non-inferiority,10,ITT,none,0,NA,NA,absolute difference,1,0,1,332,334,666,290,298,11,23,Medical chart,"loss to follow-up, protocol deviation",Cubist Pharmaceuticals,"clinical syndrome, culture",,tedizolid,linezolid,1,3,early clinical response (≥20% reduction in lesion area at 48–72 h compared with baseline),early clinical response (≥20% reduction in lesion area at 48–72 h compared with baseline),0,0,0,1,0,0,1,0,15,17,0,
59,25130297,A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia,2014,Diagn Microbiol Infect Dis,adult,levofloxacin 750 mg for 5 days versus 500 mg for 7-14 days intravenous (IV),arbitrary durations,0,0,NA,CAP,Lower respiratory tract infection,0,241,inpatient,China,high middle,5,7-14,5,9,simple randomization,non-inferiority,10,mITT,PP,0,0,NA,absolute difference,0,NA,0,121,120,223,107,104,Not reported,not reported,Medical chart,"loss to follow-up, protocol deviation",Daichii,clinical syndrome,,levofloxacin ,levofloxacin ,0,28,7–14 days after last dose,cure  ,0,0,0,1,1,0,1,0,14,15,0,
60,25295709,Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial,2014,American Journal of Respiratory and Critical Care Medicine,adult,"PCT was measured daily while in the ICU. A PCT algorithm, including 0.1 ng/ml cut-off, determined antibiotic cessation.",inflammatory markers,0,0,NA,Undifferentiated Infection or Suspected Sepsis,Sepsis,0,400,ICU,Australia,high,NA,NA,9,11,stratified randomisation,superiority,NA,ITT,none,0,NA,NA,absolute difference,1,0,1,196,198,394,Not reported,Not reported,Not reported,Not reported,Medical chart,withdrew consent,investigator initiated,clinical syndrome,,various,various,1,28,cumulative number of antibiotics treatment days at Day 28,cumulative number of antibiotics treatment days at Day 28,0,1,1,1,1,0,0,hospital los,18,16,17,90 day all cause mortality taken as clinical outcome
61,24130347,Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial,2013,Diabetes care,adult,"the antibiotics group (AG) and the surgical group (SG). Antibiotics
were given for a period of 90 days in the AG. Patients in the SG received conservative surgery with postoperative antibiotic treatment for 10 days.",arbitrary durations,0,1,0,diabetic Foot Infection,Bone and prosthetics infection,1,52,inpatient,Spain,high,10,90,Not reported,Not reported,simple randomization,difference,NA,mITT,none,0,NA,NA,absolute difference,0,NA,0,27,25,46,27,25,0,9,medical chart,loss to follow up,investigator initiated,"clinical syndrome, culture",three regimens: ciprofloxacin 500 mg b.i.d.; amoxicillin/clavulanic acid 875/125 mg b.i.d.; or trimethoprim 160 mg/sulfamethoxazole 800 mg b.i.d. The antibiotic regimen was modified according to the results of an antibiogram.,various,various,1,84,12 weeks after healing,healing,0,0,0,1,0,0,1,0,14,25,0,
62,23403680,Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial,2013,JAMA,adult,200 mg once daily dose of oral tedizolid phosphate for 6 days or 600 mg of oral linezolid every 12 hours for 10 days,arbitrary durations,1,1,1,acute bacterial skin and skin structure infections,Skin and soft tissue infection,0,667,inpatient,USA,high,6,10,Not reported,Not reported,stratified randomisation,non-inferiority,10,mITT,PP,0,0,NA,absolute difference,1,0,1,332,335,667,279,280,not reported,not reported,Not reported,"loss to follow up, withdrew consent",Trius Therapeutics,"clinical syndrome, culture",,Tedizolid,Linezolid,0,3,early clinical response at the 48- to 72-hour assessment in the ITT analysis set,early clinical response at the 48- to 72-hour assessment in the ITT analysis set,0,0,0,1,0,0,1,0,30,30,0,
63,23936304,Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial,2013,Plos One,children,receive antibiotics either according to a PCT guidance algorithm established for adult LRTI or standard care clinical guidelines,inflammatory markers,0,0,NA,LRTI,Lower respiratory tract infection,0,337,inpatient,Switzerland,high,NA,NA,5,6,stratified randomisation,difference,NA,ITT,none,0,NA,NA,absolute difference,1,0,1,168,169,337,Not reported,Not reported,Not reported,Not reported,Medical chart,NA,investigator initiated,clinical syndrome,,various,various,0,14,antibiotic prescibing rate within 14 days of randomization,"duration of antibiotic
 treatment, days",0,1,1,1,0,0,1,hospital los,62,60,0,hospitalisation taken as clinical end point
64,22760341,Comparison of clinical efficacy between 3-day combined clavulanate/ amoxicillin preparation treatment and 10-day amoxicillin treatment in children with pharyngolaryngitis or tonsillitis,2013,J infect chemo,children,3-day combined clavulanate/ amoxicillin preparation treatment and 10-day amoxicillin treatment,arbitrary durations,0,0,NA,"children with pharyngolaryngitis
or tonsillitis",Upper respiratory tract infection,0,119,outpatient,Japan,high,3,10,Not reported,Not reported,simple randomization,equivalence,not reported,ITT,none,0,NA,NA,absolute difference,0,NA,0,54,42,96,Not reported,Not reported,Not reported,Not reported,Not reported,NA,investigator initiated,clinical syndrome,"3-day treatment with a combined (Clavamox combination dry syrup for pediatric) at a dose level of 96.4 mg/kg/day (CVA 6.4 mg/kg/day, AMPC 90 mg/kg/day) in two divided doses
10-day treatment with AMPC (e.g., Widecillin, Sawacillin) at a dose level of 30 mg/kg/dayin three divided doses",amoxicillin plus clavulanate,amoxicillin,0,10,end of treatment,"Clinical efficacy was rated on a four-category scale
 (markedly effective, effective, slightly effective, or ineffective) using the Criteria for Judgment in Clinical Studies
 of Antimicrobial Drugs in the Field of Pediatrics",0,0,0,1,1,1,1,0,2,7,0,
65,23153410,Clinical impact of unsolicited post-prescription antibiotic review in surgical and medical wards: a randomized controlled trial,2013,Clin Microbiol Infect,adult,"systematic and unsolicited postprescription antibiotic review. Seven hundred and fifty-three adult patients receiving antibiotic therapy for 3–5 days were randomized to receive either a post-prescription review by the infectious disease physician (IDP), followed by a recommendation to the attending physician to modify the prescription when appropriate, or no systematic review of the prescription",ASP (ID physician or electronic programmes),0,0,NA,non-specific,non-specific,0,854,inpatient,France,high,NA,NA,6,7,simple randomization,superiority,NA,PP,none,NA,0,NA,absolute difference,1,0,1,424,430,753,376,377,0,11,Medical chart,protocol deviation,investigator initiated,clinical syndrome,,various,various,1,during hospitalisation,,length of hospital stay (the primary outcome),0,1,1,1,0,0,0,hospital los,10,10,10,60 days in hospital mortality taken as clinical end point
66,23010339,A pilot randomised controlled trial in intensive care patients comparing 7 days' treatment with empirical antibiotics with 2 days' treatment for hospital-acquired infection of unknown origin,2012,Health Technol Assess,adult,Broad-spectrum antibiotic treatment administered for 48 hours (experimental) compared with treatment for 7 days (control),arbitrary durations,0,0,NA,hospital-acquired infection of unknown origin,non-specific,0,46,ICU,UK,high,2,7,Not reported,Not reported,simple randomization,not reported,NA,ITT,none,0,NA,NA,absolute difference,1,0,0,23,23,46,23,22,0,3,Medical chart,NA,investigator initiated,clinical syndrome,Teicoplanin or meropenem,various,various,0,7,end of treatment,composite outcome of the rate of death or initiation of antibiotic therapy after the completion of the treatment schedule allocated at randomisation,1,0,0,1,0,0,1,"hospital los, direct costs, indirect costs",17,13,9,Need for further antibiotics taken as clinical outcome
67,22555328,[5 days Cefaclor vs. 10 days amoxicillin/clavulanate in the treatment of childhood streptococcal pharyngitis. Data from a randomized clinical trial],2012,Minerva Pediatr,children,"received Cefaclor, 50 mg/kg/day, administered twice daily for five days, whilst 213 children received amoxicillin/clavulanate 40 mg/kg/day administered twice daily for 10 days",arbitrary durations,0,0,NA,streptococcal pharyngitis,Upper respiratory tract infection,0,435,outpatient,Italy,high,5,10,missing,missing,missing,missing,missing,mITT,none,0,NA,NA,absolute difference,missing,missing,0,210,213,423,missing,missing,missing,missing,missing,missing,missing,missing,,cefaclor,amoxicillin/clavulanate,missing,missing,missing,eradication,0,1,0,1,1,0,missing,missing,8,3,0,only abstract available
68,22485232,Procalcitonin is a good tool to guide duration of antibiotic therapy in patients with severe acute pancreatitis. A randomized prospective single-center controlled trial.,2012,Saudi Med J,adult,"Antibiotic therapy in the study group was not applied until clinical signs and symptoms of infection appeared (PCT value was >0.5ng/ml). We discontinued the antibiotic therapy if clinical signs and symptoms of infection improved and PCT was <0.5ng/ml over 3 days. In the control group, antibiotic therapy was administrated for 2 weeks, or antibiotic therapy was continued because of confirmed infection until clinical signs and symptoms of infection disappeared over 3 days.",inflammatory markers,0,0,NA,severe acute pancreatitis,Abdominal infection,0,71,ICU,China,high middle,NA,14,11,16,simple randomization,not reported,NA,ITT,none,0,NA,NA,absolute difference,0,NA,0,35,36,71,Not reported,Not reported,Not reported,Not reported,Medical chart,NA,investigator initiated,clinical syndrome with laboratory test,,various,various,0,during hospitalisation,not stated,Not reported,0,0,0,1,0,0,0,"hospital los, direct costs",20,22,21,Case fatality taken as clinical outcome
69,23102084,A prospective randomized study to assess the optimal duration of intravenous antimicrobial prophylaxis in elective gastric cancer surgery,2012,Int Surg,adult,single-dose versus multiple-dose antimicrobial prophylaxis in terms of the incidence of surgical-site infection in gastric cancer surgery.,arbitrary durations,0,0,NA,prophylaxis in elective gastric cancer surgery,Prophylaxis (post-surgery),0,325,inpatient,Japan,high,1 dose,3,Not reported,Not reported,simple randomization,non-inferiority,8,ITT,none,0,NA,NA,absolute difference,1,0,1,164,161,325,Not reported,Not reported,Not reported,Not reported,Not reported,NA,investigator initiated,clinical syndrome,single-dose cefazolin (1 g) during surgery (single-dose group) or an additional 5 doses every 12 hours postoperatively (multiple-dose group).,cefazolin,cefazolin,0,30,30 days after the surgery,SSIs,0,0,0,1,1,0,0,0,9,6,0,
70,22726802,"Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial",2012,Lancet,adult,ciprofloxacin for 7 days and 14 days in women with community-acquired acute pyelonephritis.,arbitrary durations,1,0,NA,acute pyelonephritis,Urinary tract infection,0,248,outpatient,Sweden,high,7,14,Not reported,Not reported,simple randomization,non-inferiority,10,PP,none,NA,0,NA,absolute difference,1,0,1,83,73,156,Not reported,Not reported,Not reported,Not reported,Not reported,protocol deviation,investigator initiated,"clinical syndrome, culture",,Ciprofloxacin,Ciprofloxacin,1,60,"10–14 days after the end of treatment with ciprofloxacin. Since the second week of treatment was masked, each patient had to be seen at two early visits—ie, days 17–21 and 24–28. For patients given ciprofloxacin for 7 days, results from days 17–21 were used and, for those who were given a 14 day course, data from days 24–28 were used. Long-term outcome was assessed with a late follow-up visit on days 42–63.",compare the short-term clinical and bacteriological efficacy and safety of the two regimens,0,0,0,1,1,0,1,0,3,4,0,
71,22952580,Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment,2012,Plos One,adult,"All patients included in the study were treated with beta-lactams for 8 or 15 days combined with an aminoglycoside for the first 5 days (Table 4). In the event of a secondary pulmonary infection or the development of extrapulmonary infections, all antibiotics could be used according to the bacteriological data. Once the patient had been included in the protocol, BAL samples were taken for intubated patients prior to making any changes to antibiotic treatment (Table 5).",arbitrary durations,0,0,NA,Early-onset ventilator-associated pneumonia,Lower respiratory tract infection,0,225,ICU,France,high,8,15,8,13,stratified randomisation,equivalence,10,ITT,none,0,NA,NA,absolute difference,1,0,1,116,109,225,Not reported,Not reported,4,5,Medical chart,NA,investigator initiated,clinical syndrome,All patients included in the study were treated with beta-lactams for 8 or 15 days combined with an aminoglycoside for the first 5 day,various,various,1,90,clinical cure rate at day 21. The mortality rate was evaluated on days 21 and 90,clinical cure rate at day 21. The mortality rate was evaluated on days 21 and 90,0,0,0,1,1,0,1,1,15,16,8,
72,21620467,5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study,2011,Lacet,children,"randomly assigned children who were stable after 5 days of treatment, through site-balanced computer-generated allocation lists, to receive a further 5 days of ceftriaxone or placebo",arbitrary durations,1,0,NA,bacterial meningitis,Meningitis,0,1027,inpatient,"Bangladesh, Egypt, Malawi, Pakistan, and Vietnam","high middle, low",5,10,Not reported,Not reported,simple randomization,equivalence,1.5,PP,none,NA,0,NA,absolute difference,1,0,1,496,508,1004,Not reported,Not reported,Not reported,Not reported,Not reported,"loss to follow up, death, protocol deviation",investigator initiated,"clinical syndrome, culture",,ceftriaxone,ceftriaxone,1,40,"rate of bacteriological failure defined as positive cultures of cerebrospinal fluid or blood on days 6–40 for the originally identified organism or for H influenzae, S pneumoniae, or N meningitidis on days 6–40 in a patient from whom the first sample of cerebrospinal fluid had been culture negative",bacteriological failure or relapse,0,0,0,1,1,0,1,0,0,0,4,
73,21982465,Prospective randomized study of efficacy of 1-day versus 3-day antibiotic prophylaxis for preventing surgical site infection after coronary artery bypass graft,2011,J Formos Med Assoc,adult,efficacy of 1-day versus 3-day antibiotic prophylaxis in preventing surgical site infection (SSI) in patients undergoing coronary artery bypass graft,arbitrary durations,0,0,NA,surgical site infection after coronary artery bypass graft,Prophylaxis (post-surgery),0,231,inpatient,Taiwan,high,1,3,Not reported,Not reported,simple randomization,not reported,NA,ITT,PP,0,0,NA,absolute difference,1,1,0,120,111,231,80,70,41,0,Medical chart,NA,investigator initiated,NA,,cefazolin,cefazolin,NA,30,1 month after surgery,SSI,0,0,0,1,1,0,0,hospital los,11,7,1,
74,21959024,Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia,2011,Respir Med,children,"PCT group did not receive antibiotics if their PCT level upon admission was <0.25 ng/mL, and those receiving antibiotics from the time of admission were treated until their PCT level was ≥ 0.25 ng/mL",inflammatory markers,0,0,NA,pneuncomplicated community-acquired pneumoniaumonia,Lower respiratory tract infection,0,319,inpatient,Italy,high,NA,NA,5,11,simple randomization,difference,NA,ITT,none,0,NA,NA,absolute difference,1,1,0,155,155,310,Not reported,Not reported,Not reported,Not reported,Medical chart,withdrew consent,investigator initiated,clinical syndrome,"Clarithromycin added in severe penumonia; in severe cases regardless of age, the recommended treatment is oral amoxicillin-clavulanate or intravenous (i.v.) cefotaxime plus oral or i.v. clarithomycin.","amoxicillin, clarithromycin","amoxicillin, clarithromycin",0,28,28 days after admission,lower antibiotic use,0,1,1,1,0,0,1,hospital los,1,4,0,Recurrence of respiratory symptoms as the clinical outcome
75,20972299,"Short course versus 7-day course of intravenous antibiotics for probable neonatal septicemia: A pilot, open-label, randomized controlled trial",2011,Indian Pediatr,neonate,short course of antibiotics (48 to 96 hours) and a standard course of antibiotics (7 days) for probable neonatal sepsis,arbitrary durations,0,0,NA,probable neonatal septicemia,Sepsis,0,52,inpatient,India,lower middle,2,7,Not reported,Not reported,stratified randomisation,not reported,NA,ITT,none,0,NA,NA,absolute difference,0,NA,0,26,26,52,25,25,0,0,Medical chart,loss to follow up,investigator initiated,clinical syndrome with laboratory test,Antibiotics were prescribed as per the policy prevalent in the unit at that time. ,various,various,1,15,"""Treatment failure"" defined as reappearance of signs suggestive of sepsis within 15 days of stopping antibiotics, supported by laboratory evidence and adjudicated by a blinded expert committee.",treatment failure,0,0,0,1,1,0,0,0,0,12,2,causes of sepsis (cultures) not reported
76,21249415,Evaluation of short-term clinical efficacy of 3-day therapy with azithromycin in comparison with 5-day cefcapene-pivoxyl for acute streptococcal tonsillopharyngitis in primary care,2011,J Infect Chemother,adult,compare the efficacy of azithromycin (AZM) given oncedaily for 3 days with that of cefcapene-pivoxyl (CFPN-PI)divided into three daily doses for 5 days,arbitrary durations,0,0,NA,acute streptococcal tonsillopharyngitis,Upper respiratory tract infection,0,168,outpatient,Japan,high,3,5,Not reported,Not reported,simple randomization,not reported,NA,mITT,none,0,NA,NA,absolute difference,0,NA,0,93,75,159,not reported,not reported,Not reported,Not reported,Not reported,loss to follow up,Not reported,"clinical syndrome, culture",,Azithromycin,cefcapene-pivoxyl,0,8,followed up on day 4 and 8,clinical outcome on day 4,0,0,0,1,0,0,1,0,19,32,0,Trial of a new drug but no funding statement
77,21269858,Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media,2011,Int J Inf Dis,children,single 60-mg/kg dose of azithromycin extended-release (ER) versus a 10-day regimen of amoxicillin/clavulanate 90/6.4 mg/kg per day in children with acute otitis media at high risk of persistent or recurrent middle ear infection,arbitrary durations,1,0,NA,acute otitis media,Upper respiratory tract infection,0,923,outpatient,India,lower middle,1 dose,10,Not reported,Not reported,stratified randomisation,not reported ,NA,mITT,PP,0,0,NA,absolute difference,0,NA,1,462,461,821,412,409,0,189,self reporting,loss to follow up,Pfizer Inc,clinical syndrome,,Azithromycin,amoxicillin/clavulanate,0,14,test of cure day 12-14,clinical response at the test-of-cure visit in the bacteriologic eligible population,0,0,0,1,1,0,1,0,20,16,0,All children randomized to treatment with azithromycin ER received their single dose of active treatment; 59% of children randomized to amoxicillin/clavulanate received the full course of 20 doses.
78,21507143,Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia,2011,Respirology,adult,"The control group received antibiotics according to current guidelines. In the PCT group, antibiotic treatment was based on PCT levels as follows: <0.1 µg/L, strongly discouraged; ≤0.25 µg/L, discouraged; >0.25 µg/L, encouraged.",inflammatory markers,0,0,NA,low risk CAP,Lower respiratory tract infection,0,172,inpatient,China,high middle,NA,NA,5,7,simple randomization,difference for duration of antibiotics,NA,mITT,PP,0,0,NA,absolute difference,1,0,1,86,86,162,77,79,Not reported,Not reported,Medical chart,"loss to follow up, withdrew consent",investigator initiated,clinical syndrome,,various,various,0,28,"At 4-week follow up, all patients had survived and laboratory and clinical outcomes were similar in the two groups",total antibiotic use and duration of antibiotic treatment,0,1,1,1,0,0,0,0,15,11,0,Treatment success was taken as the clinical outcome
79,20185423,Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection,2010,Eur Respir J,adult,comparing standard care with PCT-guided antimicrobial treatment in 550 patients,inflammatory markers,0,0,NA,acute respiratory infection,Respiratory tract infection,0,571,inpatient,Germany,high,NA,NA,8,8,simple randomization,non-inferiority,not reported,mITT,none,0,NA,NA,absolute difference,1,0,1,275,275,550,275,275,Not reported,Not reported,Medical chart,protocol deviation,Not reported,clinical syndrome,,various,various,0,28,,"number of days with impairment
during everyday life and/or leisure activities due to the
respiratory tract infection within the first 14 days according to
self-assessment",0,0,0,1,0,0,1,0,28,32,0,"In the PCT group, the advice following PCT determination was not to give antibiotics in any patient; however, the advice was overruled in 36 (13.1%)
patients. Up to days 14 and 28, an additional nine and five patients in the PCT group received antibiotics in the group with an initial decision not to treat, and eight and one patient in the group not treated following recommendation after PCT measurement, a
total of 59 (21.5%) patients on antibiotics as opposed to 101 (36.7%) in the control group (p50.0005) (tables 2 and 3). Only one out of two patients in the control group with a PCT level of <0.25 ng?mL-1 received an antibiotic. Thus, in spite of overruling, the PCT strategy permitted at least for a 41.6% reduction in antibiotic use.
RTI at day 28 taken as clinical outcome"
80,20185560,"Ten Versus 14 Days of Antibiotic Therapy in Culture-Proven Neonatal Sepsis: A Randomized, Controlled Trial",2010,J Trop Pediatr,neonate,10-day course of antibiotic therapy with the conventional 14-day course in blood culture-proven neonatal sepsis,arbitrary durations,0,0,NA,culture-proven neonatal sepsis,Sepsis,1,60,inpatient,India,lower middle,10,14,13,18,simple randomization,not reported,NA,ITT,none,0,NA,NA,absolute difference,0,NA,0,30,30,60,not reported,not reported,not reported,not reported,not reported,NA,investigator initiated,"clinical syndrome, culture",,various,various,1,28,,"treatment failure within
28 days, defined by either positive CRP or positive
blood culture growing the same organism as cultured
earlier or clinical relapse.",0,0,0,1,1,0,0,hospital los,3,3,2,
81,21209531,Comparison of single versus multiple doses of antibiotic prophylaxis in reducing post-elective caesarean section infectious morbidity,2010,Kathmandu Univ Med J (KUMJ),adult,single dose versus multiple doses of a first generation cephalosporin (with Metronidazole),arbitrary durations,0,0,NA,postoperative infectious morbidity in elective caesarean section,Prophylaxis (post-surgery),0,100,inpatient,Nepal,lower middle,1 dose,7,Not reported,Not reported,simple randomization,not reported,NA,ITT,none,0,NA,NA,absolute difference,0,NA,0,50,50,100,not reported,not reported,not reported,not reported,not reported,NA,investigator initiated,NA,,"cefazolin, metronidazole","cefazolin, metronidazole",0,not reported,not reported,not reported,0,0,0,1,1,0,0,0,4,6,0,development of febrile morbidity taken as clinical outcome
82,20097417,Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial,2010,Lancet,adult,antibiotics were started or stopped based on predefined cut-off ranges of procalcitonin concentrations; the control group received antibiotics according to present guidelines,inflammatory markers,0,0,NA,non-specific,Lower respiratory tract infection,0,630,ICU,France,high,NA,NA,10,13,stratified randomisation,non-inferiority,10,mITT,none,0,0,NA,absolute difference,1,0,1,311,319,621,149,178,not reported,not reported,medical chart,protocol deviation,investigator initiated,clinical syndrome,,various,various,1,60,mortality at days 28 and 60 (non-inferiority analysis),mortality at days 28 and 60 (non-inferiority analysis),0,1,0,1,0,0,0,hospital los,30,26,28,Very high non-adherence
83,20585969,A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections,2010,J Infect Chemother,adult,single-dose fosfomycin and 5-day ciprofloxacin,arbitrary durations,0,0,NA,uncomplicated lower urinary tract infections in female,Urinary tract infection,0,260,outpatient,Turkey,high middle,1,5,Not reported,Not reported,simple randomization,not reported,NA,PP,none,0,NA,NA,absolute difference,0,NA,0,130,130,142,77,65,not reported,not reported,not reported,protocol deviation,not reported,"clinical syndrome, culture",,fosfomycin,ciprofloxacin,0,60,(1) diagnosis of infection confirmed byclinical signs and symptoms; (2) a single pathogen isolatedfrom pretreatment culture; (3) urine culture repeated 7–10and 60 days after therapy; and (4) no other effective anti-biotics against the causative organism,(1) diagnosis of infection confirmed byclinical signs and symptoms; (2) a single pathogen isolatedfrom pretreatment culture; (3) urine culture repeated 7–10and 60 days after therapy; and (4) no other effective anti-biotics against the causative organism,1,0,0,1,1,1,1,0,17,19,0,
84,20842069,"Short- versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture-positive cases",2010,Pediatr Infect Dis J,children,clindamycin or a first-generation cephalosporin for 20 or 30 days,arbitrary durations,0,1,0,acute hematogenous osteomyelitis of childhood,Bone and prosthetics infection,1,131,inpatient,Finland,high,20,30,20,30,simple randomization,non-inferiority,15,ITT,none,0,NA,NA,absolute difference,0,NA,0,67,64,131,62,60,5,0,medical chart,NA,Orion Pharma company,"clinical syndrome, culture",,"clindamycin, amoxicillin, cephalosporin","clindamycin, amoxicillin, cephalosporin",1,365,"2 weeks, and 3 and ≥12 months post hospitalization","full recovery (having no symptoms or signs of AHOM at the end of the follow-up period, with no readministration of antimicrobial for an osteoarticular indication since the primary treatment)",0,0,0,1,1,0,0,0,0,0,0,
85,20332194,Comparison of 48 h and 72 h of prophylactic antibiotic therapy in adult cardiac surgery: a randomized double blind controlled trial,2010,J Antimicrob Chemother,adult,prophylactic antibiotic therapy for either 48 h (the 48 h group) or 72 h (the 72 h group),arbitrary durations,1,0,NA,elective coronary artery bypass grafting (CABG) and valve surgery,Prophylaxis (post-surgery),0,235,inpatient,India,lower middle,2,3,Not reported,Not reported,simple randomization,difference,NA,mITT,PP,0,0,NA,absolute difference,0,NA,0,125,110,227,100,100,17,2,medical chart,protocol deviation,investigator initiated,NA,All the patients received intravenous ceftazidime pentahydrate and intravenous amikacin sulphate injection at the time of anaesthesia induction and a second dose was given when the duration of surgery exceeded 5 h.,"ceftazidime, amikacin","ceftazidime, amikacin",0,30,3 months after discharge to look for any late appearance of surgical site infection.,Superficial surgical site infection was defined as infection occurring within 30 days after the operative procedure and involving only skin and subcutaneous tissue of the incision in addition to one of the signs or symptoms of infection with or without purulent discharge from the superficial incision or positive culture of the fluid or tissue from the superficial incision site.,0,0,0,1,0,0,0,0,4,7,0,
86,19776651,Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial,2010,Neonatology,neonate,"standard treatment based on conventional laboratory parameters (standard group) or to PCT-guided treatment (PCT group). Minimum duration of antibiotic therapy was 48–72 h in the standard group, whereas in the PCT group antibiotic therapy was discontinued when two consecutive PCT values were below predefined age-adjusted cut-off values",inflammatory markers,0,0,NA,suspected neonatal early-onset sepsis,Sepsis,0,121,ICU,Switzerland,high,NA,NA,3,4,simple randomization,difference,NA,mITT,none,0,NA,NA,relative difference,0,NA,0,61,60,121,not reported,not reported,not reported,not reported,not reported,NA,BRAHMS Diagnostica,clinical syndrome,,various,various,1,30,"observation periods were the same in both
groups with a minimum of 3 days of hospitalization and a followup interview after 1 month (telephone interview about intercurrent illness, physician visits, medications and hospitalizations).",proportion of infants treated with antibiotics for ≥72 h,0,1,1,0,0,0,0,0,not reported,not reported,0,safety endpoint (clinical outcome) not clearly reported
87,19576090,[The value of serum procalcitonin in treatment of community acquired pneumonia in outpatient],2009,Zhonghua Nei Ke Za Zhi,adult,"On the base of similarly normal treatment, the control group received antibiotics according to the attending physicians and the PCT group were treated with antibiotics according to serum PCT levels: antibiotic treatment was applied with PCT level > or = 0.25 microg/L and was discouraged with PCT level < 0.25 microg/L.",inflammatory markers,0,0,0,CAP,Lower respiratory tract infection,0,127,outpatient,china,high middle,NA,NA,missing,missing,simple randomization,difference,NA,ITT,none,0,NA,NA,absolute difference,missing,missing,0,63,64,127,missing,missing,missing,missing,missing,missing,missing,clinical syndrome,,various,various,0,missing,missing,missing,0,0,0,1,0,0,0,direct cost,8,13,0,only abstract available
88,19416298,Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission--a randomized trial,2009,Clin Microbiol Infect,adult,"The cut-off point for recommending antibiotic
treatment was PCT ‡0.25 lg/L. Physicians could overrule treatment guidelines",inflammatory markers,0,0,NA,suspected lower respiratory tract infections,Lower respiratory tract infection,0,223,inpatient,Denmark,high,NA,NA,5,7,simple randomization,superiority,NA,mITT,none,0,NA,NA,absolute difference,1,0,1,110,113,210,61,105,42,2,medical chart,"withdrew consent, protocol deviation",investigator initiated,clinical syndrome,,various,various,0,during hospitalisation,,"antibiotic use (defined as days of
antibiotic treatment during hospitalization) and length of
hospital stay (one night spent in the hospital was counted as
2 days of admission)",0,1,1,1,0,0,0,hospital los,7,5,1,Need for ICU care taken as clinical outcome
89,19097848,[Duration of antibiotic therapy for ventilator-associated pneumonia: comparison of 7 and 10 days. A pilot study],2009,Ann Fr Anesth Reanim,adult,Ten-day group: ten-day antibiotic therapy. Seven-day group: short-term antibiotic therapy for seven days,arbitrary durations,0,0,NA,VAP,Lower respiratory tract infection,0,39,ICU,Tunisia,low-middle,7,10,not reported,not reported,simple randomization,non-inferiority,not reported,ITT,none,0,NA,NA,absolute difference,0,NA,0,not reported,not reported,30,14,16,not reported,not reported,not reported,"deemed end of life, did not fulfil inclusion criteria",investigator initiated,"clinical syndrome, culture, laboratory tests",,various,various,1,28,"14- and 28-day mortality, the number of days without antibiotics","14- and 28-day mortality, the number of days without antibiotics",0,1,1,1,1,0,0,hospital and ICU los,31,7,19,14 day mortality taken as clinical outcome
90,19493352,Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial,2009,Crit Care,adult,"Antibiotic therapy in the PCT-guided group was discontinued, if clinical signs and symptoms of infection improved and PCT decreased to <1 ng/ml or the PCT value was >1 ng/ml, but had dropped to 25 to 35% of the initial value over three days. In the control group antibiotic treatment was applied as standard regimen over eight days.",inflammatory markers,0,0,NA,non-specific,non-specific,0,110,ICU,Germany,high,NA,8,6,8,simple randomization,difference,NA,ITT,none,0,NA,NA,absolute difference,0,NA,0,57,53,110,not reported,not reported,not reported,not reported,not reported,NA,investigator initiated,clinical syndrome," For both groups, antibiotics were selected based on confirmed or highly suspected bacterial infections. The type of antibiotic substance chosen was either calculated according to the expected microbiologic spectrum and/or adjusted to the isolated organisms whenever possible",various,various,1,during ICU stay,,not reported,0,0,0,1,0,0,0,ICU los,26,26,26,mortality taken as clinical outcome
91,19797133,Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study,2009,Eur Respir J,adult,an antibiotic discontinuation strategy according to guidelines (control group) or to serum procalcitonin concentrations (procalcitonin group) with an antibiotic regimen selected by the treating physician,inflammatory markers,0,0,NA,VAP,Lower respiratory tract infection,0,101,ICU,Switzerland,high,NA,NA,not reported,not reported,simple randomization,superiority,NA,ITT,none,0,NA,NA,absolute difference,1,0,1,51,50,101,not reported,not reported,not reported,not reported,not reported,NA,Brahms AG,"clinical syndrome, culture, laboratory tests","Drug selection was left to the discretion of the treating physicians, including any adaptation considered necessary as a function of clinical, laboratorial, radiological or microbiological results, including bacteriology susceptibility patterns.",various,various,1,28,28 days after VAP onset,number of antibiotic-free days alive assessed 28 days after enrollment in the study,0,1,1,1,1,0,0,hospital and ICU los,10,14,20,Clinical outcome taken as VAP-related clinical deterioration days 1-28
92,19323633,"Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis",2009,CID,children,culture-positive septic arthritis were randomized to receive clindamycin or a first-generation cephalosporin for 10 days or 30 days (intravenously for the first 2-4 days). The number of surgical procedures was kept to a minimum. Illness was monitored with preset criteria. Antimicrobial therapy was discontinued when the clinical response was good and the C-reactive protein level decreased to 20 mg/L.,arbitrary durations,0,1,0,Septic arthritis,Bone and prosthesis infection,1,130,inpatient,Finland,high,10,30,10,30,simple randomization,non-inferiority,15,ITT,none,0,NA,NA,absolute difference,1,0,1,63,67,130,not reported,67,not reported,0,medical chart,NA,Orion Pharma company,culture of sterile site,"clindamycin [1, 18–20] (40 mg/kg per day every 6 h) [4, 20] or a first-generation cephalosporin (see below; 150 mg/kg per day every 6 h) [4, 21] was used. ampicillin or amoxicillin (both 200 mg/kg per day every 6 h [4]) was also given to children aged 0–4 years until the causative pathogen was identified; the treatment course was completed with only 1 antimicrobial.",various,various,1,365,12 months after therapy,full recovery without need for further administration of antimicrobial therapy because of an osteoarticular indication during the 12 months after therapy,0,0,0,1,1,0,1,0,0,2,0,
93,19034493,Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study,2009,Langenbecks Arch Surg,adult,"PCT-guided or a control group requiring antibiotic treatment. All patients received a calculated antibiotic regimen according to the presumed microbiological spectrum. In the PCT-guided group, antibiotic treatment was discontinued if clinical signs of infection improved and the PCT value was either <1 ng/ml or decreased to <35% of the initial concentration within three consecutive days. In the control group, antibiotic treatment was directed by empirical rules.",inflammatory markers,0,0,NA,surgical ICU patients with severe sepsis,Sepsis,0,27,ICU,Germany,high,NA,NA,7,8,simple randomization,difference,NA,ITT,none,0,NA,NA,absolute difference,0,NA,0,14,13,27,not reported,not reported,not reported,not reported,not reported,NA,investigator initiated,"clinical syndrome, culture, laboratory tests","For either group, a calculated antibiotic regimen according to the underlying infectious pathology was applied.",various,various,1,during ICU stay,,not reported,0,0,0,1,0,0,0,"hospital and ICU los, direct cost",21,23,22,mortality taken as primary outcome
94,18242357,"A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis",2008,Urology,adult,either levofloxacin 750 mg intravenously or orally once daily for 5 days or ciprofloxacin 400 mg intravenously and/or ciprofloxacin 500 mg orally twice daily for 10 days,arbitrary durations,1,0,NA,complicated UTI or acute pyelonephritis (AP),Urinary tract infection,0,1102,inpatient,USA,high,5,10,not reported,not reported,simple randomization,non-inferiority,15,mITT,PP,0,0,NA,absolute difference,0,NA,1,543,559,1093,not reported,not reported,not reported,not reported,not reported,protocol deviation,investigator initiated,"clinical syndrome, culture, laboratory tests",,levofloxacin,ciprofloxacin,0,22,study day 15-22,microbiologic eradication at post-therapy (study days 15-22),0,1,0,1,1,0,1,0,14,11,0,"Potential limitations are that this analysis is based on a subset of subjects from a larger study and, because of different durations of therapy, the results may be biased against levofloxacin. There are limitations to this study. Patients receiving
levofloxacin concluded therapy 5 days sooner than did patients receiving ciprofloxacin, which disadvantages the
assessment at EOT and PT in favor of the longer-course
regimen."
95,18662172,A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria,2008,Int J Clin Pract,adult,daptomycin at 10 mg/kg every 24 h for 4 days [high-dose short duration (HDSD) regimen] vs. standard of care therapy with vancomycin or semi-synthetic penicillin for the treatment of cSSSI.,arbitrary durations,0,1,1,complicated skin and skin structure infections caused by gram-positive bacteria,Skin and soft tissue infection,0,100,inpatient,USA,high,4,NA,4,10,simple randomization,difference,NA,mITT,none,0,NA,NA,absolute difference,0,NA,0,50,50,96,48,33,0,15,medical chart,protocol deviation,Cubist Pharmaceuticals,"clinical syndome, culture",,daptomycin,"vancomycin, penicillin",0,end of treatment,"Comparisons
of the severity of clinical signs between daptomycin
patients at EOT and comparator patients at day 5
and at EOT were performed.","clinical assessment at baseline, EOT and TOC. Investigators assessed the site of
infection for oedema, erythema, fluctuance, purulent
drainage, induration, necrotic tissue, tenderness and
ulceration. The investigators determined the clinical
response of the patient at EOT and TOC by comparing the patient’s signs and symptoms to those
recorded at baseline and by making an overall clinical assessment using the following categories: cure,
defined as resolution of clinically significant signs
and symptoms associated with the cSSSI present at
baseline; improved, defined as partial resolution of
such signs and symptoms; failure, defined as inadequate clinical response to therapy and unable to evaluate if the patient was lost to follow-up",0,0,0,1,1,0,1,0,25,14,0,
96,17846853,"A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs >or=5 days in community-acquired intraabdominal infection",2008,J Gastrointest Surg,adult,ertapenem (1 g/day) 3 days (group I) vs ≥5 days (group II),arbitrary durations,1,0,NA,"localized peritonitis (appendicitis vs non-appendicitis) of mild to moderate severity, requiring surgical intervention.",Abdominal infection,1,111,inpatient,Italy,high,3,NA,3,6,stratified randomisation,difference,NA,mITT,none,0,NA,NA,absolute difference,0,NA,0,42,48,90,not reported,not reported,not reported,not reported,not reported,protocol deviation,Merk,"clinical syndrome, culture, laboratory tests",,ertapenem,ertapenem,1,28,clinical outcome assessed 2 and 4 weeks after ertapenem,"clinical response considered the primary efficacy outcome
was assessed at the test-of-cure (TOC) visit 2 and 4 weeks
after discontinuation of antibacterial therapy",0,0,0,1,1,0,1,0,7,10,0,
97,18721198,Prospective assessment of the efficacy of single dose versus traditional 3-day antimicrobial prophylaxis in 12-core transrectal prostate biopsy,2008,Int J Urol,adult,"The ﬁrst group (139 patients) received a single gram of intramuscular ceftriaxone,while the second group (131 patients) had a 3-day course of oral ciproﬂoxacin. The third group (130 patients) had single oral 500 mg ofciproﬂoxacin",arbitrary durations,0,0,NA,12-core transrectal prostate biopsy,Prophylaxis (post-surgery),0,261,inpatient,Turkey,high middle,1 dose,3,not reported,not reported,simple randomization,difference,NA,ITT,none,0,NA,NA,absolute difference,0,NA,0,130,131,261,not reported,not reported,not reported,not reported,not reported,NA,investigator initiated,NA,,cetftriaxone,ciprofloxacin,0,14,2 weeks after biopsy,"any complications after the biopsy were recorded. The complications were defined as mild or severe. Minor complications were
expected side effects of the biopsy such as pain, dysuria, hematospermia, hematuria, mild fever, and rectal bleeding. Severe complications
that required hospitalization were vasovagal episode, urinary retention,
infectious complications such as acute prostatitis, acute epididymitis,
fever (temperature greater than 38°C), sepsis and hematuria or rectal
bleeding",0,0,0,1,1,0,0,0,2,2,0,added major complications in 1 day (single dose IM ceftriaxone and single dose cipro) vs 3 day
98,18096708,Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial,2008,Am J Respir Crit Care Med,adult,"In patients randomly assigned to the intervention group, antibiotics were stopped when PCT levels had decreased 90% or more from the initial value (if clinicians agreed) but not before Day 3 (if baseline PCT levels were <1 microg/L) or Day 5 (if baseline PCT levels were >/=1 microg/L). In control patients, clinicians decided on the duration of antibiotic therapy based on empirical rules.",inflammatory markers,0,0,NA,non-specific,Sepsis,0,79,ICU,Switzerland,high,NA,NA,6,10,simple randomization,difference,NA,ITT,PP,0,0,NA,absolute difference,1,0,1,39,40,79,31,37,6,0,medical chart,NA,investigator initiated,"clinical syndrome, culture, laboratory tests","All patients received initial antibiotic therapy based on local guidelines and susceptibility patterns, according to the decision of the treating physician, who was unaware of the patient's initial PCT levels.",various,various,1,28,28 day mortality,duration of antibiotic therapy for the initial infection,0,1,1,1,0,0,0,hospital and ICU los,21,20,20,28 day mortality taken as clinical outcome
99,18343748,Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: an open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days,2008,J Chemother,adult,"3-day course of oral azithromycin 1 g once daily was at least as effective as
a standard 7-day course of oral amoxicillin-clavulanate 875/125 mg twice daily",arbitrary durations,0,0,NA,CAP,Lower respiratory tract infection,0,267,outpatient,Italy,high,3,7,not reported,not reported,stratified randomisation,non-inferiority,10,ITT,PP,0,0,NA,absolute difference,1,0,1,136,132,267,133,129,0,1,self reporting,NA,Pfizer Inc,clinical syndrome,,Azithromycin,amoxicillin/clavulanate,0,12,clinical response in the intent-to-treat population at the end of therapy (day 8 to 12),clinical response,0,0,0,1,1,0,1,0,7,7,0,
100,17288699,"Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis",2007,Curr Med Res Opin,adult,clarithromycin extended-release (ER) 1000 mg once daily for 5 days or a comparator agent – clarithromycin immediate-release (IR) 500 mg twice daily for 7 days (in North America) or telithromycin 800 mg once daily for 5 days (in France),arbitrary durations,1,0,NA,acute bacterial exacerbation of chronic bronchitis,Lower respiratory tract infection,0,818,outpatient,"USA, France",high,5,7,not reported,not reported,simple randomization,difference,NA,mITT,none,0,NA,NA,absolute difference,0,NA,1,388,387,775,353,355,not reported,not reported,not reported,Did not satisfy inclusion criteria,investigator initiated,clinical syndrome,,clarithromycin,clarithromycin,0,40,"Clinical and bacteriological responses were determined
at the follow-up visit (between days 14 and 40 for the
study conducted in North America and on day 8 for
the study conducted in France). ‘Clinical response’ was
classified as cure, failure, or indeterminate. ‘Clinical
cure’ was defined as resolution/improvement of signs
and symptoms of ABECB to pre-acute levels. ‘Clinical
failure’ was defined as continuation or worsening of
ABECB signs and symptoms accompanied by the need
for additional antimicrobial therapy. ‘Indeterminate’
was used when evaluation was not possible.",clinical cure,0,0,0,1,1,0,1,0,10,10,0,
101,17329271,Duration of antimicrobial prophylaxis in patients undergoing hepatectomy: a prospective randomized controlled trial using flomoxef,2007,J Antimicrob Chemother,adult,"flomoxef sodium as antimicrobial prophylaxis for 2 days (89 patients) or 5 days (91 patients), including the operation day",arbitrary durations,0,0,NA,hepatectomy,Prophylaxis (post-surgery),0,180,inpatient,Japan,high,2,5,not reported,not reported,simple randomization,non-inferiority,10,ITT,none,0,NA,NA,absolute difference,1,0,1,89,91,180,89,91,0,0,medical chart,NA,investigator initiated,NA,,flomoxef,flomoxef,0,30,30 days after surgery,incidence of SSI,0,0,0,1,1,0,1,hospital los,8,7,0,
102,17587070,"Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study",2007,Eur J Clin Microbiol Infect Dis,adult,"The aim of this multicenter study was to determine whether initial treatment with intravenous ceftriaxone (CRO) for 3 weeks should be extended with a period of adjunct oral antibiotic therapy. A total of 152 consecutive patients with LB were randomized in a double-blind fashion to receive either amoxicillin (AMOX) 1 g or placebo (PBO) twice daily for 100 days. Both groups received an initial treatment of intravenous CRO 2 g daily for 3 weeks, followed by the randomized drug or PBO",arbitrary durations,1,0,NA,Lyme disease,Lyme disease,1,145,inpatient,Turkey,high middle,21,121,not reported,not reported,simple randomization,difference,NA,ITT,none,0,NA,NA,absolute difference,0,NA,0,72,73,145,not reported,not reported,not reported,not reported,not reported,NA,"Bristol–Myers Squibb, Roche","clinical syndrome, laboratory tests",,ceftriaxone,"cetriaxone, amoxicillin",1,365,,"outcomes were measured by the patients themselves and by
the investigators using the VAS at the visits at the end of
CRO treatment as well as 1, 3, 6, and 12 months later",0,0,0,1,1,0,1,0,8,13,4,not having excellent clinical score at the end of 12 months taken as clinical outcome
103,17189096,Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis,2007,International Journal of Antimicrobial Agents,adult,azithromycin (500 mg once a day (qd) for 3 days) was compared with moxifloxacin (400 mg qd for5 days) for the treatment of outpatients with AECB (forced expiratory volume in 1 s (FEV1) >35%),arbitrary durations,0,0,NA,acute bacterial exacerbations of chronic bronchitis,Lower respiratory tract infection,0,342,outpatient,USA,high,3,5,not reported,not reported,simple randomization,non-inferiority,10,mITT,none,0,NA,NA,absolute difference,1,0,1,169,173,342,not reported,not reported,not reported,not reported,self reporting,NA,Pfizer Inc,clinical syndrome,,Azithromycin,moxifloxacin,0,26,clinical response at Days 22–26,clinical response at Days 22–26,0,0,0,1,1,0,1,0,20,19,0,More than 90% of patients in each treatment group completed therapy for the number of days specified in the protocol.
104,17408924,Single-dose and multi-dose clindamycin therapy fails to demonstrate efficacy in preventing infectious and inflammatory complications in third molar surgery,2007,Int J Oral Maxilo Surg,adult,(1) single dose of oral clindamycin administered preoperatively (single-dose group); (2) clindamycin administered preoperatively with continued therapy for 5 days (5-day group); and (3) a placebo group,arbitrary durations,0,0,NA,third molar surgery,Prophylaxis (post-surgery),0,100,outpatient,Poland,high,1 dose,5,not reported,not reported,simple randomization,difference,NA,mITT,none,0,NA,NA,absolute difference,0,NA,0,31,28,86,not reported,not reported,not reported,not reported,not reported,"loss to follow up, protocol deviation",investigator initiated,NA,,clindamycin ,clindamycin ,0,7,"first, second and seventh days postsurgery: trismus, facial swelling, body temperature, lymphadenopathy, alveolar osteitis and subjective pain sensations.","first, second and seventh days postsurgery: trismus, facial swelling, body temperature, lymphadenopathy, alveolar osteitis and subjective pain sensations.",0,0,0,1,0,0,0,0,3,7,0,Both single and multidose regimens failed to demonstrate benefit. Alveolar osteitis was taken as the clinical outcome
105,17514671,Randomized clinical trial of single- versus multiple-dose antimicrobial prophylaxis in gastric cancer surgery,2007,Br J Surg,adult,single- or multiple-dose antimicrobial prophylaxis,arbitrary durations,0,0,NA,gastric cancer surgery,Prophylaxis (post-surgery),0,490,inpatient,Japan,high,1 dose,4,not reported,not reported,simple randomization,non-inferiority,7,mITT,none,0,NA,NA,absolute difference,1,0,1,246,244,486,not reported,not reported,not reported,not reported,not reported,loss to follow up,investigator initiated,NA,cefazolin or ampicillin–sulbactam,various,various,0,42,6 weeks postop,SSI,0,0,0,1,1,0,0,0,10,9,0,
106,17880755,A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis,2007,Curr Med Res Opin,adult,"once-daily, 5-day course of levofloxacin
750mg compared to a twice-daily, 10-day course
of ciprofloxacin",arbitrary durations,1,0,NA,"complicated urinary tract
infections (cUTI) and acute pyelonephritis ",Urinary tract infection,0,311,inpatient,USA,high,5,10,not reported,not reported,simple randomization,non-inferiority,15,mITT,PP,0,0,NA,absolute difference,0,NA,0,146,165,192,not reported,not reported,not reported,not reported,not reported,protocol deviation,"PriCara, a unit of Ortho-McNeil","clinical syndrome, culture, laboratory tests",,levofloxacin,ciprofloxacin,1,22,microbiologic eradication at post-therapy (study days 15–22).,microbiologic eradication at post-therapy (study days 15–22).,0,1,0,1,1,0,1,0,17,20,0,"Potential limitations are that this analysis is based on a subset of subjects from a larger study and, because of different durations of therapy, the results may be biased against levofloxacin. Same trial as 18242357 but only analysed those with AP."
107,17537866,"Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study",2007,J Antimicrob Chemother,adult,320 mg of oral gemifloxacin once daily for 5 or 7 days. Over 95% of all patients in each cohort had a Fine score of ≤III,arbitrary durations,1,0,NA,CAP,Lower respiratory tract infection,0,512,inpatient,USA,high,5,7,not reported,not reported,simple randomization,non-inferiority,10,mITT,PP,0,0,NA,absolute difference,1,0,1,256,256,510,242,227,0,11,self reporting,protocol deviation,multiple drug companies,clinical syndrome,,Gemifloxacin,Gemifloxacin,0,30,"clinical response (success or failure) at follow-up (visit 4, days 24–30)","clinical response (success or failure) at follow-up (visit 4, days 24–30)",0,0,0,1,1,0,1,0,7,13,0,
108,17354160,Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project,2007,Scand J Prim Health Care,adult,"three different regimens of pivmecillinam (Selexid®): 200 mg×3×7 days, 200 mg×2×7 days or 400 mg×2×3 days or placebo (i.e. all patients were given 2 + 1+2 identical tablets each day for 7 days).",arbitrary durations,1,0,NA,uncomplicated lower urinary tract infection in women,Urinary tract infection,0,855,outpatient,Sweden,high,3,7,not reported,not reported,simple randomization,difference,NA,mITT,none,1,NA,longer,absolute difference,1,0,1,285,570,657,not reported,not reported,not reported,not reported,not reported,protocol deviation,LEO Pharma,"clinical syndrome, culture, laboratory tests",,pivmecillinam,pivmecillinam,1,49,"Symptoms registered at inclusion, during therapy and at follow-up visits after 8–10 and 35–49 days",symptom resolution,0,0,0,1,1,0,1,0,16,6,0,short term follow up considered for clinical outcome - bacterial cure
109,17173219,A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis,2007,CID,adult,"4-arm
study that compared metronidazole for 7 days versus 14 days, plus or minus azithromycin on days 1 and 3",arbitrary durations,1,0,NA,Vaginosis,Vaginosis,0,568,outpatient,USA ,high,7,14,not reported,not reported,simple randomization,difference,NA,mITT,PP,1,1,longer,absolute difference,0,NA,1,287,280,567,228,221,not reported,not reported,self reporting,not reported,Pfizer Inc,"clinical syndrome, laboratory test",,"Azithromycin, metronidazole","Azithromycin, metronidazole",1,21,"Follow-up visits were conducted 7 days after the completion of therapy (on day 21), 21 days after the completion of therapy (days 35–40), and then monthly for an additional 2 visits.","cured if the vaginal pH and whiff test results normalized and if clue cells were absent. Improvement was defined as normalization of 2 of the 3 criteria, and failure was defined as normalization of 0 or 1 of the criteria",0,1,0,1,0,0,1,0,55,36,0,adhrent populatiomn counted with those >80% self reported compliance reported in the paper
110,17391383,"Three vs. 10 days of amoxycillin-clavulanic acid for type 1 acute exacerbations of chronic obstructive pulmonary disease: a randomised, double-blind study",2007,Clin Microbiol Infect,adult,3 vs. 10 days with amoxycillin–clavulanic acid of hospitalised patients with AECOPD who had improved substantially after initial therapy for 3 days,arbitrary durations,1,0,NA,type 1 acute exacerbations of chronic obstructive pulmonary disease,Lower respiratory tract infection,0,48,inpatient,Netherlands,high,3,10,not reported,not reported,simple randomization,non-inferiority,10,mITT,none,0,NA,NA,absolute difference,1,1,0,23,25,46,not reported,not reported,3,0,self reporting,protocol deviation,GSK,clinical syndrome,,amoxycillin-clavulanic acid,amoxycillin-clavulanic acid,1,21,final assessment 3 months,cured on day 21,0,0,0,1,1,0,0,hospital los,24,20,0,
111,16763247,"Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study",2006,BMJ,adult,Patients who had substantially improved after three days' treatment with intravenous amoxicillin were randomly assigned to oral amoxicillin (n = 63) or placebo (n = 56) three times daily for five days.,arbitrary durations,1,0,NA,CAP,Lower respiratory tract infection,0,121,inpatient,Netherlands,high,3,8,not reported,not reported,simple randomization,non-inferiority,10,ITT,PP,0,0,NA,absolute difference,0,NA,0,57,64,119,47,49,not reported,not reported,not reported,protocol deviation,investigator initiated,clinical syndrome,,amoxyillin,various,0,10,"We assessed study outcomes at day 10, indicated as test of cure, and at late follow-up (day 28)",clinical cure rate at test of cure,0,0,0,1,1,0,0,hospital los,11,11,0,
112,17011409,Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis,2006,Otolaryngol Head Neck Surg,adult,"faropenem medoxomil, 300 mg twice daily for seven or ten days, with cefuroxime axetil 250 mg twice daily for ten days in adults with acute bacterial sinusitis",arbitrary durations,1,0,NA,acute bacterial sinusitis ,Upper respiratory tract infection,0,1106,outpatient,"USA, Canada",high,7,10,not reported,not reported,simple randomization,non-inferiority,10,PP,ITT,0,0,NA,absolute difference,1,0,1,366,733,861,295,566,0,76,self reporting,protocol deviation,not reported,"clinical syndrome, laboratory test",,faropenem medoxomil,cefuroxime axetil,0,21,"clinical response at the test-of-cure
visit (7-21 days after the completion of treatment)",clinical response at the test-of-cure visit (7-21 days after the completion of treatment),0,0,0,1,0,0,1,0,20,22,0,
113,17030532,Randomized controlled trial of 7-Day vs. 14-Day antibiotics for neonatal sepsis,2006,J Trop Pediatr,neonate,7-day intravenous antibiotic regimen with the standard 14-day regime in blood-culture-proven sepsis in neonates,arbitrary durations,0,0,NA,non-specific,Sepsis,0,69,ICU,India,low-middle,7,14,not reported,not reported,stratified randomisation,difference,NA,ITT,PP,1,FALSE,longer,absolute difference,0,NA,0,34,35,69,not reported,not reported,not reported,not reported,not reported,NA,investigator initiated,"clinical syndrome, culture, laboratory tests",,various,various,1,28,occurrence of any one of the following within 28 days after antibiotic completion,treatment failure,0,0,0,1,1,0,1,0,18,3,0,
114,16362397,"Single-dose metronidazole vs 5-day multi-drug antibiotic regimen in excision of pilonidal sinuses with primary closure: A prospective, randomized, double-blinded pilot study",2006,Int J Colorectal Dis,adult,single-dose intravenous (i.v.) administration of metronidazole preoperatively or a broad-spectrum multi-drug regimen.,arbitrary durations,1,0,NA,excision of pilonidal sinuses with primary closure,Prophylaxis (post-surgery),0,50,inpatient,UK,high,1 dose,5,not reported,not reported,simple randomization,difference,NA,ITT,none,1,NA,longer,absolute difference,0,NA,0,25,25,50,not reported,not reported,not reported,not reported,not reported,NA,investigator initiated,NA,,metronidazole,"cefuroxime, metronidazole, co-amoxiclav",0,28,4 weeks postop,wound breakdown,0,0,0,1,0,0,0,"direct cost, cost of complications",44,12,0,wound status worse than grade III at week 4 considered as clinical outcome
115,16603606,Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial,2006,Am J Respir Crit Care Med,adult,"antibiotic treatment was based on serum procalcitonin concentrations as follows: strongly discouraged, less than 0.1 μg/L; discouraged, less than 0.25 μg/L; encouraged, greater than 0.25 μg/L; strongly encouraged, greater than 0.5 μg/L.",inflammatory markers,0,0,NA,CAP,Lower respiratory tract infection,0,302,inpatient,Switzerland,high,NA,NA,5,12,simple randomization,superiority,NA,ITT,none,0,NA,NA,absolute difference,1,0,1,151,151,302,not reported,not reported,not reported,not reported,not reported,NA,investigator initiated,clinical syndrome,,various,various,1,42,"incidence density ratio of antibiotic exposure was calculated as total antibiotic exposure time divided by total follow-up time, until Week 6 (expressed as relative risk)","total antibiotic use (i.e., antibiotic prescription [percentage] and duration [patient days])",0,1,1,1,0,0,0,"direct, indirect cost",16,18,13,outcome at follow up (treatment success) taken as outcome
116,15814044,Comparative trial of short-course ofloxacin for uncomplicated typhoid fever in Vietnamese children,2005,Annals of Tropical Paediatrics,Children,comparison of 2 or 3 days of oral ofloxacin (10 mg/kg/day) for uncomplicated typhoid fever,arbitruary duration,0,0,NA,uncomplicated typhoid fever,Gastrointestinal infection,1,235,inpatient,Vietnam,low-middle,2,3,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
117,15725048,"Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomized study",2005,Treatments in Respiratory Medicine,adult,andomization 1 : 1 to azithromycin 500 mg once daily for 3 days or clarithromycin 500 mg twice daily for 10 days.,arbitruary duration,1,0,NA,acute exacerbation of chronic bronchitis (AECB) ,Lower respiratory tract infection,0,322,outpatient,"Argentina, Brazil, Canada, Chile, Costa Rica, India, South Africa, and USA","high middle, high middle, high, high, high middle, low middle, high, high",3,10,NA,NA,NA,equivalency,NA,mITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
118,15943731,Optimum duration of prophylactic antibiotics in acute non-perforated appendicitis,2005,ANZ Journal of Surgery,adult,patients with intraoperatively diagnosed NPA were randomized by opening sealed envelopes into one of three treatment protocols: (i) no further antibiotics; (ii) two more doses of i.v. antibiotics; or (iii) a 5-day course of antibiotics.,arbitruary duration,0,0,NA,postoperative infection after acute non-perforated appendicitis surgery,Prophylaxis (post-surgery),0,294,inpatient,Hong Kong,high,2,5,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
119,16392777,Acute uncomplicated lower urinary tract infections in general practice: Clinical and microbiological cute rates after three- versus five-day treatment with trimethoprim,2005,European Journal of General Practice ,adult,patients received a prescription for either a three-day or five-day regimen of trimethoprim,arbitruary duration,1,0,NA,Acute uncomplicated lower urinary tract infections,Urinary tract infection,0,324,outpatient,Netherlands,high,3,5,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
120,15705638,Impact of an interdisciplinary strategy on antibiotic use: A prospective controlled study in three hospitals,2005,Journal of Antimicrobial Chemotherapy,adult,"Hospitals were randomly assigned to no intervention (hospital A, control), implementation of guidelines only (hospital B, low grade intervention), or implementation of guidelines with their reinforcement by a clinical pharmacist (hospital C, high grade intervention).",treatment protocol,0,0,NA,non-specific,non-specific,0,1200,inpatient,Switzerland,high,NA,NA,NA,NA,NA,difference,NA,mITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
121,14970093,Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial,2004,Canadian Medical Association Journal,adult,"randomly assigned to receive either ciprofloxacin 250 mg twice daily orally for 3 days followed by placebo for 4 days (the 3-day group, 93 patients) or ciprofloxacin 250 mg twice daily orally for 7 days (the 7-day group, 90 patients).",arbitruary duration,1,0,NA,acute uncomplicated UTI,Urinary tract infection,0,183,inpatient and outpatient,Canada,high,3,7,NA,NA,NA,non-inferiority,10,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
122,15194131,Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections,2004,International Journal of Antimicrobial Agents,adult,"randomly assigned, in a double-blind, double-dummy manner to either gatifloxacin 400 mg as a single dose, gatifloxacin 200 mg once daily for 3 days, or ciprofloxacin 250 mg twice daily for 3 days in a ratio of 1:1:1",arbitruary duration,1,0,NA,acute uncomplicated urinary tract infection ,Urinary tract infection,0,183,outpatient,"Belgium,  Croatia , France , Germany , The Netherlands , United Kingdom ",high,1,3,NA,NA,NA,equivalence,10,mITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"either gatifloxacin 400 mg as a single dose, gatifloxacin 200 mg once daily for 3 days, or ciprofloxacin 250 mg twice daily for 3 days"
123,15303634,Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin,2004,Respir Med,adult,receive either oral gemifloxacin 320 mg once daily for 7 days or oral amoxicillin/clavulanate 1 g/125 mg three times daily for 10 days,arbitruary durations,1,0,NA,community-acquired pneumonia of suspected pneumococcal origin,Lower respiratory tract infection,0,324,inpatient,"France, Poland and the Republic of South Africa","high, high middle",7,10,NA,NA,NA,non-inferiority,15,PP,ITT,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
124,15356779,"A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury",2004,Clinical Infectious Diseases,adult,"Subjects were randomized, by use of a computer-generated randomization sequence, to receive either 250 mg of ciprofloxacin orally b.i.d. for 3 days, followed by identical placebo tablets given for 11 days, or 250 mg of ciprofloxacin orally b.i.d. for 14 days (all obtained from Bayer)",arbitruary durations,1,0,NA,acute urinary tract infection in patients with spinal cord injury,Urinary tract infection,0,60,inpatient,Canada,high,3,14,NA,NA,NA,difference,NA,ITT,none,1,NA,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,The final study enrollment of 60 patients (30 in each treatment arm) provided a 50% power to identify a 20% difference in outcomes or an 80% power to identify a 35% difference in outcomes.
125,15136392,A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia,2004,CHEST/Clinical Investigations in Critical Care,adult,Patients were randomly assigned to have the duration of empiric antibiotic therapy for VAP determined using a formalized antibiotic discontinuation policy (discontinuation group) or according to the clinical judgment of the treating ICU physicians (conventional group),treatment protocol,0,0,NA,VAP,Lower respiratory tract infection,0,302,ICU,US,high,NA,NA,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
126,15373886,Impact of regular attendance by infectious disease specialists on the management of hospitalised adults with community-acquired febrile syndromes,2004,Clinical Microbiology and Infection,adult,"In ward 1, all senior physicians were IDS, whereas those in ward 2 belonged to other sub-specialties. Admission of patients from the emergency room to either of the wards was on a random basis",ASP (ID physician or electronic programmes),0,0,NA,non-specific,Not specified,0,402,inpatient,Isreal,high,NA,NA,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
127,15609652,[Feasibility of short-term antibiotic prophylaxis after pulmonary resection],2004,Kyobu Geka,adult,either a short-duration prophylaxis group that was given 4 g of cefmetazole sodium for 2 days or a long-duration patients group,arbitruary durations,0,0,NA,postoperative infection after lung cancer surgery,Prophylaxis (post-surgery),0,40,inpatient,Japan,high,2,7,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
128,15303633,"A randomized, double-blind study comparing 5 days oral gemifloxacin with 7 days oral levofloxacin in patients with acute exacerbation of chronic bronchitis",2004,Respiratory Medicine,adult,A total of 360 adults (>40 years of age) with AECB were randomly assigned to receive gemifloxacin 320 mg once daily for 5 days or levofloxacin 500mg once daily for 7 days.,arbitruary durations,1,0,NA,acute exacerbation of chronic bronchitis,Lower respiratory tract infection,0,360,inpatient,US,high,5,7,NA,NA,NA,non-inferiority,13,ITT,PP,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Discrepancy on n_randomized - Therefore, a total of 361 patients from 61 centres in Germany, UK and USA, were randomized to receive study medication and 360 patients received at least one dose; these 360 patients made up the Safety Population and the Intent to Treat (ITT) Population."
129,15302637,Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis,2004,Archives of internal medicine,adult,"43 were randomized to receive 5 more days of levofloxacin therapy (10 days total antibiotic treatment), and 44 subjects to receive 5 more days of placebo therapy (5 days of total antibiotic treatment)",arbitruary durations,1,0,NA,uncomplicated cellulitis,Skin and soft tissue infection,0,87,outpatient,US,high,5,10,NA,NA,NA,equivalency,20,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
130,15365537,Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis,2004,Otolaryngology–Head and Neck Surgery,adult,"Enrolled patients were randomized in a 1:1 ratio to either oral telithromycin 800 mg once daily (2 × 400-mg capsules in the morning) for 5 days followed by 5 days of placebo, or oral moxifloxacin 400 mg once daily in the morning for 10 days.",arbitruary durations,1,0,NA,acute bacterial rhinosinusitis,Upper respiratory tract infection,0,349,outpatient,US,high,5,10,NA,NA,NA,equivalency,15,mITT,PP,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
131,15084807,Streptococcal-A tonsillopharyngitis: a 5-day course of cefuroxime axetil versus a 10-day course of penicillin V. results depending on the children's age,2004,Chemotherapy,children,"children aged 1-17 years with acute tonsillopharyngitis and a positive culture for GABHS were treated with cefuroxime axetil (CAE) 20 mg/kg/day (max. 500 mg) b.i.d. for 5 days or with PenV 50,000 IU/kg (30 mg/kg) t.i.d. for 10 days.",arbitruary durations,0,0,NA,Streptococcal-A tonsillopharyngitis,Ear Nose Throat Infection,0,1952,outpatient,Germany,high,5,10,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
132,15214873,"Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis",2004,Clinical Microbiology and Infection,adult,"Patients were randomised to receive oral telithromycin 800 mg once-daily in the morning for 5 days, or a comparator antimicrobial (penicillin V 500 mg three-times-daily (Study 3004) or clarithromycin 250 mg twice-daily (Study 3008)) for 10 days.",arbitruary durations,1,0,NA,acute GABHS tonsillopharyngitis,Ear Nose Throat Infection,0,860,outpatient,"Belgium, Canada, Czech Republic, Denmark, Finland, Germany, Hungary, New Zealand, South Africa, Switzerland, UK, USA",high,5,10,NA,NA,NA,equivalency,not reported,mITT,PP,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
133,15361727,"Two dosages of clarithromycin for five days, amoxicillin/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitis",2004,The Pediatric Infectious Disease Journal,children,"The treatment options were: clarithromycin (30 mg/kg/day given in 2 divided doses; maximum dose, 500 mg twice a day) for 5 days; clarithromycin (15 mg/kg/day given in 2 divided doses; maximum dose, 250 mg twice a day) for 5 days; amoxicillin/clavulanate (43.8/6.2 mg/kg/day given in 2 divided doses; maximum dose, 1 g twice a day) for 5 days; penicillin V [30 mg/kg/day given in 3 divided doses; maximum dose 450 mg (750,000 IU) 3 times a day] for 10 days.",arbitruary durations,0,0,NA,acute group A streptococcal tonsillopharyngitis,Ear Nose Throat Infection,0,626,outpatient,Greece,high,5,10,NA,NA,NA,non-inferiority,10,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
134,12681877,A randomized clinical trial of prophylaxis for vacuum abortion: 3 versus 7 days of doxycycline,2003,Obstetrics & Gynecology,adult,1) 100 mg of doxycycline administered orally twice a day for 7 days or 2) 100 mg of doxycycline orally twice a day for 3 days followed by an oral placebo twice daily for the last 4 days.,arbitruary durations,0,0,NA,endometritis after elective first-trimester vacuum abortion,Prophylaxis (post-surgery),0,800,inpatient,US,high,3,7,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
135,12870368,Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis,2003,Journal of International Medical Research ,adult,"Patients received either 800 mg telithromycin orally once a day for 5 days, with a placebo counterpart to establish a twice-daily dosing regimen, followed by matching placebo for 5 days, or 500 mg cefuroxime axetil orally twice daily 500 mg cefuroxime axetil orally twice daily for 10 days.",arbitruary durations,1,0,NA,acute exacerbations of chronic bronchitis (AECB),Lower respiratory tract infection,0,376,outpatient,"US, Canada",high,5,10,NA,NA,NA,equivalency,15,PP,mITT,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
136,14503094,Efficacy and tolerability of telithromycin for 5 or 10 days vs amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis,2003,"Ear, Nose & Throat Journal",adult,"randomized to receive either telithromycin for 5 days followed by placebo for 5 days, telithromycin for 10 days, or amoxicillin/clavulanic acid for 10 days.",arbitruary durations,1,0,NA,acute maxillary sinusitis,Upper respiratory tract infection,0,754,outpatient,US,high,5,10,NA,NA,NA,not reported,NA,PP ,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
137,12645831,Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis,2003,Respiratory Medicine,adult,"the clinical and bacteriological efficacy, safety and tolerability of oral gemifloxacin (320 mg once daily, 5 days) was compared with sequential intravenous (i.v.) ceftriaxone (1 g once daily, maximum 3 days) followed by oral cefuroxime axetil (500 mg twice daily, maximum 7 days)",arbitruary durations,0,0,NA,acute exacerbations of chronic bronchitis,Lower respiratory tract infection,0,274,inpatient,UK,high,5,max 10,NA,NA,NA,non-inferiority,15,PP,ITT,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Discrepancy on antibiotic long protocol (max 7 vs max 10 days)
the clinical and bacteriological efficacy, safety and tolerability of oral gemifloxacin (320 mg once daily, 5 days) was compared with sequential intravenous (i.v.) ceftriaxone (1 g once daily, maximum 3 days) followed by oral cefuroxime axetil (500 mg twice daily, maximum 7 days) vs A 5-day course of oral gemifloxacin was shown by this study to be at least equivalent to sequential i.v. ceftriaxone/cefuroxime axetil (for up to 10 days)"
138,12847531,Pneumonia in term neonates: laboratory studies and duration of antibiotic therapy,2003, journal of perinatology,neonate,ompare 2 days of antibiotic therapy (AT) to 4 days of AT in neonates with pneumonia,arbitruary durations,0,0,NA,pneumonia,Lower respiratory tract infection,0,26,inpatient,US,high,2,4,NA,NA,NA,not reported,NA,PP,none,NA,1,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
139,14526317,Duration of antibiotic therapy after preterm premature rupture of fetal membranes,2003,American Journal of Obstetrics and Gynecology,adult,comparing 3 days of ampicillin with 7 days ampicillin in patients with PPROM.,arbitruary durations,0,0,NA,preterm premature rupture of fetal membranes,Prophylaxis (post-surgery),1,48,inpatient,US,high,3,7,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
140,14625336,Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial,2003,The Journal of the American Medical Association ,adult,A total of 197 patients were randomly assigned to receive 8 days and 204 to receive 15 days of therapy with an antibiotic regimen selected by the treating physician.,arbitruary durations,0,0,NA,VAP,Lower respiratory tract infection,0,197,ICU,France,high,8,15,NA,NA,NA,non-inferiority,10,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
141,12685882,Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up,2003,Scandinavian Journal of Infectious Diseases,adult,randomized to oral treatment with ciprofloxacin 500 mg twice daily for 2 or 4 weeks.,arbitruary durations,0,0,NA,male urinary tract infection,Urinary tract infection,0,114,inpatient,Sweden,high,14,28,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
142,12729423,"Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial",2003,Annals of Internal Medicine,adults,"randomly assigned to one of three treatment groups: 1) a single 2-g dose of intravenous ceftriaxone followed by 10 days of oral doxycycline capsules twice daily, then by 10 days of oral placebo capsules [cornstarch], identical in appearance to the doxycycline capsules, twice daily; 2) a placebo injection [5% dextrose] followed by 10 days of oral doxycycline, 100 mg twice daily, and then by 10 days of oral placebo twice daily; or 3) a placebo injection followed by 20 days of oral doxycycline twice daily.",arbitruary durations,1,0,NA,Lyme disease,Lyme disease,0,180,outpatient,US,high,10,20,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
143,12405169,Seven days vs. 10 days ceftriaxone therapy in bacterial meningitis,2002,Journal of Tropical Pediatrics,children,"Randomization of children togroup  I  (7  days  of  therapy)  or  group  II  (10  days  oftherapy)  was  done  on  the  seventh  day.  In  childrenrandomized  to  group  II,  antibiotics  were  continuedfurther  to  complete  a  course  of  10  days",arbitruary durations,0,0,NA,bacterial meningitis,Meningitis,1,69,inpatient,India,lower middle,7,10,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
144,12480424,"Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial",2002,The Lancet,children,"randomly assigned eligible patients to either single-dose azithromycin suspension (20 mg/kg bodyweight; maximum individual dose 1 g) plus erythromycin placebo, or erythromycin estolate suspension (12·5 mg/kg bodyweight, maximum individual dose 500 mg) every 6 h for 3 days plus azithromycin placebo",arbitruary durations,1,0,NA, childhood cholera,Bacterial infection,1,128,inpatient,Bangladesh,lower middle,1,3,NA,NA,NA,equivalency,15,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
145,12011543,Efficacy and tolerability of once-daily therapy with telithromycin for 5 or 10 days for the treatment of acute maxillary sinusitis,2002,Chemotherapy,adult,subsequently randomized to receive oral teli-thromycin 800 mg once daily for 5 or 10 days.,arbitruary durations,0,0,NA,Acute Maxillary Sinusitis,Upper respiratory tract infection,1,341,outpatient,"Austria, Croatia, CzechRepublic, Denmark, Finland, France, Germany, Greece and Swe-den",high,5,10,NA,NA,NA,equivalency,15,PP,mITT,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
146,12161723,Short treatment durations for acute bacterial rhinosinusitis: Five days of gemifloxacin versus 7 days of gemifloxacin,2002,Otolaryngology–Head and Neck Surgery,adult,"randomized to receive oral gemifloxacin 320 mg once daily for 5 days and a matching placebo once daily on the subsequent 2 days, or oral gemifloxacin 320 mg once daily for 7 days.",arbitruary durations,1,0,NA,acute bacterial rhinosinusitis (ABRS).,Upper respiratory tract infection,0,423,outpatient,"Belgium, Canada, Estonia, Finland, Germany, Ireland, Italy, Lithuania, and the Netherlands.",high,5,7,NA,NA,NA,difference,NA,PP,ITT,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
147,12243918,Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial,2002,The Lancet,children,"All children received 15 mg/kg oral amoxicillin every 8 h for 3 days. We gave every child two bottles—one contained active amoxicillin, which was used for the first 3 days, and the second, used in the next 2 days, contained either active medicine or placebo.",arbitruary durations,1,0,NA,childhood pneumonia,Lower respiratory tract infection,0,2000,outpatient,Pakistan ,lower middle,3,5,NA,NA,NA,equivalency,5,PP,ITT,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
148,12526248,The treatment duration of acute maxillary sinusitis: how long should it be? A nasal smear controlled study,2002,Rhinology,adult,"Patients in group 1 received treatment for 7 days; groups 2, 3, and 4 received 14, 21, and 28 days, respectively.",arbitruary durations,0,0,NA,acute maxillary sinusitis,Upper respiratory tract infection,0,40,outpatient,Turkey,high middle,14,28,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,These findings show that the most appropriate duration of treatment in acute maxillary sinusitis should be at least 14 days according to nasal smear results.
148,12526248,The treatment duration of acute maxillary sinusitis: how long should it be? A nasal smear controlled study,2002,Rhinology,adult,"Patients in group 1 received treatment for 7 days; groups 2, 3, and 4 received 14, 21, and 28 days, respectively.",arbitruary durations,0,0,NA,acute maxillary sinusitis,Upper respiratory tract infection,0,40,outpatient,Turkey,high middle,14,21,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,These findings show that the most appropriate duration of treatment in acute maxillary sinusitis should be at least 14 days according to nasal smear results.
148,12526248,The treatment duration of acute maxillary sinusitis: how long should it be? A nasal smear controlled study,2002,Rhinology,adult,"Patients in group 1 received treatment for 7 days; groups 2, 3, and 4 received 14, 21, and 28 days, respectively.",arbitruary durations,0,0,NA,acute maxillary sinusitis,Upper respiratory tract infection,0,40,outpatient,Turkey,high middle,7,14,NA,NA,NA,not reported,NA,ITT,none,1,NA,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,These findings show that the most appropriate duration of treatment in acute maxillary sinusitis should be at least 14 days according to nasal smear results.
149,11815577,"Five day clarithromycin modified release versus 10 day penicillin V for group A streptococcal pharyngitis: A multi-centre, open-label, randomized study",2002,Journal of Antimicrobial Chemotherapy,adult,Patients were randomized to receive one tablet containing 500 mg of clarithromycin MR once a day for 5 days or one tablet containing 590 mg (1 million units) of penicillin V three times a day for 10 days.,arbitruary durations,0,0,NA,group A streptococcal pharyngitis,Upper respiratory tract infection,0,349,outpatient,France,high,5,10,NA,NA,NA,difference,NA,ITT,PP,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
150,11906502,Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women,2002,Clinical Microbiology and Infection,adults,a single dose of 500 mg of ciprofloxacin versus 3 days 400 mg twice-daily of norfloxacin,arbitruary durations,1,0,NA,uncomplicated urinary tract infections,Urinary tract infection,0,325,outpatient,Spain,high,1,3,NA,NA,NA,equivalency,10,ITT,PP,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
151,11219483,"Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis",2001,Clinical Therapeutics,adults,randomly assigned to receive gatifloxacin* 400 mg once daily for 5 or 7 days or clarithromycint 500 mg twice daily for 10 days in a doubledummy fashion. P,arbitruary durations,1,0,NA,acute exacerbation of chronic bronchitis,Lower respiratory tract infection,0,527,inpatient,US,high,5,7,NA,NA,NA,equivalency,15,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
151,11219483,"Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis",2001,Clinical Therapeutics,adults,randomly assigned to receive gatifloxacin* 400 mg once daily for 5 or 7 days or clarithromycint 500 mg twice daily for 10 days in a doubledummy fashion. P,arbitruary durations,1,0,NA,acute exacerbation of chronic bronchitis,Lower respiratory tract infection,0,527,inpatient,US,high,5,10,NA,NA,NA,equivalency,15,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
152,11686426,Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis,2001,"Annals of Allergy, Asthma & Immunology",adults,randomized 1:1 to double-blind treatment with 5 days of cefprozil or 10 days of clarithromycin,arbitruary durations,1,0,NA,acute exacerbation of chronic bronchitis,Lower respiratory tract infection,0,295,outpatient,US,high,5,10,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
153,11266417,"Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections",2001,Journal of Antimicrobial Chemotherapy,children,Patients  were  assigned  randomly  to  treatment  with  oralazithromycin  suspension  (10  mg/kg/24  h)  in  a  single  dosefor  3  days  or  co-amoxiclav  suspension  (45/11.25  mg/kg/24 h) tds for 10 days,arbitruary durations,1,0,NA,community-acquired acute lower respiratory tract infection (LRTI),Lower respiratory tract infection,0,118,inpatient,Netherlands,high,3,10,NA,NA,NA,equivalency,10,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
154,11285152,Successful shortening from seven to four days of parenteral beta-lactam treatment for common childhood infections: a prospective and randomized study,2001,International Journal of Infectious Diseases,children,"the patients were divided into four categories: pneumonia (acute respiratory symptoms and alveolar consolidation in chest radiograph), other respiratory infections (as for pneumonia, but without alveolar consolidation), sepsis-like infections (clinically ill but no respiratory symptoms, fever at least 385°C [101.3”F],and an initial CRP 100 mg/L),s,9 and other likely bacterial infections (clinically ill enough to receive antimicrobials but no respiratory symptoms, low fever, or only marginally increased CRP),’ cellulitis and lymphadenitis were examples in this category.” The randomization of medication for 4 days or 7 days was done by a computer-generated list kept at the University Hospital, to assign patients in the four groups.",arbitruary durations,0,0,NA,various,Not specified,0,178,inpatient,Finland,high,4,7,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
155,11711256,"Tolerability of 3-day, once-daily azithromycin suspension versus standard treatments for community-acquired paediatric infectious diseases",2001,International  Journal  of  Antimicrobial  Agents  1,children,"randomised  to  treatment  witheither  oral  azithromycin  suspension  (10  mg/kg,  oncedaily for 3 days) or an approved regimen of the follow-ing  comparators:  amoxycillin/clavulanic  acid,  cefaclor cefixime,  ceftriaxone,  clarithromycin,  erythromycin,  orpenicillin  V",arbitruary durations,0,0,NA,community-acquired  paediatric  infectious diseases,Not specified,0,2425,outpatient,Latin   America   and   Europe,high,3,10,NA,NA,NA,difference,NA,ITT,none,1,NA,short,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
156,11868759,Efficacy of short-course therapy with the ketolide telithromycin compared with 10 days of penicillin V for the treatment of pharyngitis/tonsillitis,2001,Scandinavian Journal of Infectious Diseases,adult,Eligible subjects were randomized (1 : 1) to receive oral telithromycin 800 mg once daily for 5 d or penicillin V 500 mg three times daily for 10 d.,arbitruary durations,1,0,NA,pharyngitis/tonsillitis,Upper respiratory tract infection,0,396,outpatient,"Belgium, Czech Republic, Denmark, Finland, Germany, Hungary, New Zealand, South Africa, Switzerland and the UK",high,5,10,NA,NA,NA,equivalency,15,PP,mITT,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
157,15704358,[Five days ceftibuten versus 10 days penicillin in the treatment of 2099 patients with A-streptococcal tonsillopharyngitis],2001,Fortschritte der Medizin Originalien,children,"compare the efficacy and safety of a five day regimen of ceftibuten (9 mg/kg KG, once daily) with 10 days of penicillin V (50,000 I.E./kg KG, divided in three doses)",arbitruary durations,0,0,NA,Group  A-streptococcal tonsillopharyngitis,Upper respiratory tract infection,0,1834,outpatient,Germany,high,5,10,NA,NA,NA,equivalency,not reported,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
158,11207174,Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring,2001,Archives of Disease in Childhood,children,"Children with acute pyelonephritis were treated with antibiotics administered either intravenously for 10 days then orally for five days, or intravenously for three days then orally for 12 days",arbitruary durations,0,0,NA,Acute pyelonephritis,Urinary tract infection,0,435,inpatient,Switzerland,high,3,10,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
159,11076325,Neonatal pneumonia: comparison of 4 vs 7 days of antibiotic therapy in term and near-term infants,2000,Journal of Perinatology,neonates,Infants who were asymptomatic after 48 hours of antibiotic therapy were prospectively randomized to a 4-day group (n = 35) or a 7-day group (n = 38).,arbitruary durations,0,0,NA,Neonatal pneumonia,Lower respiratory tract infection,0,73,inpatient,US,high,4,7,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
160,10749463,Randomized trial of four vs. seven days of ceftriaxone treatment for bacterial meningitis in children with rapid initial recovery,2000,The Pediatric Infectious Disease Journal ,children,"The patients fulfilling the criteria of rapid initial recovery were assigned, irrespective of etiology, to one of two treatment groups before the fifth dose of ceftriaxone. Children born on an even date had therapy stopped (4-day group), whereas those born on an odd date received three more doses (7-day group).",arbitruary durations,0,0,NA,bacterial meningitis,Meningitis,1,102,inpatient,Chile,high,4,7,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
161,10634735,Penicillin for acute sore throat: randomised double blind trial of seven days versus three days treatment or placebo in adults,2000,The BMJ,adults,"Patients were randomly assigned to one of three treatment groups: penicillin V for seven days, penicillin V for three days followed by placebo for four days, or placebo for seven days",arbitruary durations,1,0,NA,acute sore throat,Upper respiratory tract infection,0,561,outpatient,Netherlands,high,4,7,NA,NA,NA,equivalency,not reported,ITT,none,1,NA,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
162,10877166,Treatment of shigellosis with cefixime: two days vs. five days,2000,The Pediatric Infectious Disease Journal ,children,Patients were randomized to receive either 2 days of cefixime (8 mg/kg(day) given once daily followed by 3 days of placebo or 5 days of cefixime,arbitruary durations,1,0,NA,shigellosis ,Gastrointestinal infection,0,74,inpatient,US,high,2,5,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
163,10934078,Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription,2000,American Journal of Respiratory and Critical Care Medicine,adults,"Patients in the control group received the current standard therapy, i.e., the choice, number, and duration of antibiotics was at the discretion of the care providers. These patients were merely followed in an observational fashion with no interventions from the investigators. .Patients randomized to the experimental group received ciprofloxacin 400 mg intravenously every 8 h for 3 d. Addition of other antibiotics was not allowed in the ciprofloxacin monotherapy arm.",arbitruary durations,0,0,NA,pulmonary infiltrates ,Lower respiratory tract infection,0,81,ICU,US,high,3,10-21,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Because the study was not blinded, physicians and care providers could see the results. We observed a trend toward physicians prescribing fewer antibiotics for shorter duration in patients randomized to standard therapy as the study progressed.  fter interviewing the investigators and attending physicians and reviewing the results, the protocol was terminated because the institutional review board determined that it was unethical to continue to study."
164,10975012,Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid,2000,Transactions of the Royal Society of Tropical Medicine,children,"Children were randomized in blocks of 10 to receive oral treatment with either nalidixic acid (Gateway Pharmaceuticals, Australia) 55 mg/kg daily divided into 4 equal doses for a total of 5 days or ofloxacin (Roussel-UCLAF, Paris, France) 7.5 mg/kg given immediately and then again 12 h later (total dose 15 mg/W)",arbitruary durations,0,0,NA,bacillary dysentery,Gastrointestinal infection,0,74,inpatient,Vietnam,lower middle,1,5,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
165,10980174,Eradication of non-typhoid salmonellae in acute enteritis after therapy with ofloxacin for 5 or 10 days,2000,ournal of Antimicrobial Chemotherapy,adult,"Thirty and 19 patients were randomized, double blinded, to 400 mg ofloxacin od for 5 days (ofloxacin for 5 days followed by placebo for 5 days) or 10 days, respectively.",arbitruary durations,1,0,NA,acute enteritis,Gastrointestinal infection,0,49,inpatient,Norway,high,5,10,NA,NA,NA,not reported,NA,ITT,none,1,NA,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
166,10993623,Complicated appendicitis: is there a minimum intravenous antibiotic requirement? A prospective randomized trial,2000,The American Surgeon,adult,Group 1 patients were given a minimum 5-day IV antibiotic course whereas Group 2 patients had no minimum IV antibiotic requirement. Group 1 patients received more IV antibiotics than Group 2 patie,arbitruary durations,0,0,NA,complicated (perforated or gangrenous) appendicitis,Abdominal infection,0,94,inpatient,US,high,4,6,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
167,10933649,Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infections,2000,Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infections,adult,Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infections,arbitruary durations,1,0,NA,Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infections,Skin and soft tissue infection,0,439,outpatient,US,high,5,7,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
168,10819344,Five vs. ten days of antibiotic therapy for acute otitis media in young children,2000,The Pediatric Infectious Disease Journal ,children,"At the initial visit patients were assigned by means of a telephonic computer-generated code to receive either 10 days of treatment with cefpodoxime-proxetil, 8 mg/kg/day divided twice daily, or 5 days of the same regimen followed by 5 days of placebo therapy.",arbitruary durations,1,0,NA,acute otitis media,Ear Nose Throat Infection,0,450,outpatient,France,high,5,10,NA,NA,NA,difference,NA,PP,ITT,1,1,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
169,11006450,Efficacy of ceftibuten in 5 versus 10 days treatment of recurrent acute otitis media in children,2000,International Journal of Pediatric Otorhinolaryngology,children,The patients were randomized to ceftibuten 9 mg/kg/day as a single dose for 5 or 10 days.,arbitruary durations,0,0,NA,recurrent acute otitis media,Ear Nose Throat Infection,0,180,outpatient,Sweden,high,5,10,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
170,11055597,Short course therapy with cefitbuten versus azithromycin in pediatric streptococcal pharyngitis,2000,The Pediatric Infectious Disease Journal ,children,Patients with a positive rapid test for GABHS were randomized to receive ceftibuten (provided as oral suspension 36 mg/ml or tablet 400 mg) as a once daily dose of 9 mg/kg (or 1 tablet if the weight was ≥50 kg) for 5 days or azithromycin (provided as oral suspension 40 mg/ml or tablet 500 mg) in once daily doses of 10 mg/kg (or 1 tablet if the weight was ≥50 kg) for 3 days.,arbitruary durations,0,0,NA,group A beta-hemolytic streptococcal (GABHS) pharyngitis,Upper respiratory tract infection,0,252,outpatient,Italy,high,3,5,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
171,11144396,Five-day cefdinir course vs. ten-day cefprozil course for treatment of acute otitis media,2000,The Pediatric Infectious Disease Journal ,children,Patients received cefdinir 14 mg/ kg/day divided twice a day for 5 days or cefprozil 30 mg/kg/day divided twice a day for 10 days.,arbitruary durations,0,0,NA,pediatric acute otitis media ,Ear Nose Throat Infection,0,435,outpatient,US,high,5,10,NA,NA,NA,equivalency,15,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
172,10735395,Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial,2000,The Journal of the American Medical Association ,adults,"Patients were randomized to oral ciprofloxacin, 500 mg twice per day for 7 days (with or without an initial 400-mg intravenous dose) followed by placebo for 7 days (n = 128 included in analysis) vs trimethoprim-sulfamethoxazole, 160/800 mg twice per day for 14 days (with or without intravenous ceftriaxone, 1 g) (n = 127 included in the analysis).",arbitruary durations,1,0,NA,acute uncomplicated pyelonephritis pyelonephritis,Urinary tract infection,0,378,outpatient,US,high,7,14,NA,NA,NA,difference,NA,PP,ITT,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"In conclusion, for the outcomes of bacteriologic and clinical cure, we have demonstrated that the 7-day ciprofloxacin regimen is at least as efficacious as the 14-day trimethoprim-sulfamethoxazole regimen, and statistically, the ciprofloxacin regimen was superior."
173,10090434,Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis,1999,Clinical Therapeutics,adults,Patients were randomly assigned by computer-generated code to receive either 5- or lo-day treatment with 400-mg grepafloxacin tablets to be taken once daily (approximately every 24 hours).  Patients randomized to the 5-day treatment received matching placebo tablets to be taken once daily on days 6 through 10.,arbitruary durations,1,0,NA,acute bacterial exacerbations of chronic bronchitis,Lower respiratory tract infection,0,389,outpatient,US,high,5,10,NA,NA,NA,equivalency,15,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
174,11329100,"Comparison of 7 versus 10 days of antibiotic therapy for hospitalized patients with uncomplicated community-acquired pneumonia: a prospective, randomized, double-blind study",1999,American Journal of Therapeutics,adults,"Fifty-two veterans were treated with 2 days of cefuroxime at 750 mg intravenously every 8 hours followed by group 1, 8 days oral therapy, and group 2, 5 days oral therapy followed by 3 days of placebo.",arbitruary durations,1,0,NA,CAP,Lower respiratory tract infection,0,52,inpatient,US,high,7,10,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
175,10204554,The duration of antibiotic administration in penetrating abdominal trauma,1999,American Journal of Therapeutics,adults,"Group I received 24 hours of intravenous (IV) cefoxitin with the first 1-g dose given in the emergency department (ED) immediately after the determination of a requirement for laparotomy, followed by q6h administration for a total of four doses. Group II patients received 5 days of IV cefoxitin, with the first 1-g dose given in the ED immediately after the determination of the requirement for laparotomy followed by q6h administration for a total of 20 doses.",arbitruary durations,1,0,NA,penetrating abdominal trauma,Abdominal infection,0,314,inpatient,US,high,1,5,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
176,10077192,Antibiotic prophylaxis in orthognathic surgery: A 1-day versus 5-day regimen,1999,Journal of Oral and Maxillofacial Surgery,adults,"Each group received penicillin G, two million units intravenously, immediately preoperatively, and one million units intravenously every 3 hours intraoperatively and once postoperatively 3 hours after the last intraoperative dose. Group 1 then received penicillin G, one million units intravenously, every 6 hours for eight doses, followed by penicillin V suspension 300 mg orally every 6 hours for eight doses. Group 2 received placebo in a similar dosing schedule.",arbitruary durations,1,0,NA,postoperative infection after orthognathic surgery,Prophylaxis (post-surgery),0,30,inpatient,Canada,high,1,5,NA,NA,NA,difference,NA,ITT,none,1,NA,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Only 30 patients were included in this study because it was stopped at that point because of the high incidence of infection (33.4%).
177,10457551,[Infection prophylaxis in open leg fractures. Comparison of a dose of pefloxacin and 5 days of cefazolin-oxacillin. A randomized study of 616 cases],1999,Revue de Chirurgie Orthopédique et Réparatrice de l Appareil Moteur,adults,efficacy of a single 800 mg injection of Pefloxacin (PF) versus 2 days of cefazolin (1 gr.Q.6 H) followed by 3 days of oxacillin (1 gr.Q.8 H) in patients with an open tibial fracture,arbitruary durations,1,0,NA,postoperative infection after open tibial fractures requiring single-stage bone coverage,Prophylaxis (post-surgery),1,616,inpatient,France,high,1 dose,5,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
178,10554373,Duration of antibiotic prophylaxis in high-risk patients with penetrating abdominal trauma: a prospective randomized trial,1999,Journal of Gastrointestinal Surgery,adults,Patients were randomly assigned to a short course (24 hours) or a long course (5 days) of antibiotic therapy.,arbitruary durations,1,0,NA,penetrating abdominal trauma,Abdominal infection,0,63,inpatient,US,high,1,5,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
179,10353511,One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora,1999,The Pediatric Infectious Disease Journal,children,"The children received either ceftriaxone, 50 mg/kg, as a single intramuscular dose or 80 mg/kg/day amoxicillin and 10 mg/kg/day clavulanate (amox/clav), divided into three doses/day for 10 days.",arbitruary durations,0,0,NA,acute otitis media,Ear Nose Throat Infection,0,513,outpatient,US,high,1,10,NA,NA,NA,equivalency,10,PP,ITT,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
180,10225575,"A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection",1999,Journal of Antimicrobial Chemotherapy,adults,"This multicentre, prospective, randomized, double-blind trial compared oral ciprofloxacin (100 mg bd) for 3 days with co-trimoxazole (160/800 mg bd) or nitrofurantoin (100 mg bd) for 7 days.",arbitruary durations,1,0,NA,uncomplicated urinary tract infection,Urinary tract infection,0,713,outpatient,US,high,3,7,NA,NA,NA,equivalency,10,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
181,9868662,Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group,1998,Clinical Infectious Diseases,adults,Patients were assigned randomly to receive either monotherapy with 2 g of iv ceftriaxone once daily for 4 weeks or combination therapy with 2 g of iv ceftriaxone plus 3 mg of iv gentamicin/kg of ideal body weight once daily for 2 weeks.,arbitruary durations,0,1,1,penicillin-susceptible streptococci. Endocarditis ,Vascular infection,1,67,inpatient,US,high,14,28,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
182,9666577,Prophylactic antibiotics administration head and neck cancer surgery with major flap reconstruction: 1-day cefoperazone versus 5-day cefotaxime,1998,Acta Chirurgiae Plasticae,adults,Patients were assigned randomly to receive Cefoperazone sodium for either 24 hr. (study group) or Cefotaxime sodium for 120 hr. (control group).,arbitruary durations,1,0,NA,postoperative infection after surgery of the head and neck cancer with major flap reconstruction,Prophylaxis (post-surgery),0,50,inpatient,India,lower middle,1,5,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
183,9515521,Duration of antimicrobial prophylaxis in vascular surgery,1998,The American Journal of Surgery,adults,"Patients were randomized to receive the multiple dose regimen (ie, until the lines are removed, but <:5 days) received ticarcillin 3.0 g/clavulanate 0.1 g IV at 6 hourly intervals after the initial dose, ie, for a maximum total of 20 doses.",arbitruary durations,0,0,NA,postoperative infection after vascular surgery,Prophylaxis (post-surgery),1,302,inpatient,Australia,high,1,<=5,NA,NA,NA,difference,NA,ITT,none,1,NA,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
184,9593129,Five-day cefdinir treatment for streptococcal pharyngitis,1998,Antimicrobial Agents and Chemotherapy,adults,Patients were randomized to receive either 300-mg cefdinir capsules twice a day (b.i.d.) for 5 days or 250-mg penicillin V tablets four times a day (q.i.d.) for 10 days.,arbitruary durations,0,0,NA,Streptococcal Pharyngitis,Upper respiratory tract infection,0,558,outpatient,US,high,5,10,NA,NA,NA,equivalency,not reported,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
185,9624542,A comparison between single-dose fosfomycin trometamol (Monuril®) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women,1998,International Journal of Antimicrobial Agents,adults,"Patient randomization was performed in groups of nine, two thirds of subjects receiving a single 3 g oral dose of fosfomycin trometamol supplied as FMT (Monuril, Zambon Group, 3 g sachet) and one third receiving a 5 days course of trimethoprim 200 mg twice daily supplied as TMP 200 mg unitary dose tablets (10 tablets per bottle).",arbitruary durations,0,0,NA, uncomplicated urinary tract infection ,Urinary tract infection,0,530,outpatient,UK,high,1,5,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
186,9410047,[Double-blind clinical trial comparing 5 days of dirithromycin versus 7 days of diacetylmidecamycin in acute bronchitis and acute exacerbations of chronic bronchitis],1997,Enfermedades Infecciosas y Microbiología Clínica,adults,"87 (80 evaluable) being randomly assigned to receive dirythromycin (500 mg/day over 5 days) and 87 (83 evaluable) diacetylmidecamycin (600 mg, twice daily over 7 days).",arbitruary durations,1,0,NA,acute bronchitis and acute exacerbations of chronic bronchitis,Lower respiratory tract infection,0,87,outpatient,Spain,high,5,7,NA,NA,NA,difference,NA,PP,ITT,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
187,9200361,Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections,1997,Pediatrics,adults,randomly allocated children and adults with culture-positive community-acquired pertussis to either 7 or 14 days of erythromycin estolate treatment (40 mg/kg/d; maximum dose 1 g/d).,arbitruary durations,0,0,NA,Bordetella pertussis infection,Lower respiratory tract infection,0,168,outpatient,Canada,high,7,14,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
188,9006528,A study of 5-day cefdinir treatment for streptococcal pharyngitis in children,1997,Archives of Pediatrics and Adolescent Medicine,children,"Patients were randomized to receive either 7-mg/kg cefdinir, twice daily, for 5 days or 10-mg/kg penicillin V potassium, 4 times daily, for 10 days.",arbitruary durations,0,0,NA,streptococcal pharyngitis in children,Upper respiratory tract infection,0,480,outpatient,US,high,5,10,NA,NA,NA,difference,NA,PP,none,NA,1,short,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,A 5-day regimen of cefdinir eradicated a higher proportion of S pyogenes than a 10-day regimen of penicillin V.
189,9177961,Five-day versus ten-day treatment of acute otitis media with cefprozil,1997,European Journal of Clinical Microbiology & Infectious Diseases,children, investigate the possibility of decreasing the duration of treatment of acute otitis media by comparing the clinical outcome and safety of a five-day and a ten-day course of cefprozil.,arbitruary durations,0,0,NA,acute otitis media ,Ear Nose Throat Infection,0,708,outpatient,Greece,high,5,10,NA,NA,NA,difference,NA,PP,none,NA,1,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,A five-day course of treatment with cefprozil can be recommended only if children have no history of recurrent acute otitis media.
190,8637787,Three- versus four-week administration of benzathine penicillin G: effects on incidence of streptococcal infections and recurrences of rheumatic fever,1996,Pediatrics,adults,randomly allocating all patients with RF to a 3-week or 4-week BPG prophylaxis program,arbitruary durations,0,1,0,Group A streptococcal infections and the recurrences of rheumatic fever (RF).,Rheumatic fever,1,249,outpatient,Taipei,high,21,28,NA,NA,NA,difference,NA,PP,none,NA,1,short,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
191,8698374,Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practises,1996,Genitourinary Medicine,adults,"compare the efficacy and safety of single 1 g oral azithromycin with doxycycline, 100 mg twice daily for seven days",arbitruary durations,0,0,NA,uncomplicated urogenital chlamydial infection,Vaginosis,0,597,outpatient,US,high,1,7,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
192,8818850,"Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: Results of a randomized, double-blind comparative study",1996,Journal of Antimicrobial Chemotherapy,adults,"Patients were randomly assigned to treatment with azithromycin (Pfizer), one 500-mg tablet once daily on 3 consecutive days, or co-amoxiclav (Augmentin, Beecham Research) 625 mg three times daily for 10 days.",arbitruary durations,1,0,NA,acute infectious exacerbations of chronic bronchitis and acute bronchitis or pneumonia,Lower respiratory tract infection,0,78,outpatient,Belgium,high,3,10,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
193,8849259,Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children,1996,Antimicrobial Agents and Chemotherapy,children,"Patients were randomized to receive either ofloxacin (Oflocet; Roussel, Paris, France) at 15 mg/kg of body weight divided into two daily doses given for 2 days (Ofx2) or for 3 days (Ofx3): i.e., total doses of 30 or 45 mg/kg respectively.",arbitruary durations,0,0,NA,uncomplicated multidrug-resistant typhoid fever,Gastrointestinal infection,0,100,inpatient,Vietnam,lower middle,2,3,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
194,9124864,Treatment of enteric fever with pefloxacin for 7 days versus 5 days: a randomized clinical trial,1996,Antimicrobial Agents and Chemotherapy,adults,randomized to receive pefloxacin for 5 days (group A) or 7 days (group B).,arbitruary durations,0,0,NA,enteric fever,Gastrointestinal infection,0,46,inpatient,Turkey,higher middle,5,7,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
195,8637789,Rheumatic fever prophylaxis using benzathine penicillin G (BPG): two- week versus four-week regimens: comparison of two brands of BPG,1996,Pediatrics,adults,"34 rheumatic subjects, aged 8 to 16 years were randomly assigned to receive a 4-week injection of 1.2 million U of either a locally manufactured BPG brand (22 patients) or an imported one (12 patients).",arbitruary durations,0,0,NA,upper respiratory Group A beta-hemolytic streptococcal (GABHS) infections and rheumatic fever (RF) recurrences,Upper respiratory tract infection,0,360,inpatient,Egypt,lower middle,14,28,NA,NA,NA,superiority,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
196,8864730,Short-term versus long-term antimicrobial prophylaxis in oncologic head and neck surgery,1996,Head & Neck Surgery,adults,compare efficacy and tolerability of clindamycin-cefonicid administered for 1 day versus 3 days,arbitruary durations,0,0,NA,postoperative prophylaxis after oncologic head and neck surgery,Prophylaxis (post-surgery),0,160,inpatient,Italy,high,1,3,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
197,8822290,Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media,1996,The Pediatric Infectious Disease Journal,children,"Patients received CAE for either 5 or 10 days at 30 mg/kg/day in 2 divided doses (n = 242 and 235, respectively) or AMX/CL for 10 days at 40 mg/kg/day in 3 divided doses (n = 242). Patients in the CAE (5 days) group received placebo on Days 6 through 10.",arbitruary durations,0,0,NA,acute otitis media,Ear Nose Throat Infection,0,719,outpatient,US,high,5,10,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
198,8858671,Six-day amoxicillin vs. ten-day penicillin V therapy for group A streptococcal tonsillopharyngitis,1996,The Pediatric Infectious Disease Journal,children,"The children received either oral amoxicillin (AMX) suspension, 50 mg/kg/day divided twice daily for 6 days, or oral phenoxymethyl penicillin suspension (PEN V), 45 mg/kg/day divided into three doses/day (75 000 IU/kg/day) for 10 days.",arbitruary durations,0,0,NA,group A streptococcal tonsillopharyngitis,Upper respiratory tract infection,0,321,outpatient,France,high,6,10,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
199,8922570,Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group,1996,European Journal of Clinical Microbiology & Infectious Diseases,children,treated with erythromycin estolate (40 mg/kg/d in two divided doses for five days) or penicillin V (30 mg/kg/d in three divided doses for ten days).,arbitruary durations,0,0,NA,group A streptococcal tonsillopharyngitis in children,Upper respiratory tract infection,0,227,outpatient,Germany,high,5,10,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
200,7789484,Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia,1995,European Respiratory Journal,adults,"20 patients were given azithromycin (AZ group), 500 mg oral therapy in a single daily dose for 3 days, and 20 patients clarithromycin (CL group), 250 mg b.i.d. oral therapy for at least 8 days.",arbitruary durations,0,0,NA,moderately severe community-acquired pneumonia,Lower respiratory tract infection,0,40,inpatient,Italy,high,3,8,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
201,8537264,A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis,1995,Journal of Antimicrobial Chemotherapy ,adults,"Patients eligible for inclusion were randomly assigned to treatment with either dirithromycin 500 mg once daily for 5 days or clarithromycin, 250 mg twice daily (morning and evening) for 7 days.",arbitruary durations,0,0,NA,acute bacterial exacerbation of chronic bronchitis,Lower respiratory tract infection,0,212,outpatient,UK,high,5,7,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
202,8585739,Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis,1995,Journal of Antimicrobial Chemotherapy ,adults,"Patients were assigned according to a computer-generated randomization code to receive treatment with one of three regimens: cefuroxime axetil at 250 mg twice a day for 5 days, followed by placebo twice a day for 5 days; cefuroxime axetil at 250 mg twice a day for 10 days; or amoxicillinclavulanate at 500 mg (500 mg of amoxicillin plus 125 mg of clavulanic acid) three times a day for 10 days.",arbitruary durations,0,0,NA,Secondary Bacterial Infections of Acute Bronchitis,Lower respiratory tract infection,0,537,outpatient,US,high,5,10,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
203,7573719,Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella,1995,American Journal of Tropical Medicine and Hygiene,adults,"Patients were randomly assigned to one of two treatment groups.Each patient received ciprofloxacin, 500mg(NeofloxinÂ®;BeximcoPharmaceuticalsLtd.,Dhaka,Bangladesh), orally twice a day for either 10 or 14 days",arbitruary durations,0,0,NA,enteric fever,Gastrointestinal infection,0,69,outpatient,Bangladesh,lower middle,10,14,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
204,7897784,Randomized controlled trial of 3 vs 10 days of trimethoprim/sulfamethoxazole for acute maxillary sinusitis,1995, The Journal of the American Medical Association ,adults,Subjects were randomly assigned to TMP/SMX double strength: one tablet twice daily for 10 days or one tablet twice daily for 3 days followed by 7 days of placebo.,arbitruary durations,1,0,NA,acute maxillary sinusitis,Upper respiratory tract infection,0,80,inpatient,US,high,3,10,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
205,7562017,Clindamycin/cefonicid in head and neck oncologic surgery: one-day prophylaxis is as effective as a three-day schedule,1995,Journal of Chemotherapy,adults,"Patients were randomly assigned to receive either one-day antibiotic prophylaxis (clindamycin 600 mg i.v. at induction, followed by three doses, one every 8 hours; cefonicid 1 g i.v. at induction, and 1 g after 12 hours), or three-day chemoprophylaxis (clindamycin 600 mg i.v. three times a day for three days; cefonicid 1 g i.v. at induction, followed by three doses administered after 12, 24 and 48 hours)",arbitruary durations,0,0,NA,postoperative prophylaxis after head and neck oncologic surgery,Prophylaxis (post-surgery),0,136,inpatient,Italy,high,1,3,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
206,7559195,A double-blind randomized trial comparing the efficacy and safety of a 5-day course of cefotiam hexetil with that of a 10-day course of penicillin V in adult patients with pharyngitis caused by group A β-haemolytic streptococci,1995,Journal of Antimicrobial Chemotherapy,adults,Patients were randomized to receive either CTM 200 mg bd for 5 days and a PEV placebo tds for 10 days or PEV 1 megaunit (600 mg) tds for 10 days and a CTM placebo bd for 5 days.,arbitruary durations,1,0,NA, group A beta‐haemolytic streptococci (GABHS),Upper respiratory tract infection,0,240,outpatient,France,high,5,10,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
207,7603811,Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A beta-hemolytic streptococcal pharyngitis in children,1995,The Pediatric Infectious Disease Journal,children,"randomized to receive either cefuroxime axetil suspension (N = 152; 20 mg/kg/day twice daily) for 4 days, penicillin suspension (N = 156; 45 mg/kg/day divided three times daily) for 10 days",arbitruary durations,0,0,NA,group A beta-hemolytic streptococcal pharyngitis,Upper respiratory tract infection,0,308,outpatient,France,high,4,10,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
208,7768760,High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women,1995,Journal of Antimicrobial Chemotherapy,adults,a single 3.25 g dose of co-amoxiclav as treatment of acute uncomplicated lower urinary tract infection in women was compared with that of co-trimoxazole 960 mg bd for 7 days,arbitruary durations,1,0,NA,uncomplicated lower urinary tract infection,Urinary tract infection,0,666,outpatient,UK,high,1,7,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
209,7746123,[Short-term ciprofloxacin treatment of bacillary dysentery due to Shigella dysenteriae type 1 in Rwandan refugees],1994,Medecine tropicale: revue du corps de sante colonial ,adults,compare the effectiveness of short-term treatment (1 g of ciprofloxacin in a single daily doses for 2 days) with that of the standard treatment (1 g of ciprofloxacin in two daily doses for 5 days).,arbitruary durations,1,0,NA,bacillary dysentery,Gastrointestinal infection,0,57,outpatient,Zaïre,low,2,5,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
210,8173721,"Results of a double-blind, placebo-controlled clinical trial program of single-dose ceftizoxime versus multiple-dose cefoxitin as prophylaxis for patients undergoing vaginal and abdominal hysterectomy",1994,Journal of the American College of Surgeons,adults,"a single 1 gram dose of ceftizoxime were compared with those of a standard regimen, three 2 gram doses of cefoxitin, for prophylaxis of perioperative infection in women undergoing abdominal or vaginal hysterectomy.",arbitruary durations,1,0,NA,postoperative prophylaxis after vaginal and abdominal hysterectomy,Prophylaxis (post-surgery),0,461,inpatient,US,high,1 dose,3 doses,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
211,8288664,Prophylaxis against infection in total joint arthroplasty. One day of cefuroxime compared with three days of cefazolin,1994,Journal of Bone and Joint Surgery,adults,"randomly assigned to receive either 1.5 grams of cefuroxime followed by 750 milligrams eight and sixteen hours later (for a total of one day of antibiotic treatment), or one gram of cefazolin every eight hours for nine doses (for a total of three days of antibiotic treatment)",arbitruary durations,1,0,NA,postoperative prophylaxis after total joint arthroplasty,Prophylaxis (post-surgery),1,1354,inpatient,US,high,1,3,NA,NA,NA,difference,NA,PP,ITT,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
212,7921095,Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children,1994,Archives of Pediatrics and Adolescent Medicine ,children,"All patients who met the entry criteria were randomly assigned in a 1:1:1 ratio to receive the following drugs: (1) cefpodoxime proxetil oral suspension (100 mg/5 mL) at a dose of 10 mg/kg per day divided into two equal doses and given every 12 hours, with or without food, for 5 con¬ secutive days (maximum daily dose, 200 mg); (2) cefpo¬ doxime proxetil oral suspension (100 mg/5 mL) at a dose of 10 mg/kg per day given as a single daily dose, with or without food, for 10 consecutive days (maximum daily dose, 200 mg); or (3) penicillin V potassium oral suspension (250 mg/5 mL) at a dose of 40 mg/kg per day divided into three equal doses and given on an empty stomach for 10 con¬ secutive days (maximum daily dose, 1000 mg).",arbitruary durations,0,0,NA,acute group A beta-hemolytic streptococcal tonsillopharyngitis,Upper respiratory tract infection,0,484,outpatient,US,high,5,10,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
213,8129435,Successful treatment of epiglottitis with two doses of ceftriaxone,1994,Archives of Disease in Childhood,children,"patients were randomised before the start of treatment to receive ceftriaxone or chloramphenicol. The dose of ceftriaxone was 100 mg/kg, followed by 50 mg/kg 24 hours later. The dose of chloramphenicol was 40 mg/kg followed by 25 mg/kg eight hourly for five days.",arbitruary durations,0,0,NA,epiglottitis ,Upper respiratory tract infection,0,55,inpatient,Australia,high,1,5,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
214,8191242,Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin,1994,Scandinavian Journal of Infectious Diseases,children,"Patients were randomized to receive either cefpodoxime proxetil, 100 mg bid orally for 5 days, or phenoxymethyl penicillin, 600 mg tid orally for 10 days.",arbitruary durations,0,0,NA,Group A beta-hemolytic streptococci (GABHS) ,Upper respiratory tract infection,0,220,outpatient,France and South Africa,high,5,10,NA,NA,NA,equivalence,10,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
215,7872756,Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women,1994,Antimicrobial Agents and Chemotherapy,adults,randomly assigned by acomputer to nonblind treatment witheither a single 3-g dose of fosfomycin trometamolor 5-day therapy of four daily doses of 500mg of cephalexin,arbitruary durations,0,0,NA,uncomplicated lower urinary tract infections,Urinary tract infection,0,112,outpatient,Isreal,high,1,5,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
216,8297196,Urinary tract infections with low and high colony counts in young women: Spontaneous remission and single-dose vs multiple-day treatment,1994,Archives of internal medicine,adults,Women with bacterial urinary tract infection were randomized to a group given a single dose of 1200 mg of norfloxacin and to a group treated with 400 mg of norfloxacin twice daily for 7 days.,arbitruary durations,0,0,NA,uncomplicated UTI,Urinary tract infection,0,107,outpatient,Isreal,high,1,7,NA,NA,NA,diffference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
217,8225636,Clarithromycin 250 mg b.i.d. for 5 or 10 days in the treatment of adult patients with purulent bronchitis,1993,Infection,adults,"compared the safety and efficacy of clarithromycin, 250 mg b.i.d. administered for either 5 or 10 days, i",arbitruary durations,1,0,NA,purulent bronchitis,Lower respiratory tract infection,0,221,outpatient,Germany,high,5,10,NA,NA,NA,diffference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
218,8215265,Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial,1993,Antimicrobial Agents and Chemotherapy,adults,Ceftriaxone was given to 28 patients in once-daily intravenous doses of 75 mg/kg of body weight to children and 4 g to adults for 5 days; chloramphenicol was given to 31 patients at a dosage of 60 mg/kg/day until defervescence and then at 40 mg/kg/day to complete 14 days of treatment.,arbitruary durations,0,0,NA,typhoid fever,Gastrointestinal infection,0,59,outpatient,Bangladesh,lower middle,5,14,NA,NA,NA,diffference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
219,8286514,"Outcome at three to five years of primary closure of perianal and pilonidal abscess. A randomised, double-blind clinical trial with a complete three-year followup of one compared with four days' treatment with ampicillin and metronidazole",1993,European Journal of Surgery,adults,two regimens of antibiotic treatment (ampicillin and metronidazole for one compared with four days) ,arbitruary durations,1,0,NA,perianal and pilonidal abscess,Skin and soft tissue infection,0,88,inpatient,Denmark,high,1,4,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
220,8174496,Antibiotic prophylaxis in cardiovascular surgery: a prospective randomized comparative trial of one day cefazolin versus single dose cefuroxime,1993,Drugs under experimental and clinical research,adults,one day cefazolin prophylaxis (1 g q 8 h i.v.) was compared with a single dose of cefuroxime prophylaxis (1.5 g),arbitruary durations,0,0,NA,postoperative prophylaxis after cardiovascular surgery,Prophylaxis (post-surgery),1,418,inpatient,Switzerland,high,1 dose,1,NA,NA,NA,difference,NA,ITT,none,1,NA,short,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
221,8270392,Cefuroxime prophylaxis in biliary surgery: single versus triple dose,1993,Israel Medical Association Journal,adults,"compare a single dose of cefuroxime (1.5 gi.v. on call to surgery) with the standard regimen (1.5 gi.v. on call to surgery followed by two additional doses of 750 mg i.v. each, 8 and 16 h after surgery).",arbitruary durations,0,0,NA,postoperative prophylaxis after biliary surgery,Prophylaxis (post-surgery),1,100,inpatient,Isreal,high,1 dose,3 doses,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
222,8326680,[Prospective randomized study on effect of duration of antimicrobial prophylaxis for mastectomy],1993,The Japanese Journal of Antibiotics,adults,Selected patients were treated with 600 mg of OFLX daily in 3 divided doses starting the day before surgery. One group was treated for 5 days and the other was treated for 10 days.,arbitruary durations,0,0,NA,postoperative prophylaxis after mastectomy,Prophylaxis (post-surgery),0,110,inpatient,Japan,high,5,10,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
223,8298585,Fosfomycin trometamol in a single dose versus seven days nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women,1993,Pharmacy World & Science,adults,In this study the efficacy and tolerability of a single dose of 3 g fosfomycin trometamol and the conventional treatment with nitrofurantoin 50 mg four times daily for seven days were compared.,arbitruary durations,1,0,NA,uncomplicated urinary tract infections,Urinary tract infection,0,231,outpatient,Netherlands,high,1,7,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
224,1522663,Comparative study of single dose and five days dose of gentamicin as prophylaxis in appendicectomy,1992,Journal of Pakistan Medical Association,adults,Patients in group 1 had a single intravenous injection of gentamicin (2 mg per kg) at the induction of anaesthesia while those group 2 had similar treatment followed by an eight hourly injection of gentamicin postopcratively for five days,arbitruary durations,0,0,NA,postoperative prophylaxis after appendicectomy,Prophylaxis (post-surgery),0,100,inpatient,Nigeria,lower middle,1,5,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
225,1461853,A randomized trial of one versus three doses of Augmentin as wound prophylaxis in at-risk abdominal surgery,1992,Postgraduate Medical Journal,adults,Eligible patients were randomly allocated to one or three doses of antibiotics by taking sequentially numbered stickers prepared from a table of random numbers.,arbitruary durations,0,0,NA,postoperative prophylaxis after at-risk abdominal surgery,Prophylaxis (post-surgery),0,908,inpatient,UK,high,1 dose,3 doses,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
226,1421911,Single daily doses of trimethoprim/sulphadiazine for three or 10 days in urinary tract infections,1992,Acta Paediatrica,children,atients  in  group 1 received a  single daily dose of 4 mg/kg trimethoprim together with 17.5 mg/kg sulphadiazine  for  three  days.  Patients  in  group 2 received the same dose but for 10 days.,arbitruary durations,0,0,NA,uncomplicated urinary tract infections,Urinary tract infection,0,40,outpatient,Canada,high,3,10,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
227,2019378,Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients,1991,Gastroenterology,adults,"43 were randomized to a group receiving 5 days and 47 to a group receiving 10 days of single-agent cefotaxime, 2 g IV every 8 hours.",arbitruary durations,0,1,0,spontaneous bacterial peritonitis,Abdominal infection,0,90,inpatient,US,high,5,10,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
228,2039326,Randomized trial of one-dose versus six-dose cefazolin prophylaxis in elective general thoracic surgery,1991,The Annals of Thoracic Surgery,adults,compare the efficacy of one to six doses of cefazolin as prophylaxis in general thoracic surgery,arbitruary durations,1,0,NA,postoperative prophylaxis after elective general thoracic surgery,Prophylaxis (post-surgery),0,208,inpatient,UK,high,1,2,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
229,1926651,Single-dose fosfomycin trometamol (Monuril) versus multiple-dose norfloxacin: results of a multicenter study in females with uncomplicated lower urinary tract infections,1991,Urologia Internationalis,adults,"comparing the efficacy and safety of Fosfomycin trometamol (Monuril), 3-gram single dose, and Norfloxacin (Noroxine 400), 400 mg twice daily for 5 days",arbitruary durations,0,0,NA,uncomplicated lower urinary tract infections,Urinary tract infection,0,63,outpatient,France,high,1,5,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
230,2012351,How long should catheter-acquired urinary tract infection in women be treated? A randomized controlled study,1991,Annals of Internal Medicine,adults,"randomly assigned to receive no therapy, a single dose (320-1600 mg) of therapy with trimethoprim-sulfamethoxazole, or 10 days (160-800 mg twice daily) of therapy.",arbitruary durations,0,0,NA,catheter-acquired urinary tract infection,Urinary tract infection,0,119,inpatient,Canada,high,1,10,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
231,2105115,Single dose cefotaxime plus metronidazole versus three dose cefuroxime plus metronidazole as prophylaxis against wound infection in colorectal surgery: multicentre prospective randomised study,1990,The BMJ,adults,"Group 1 received cefotaxime 1 g intravenously plus metronidazole 500 mg intravenously preoperatively. Group 2 received cefuroxime 1.5 g intravenously plus metronidazole 500 mg intravenously preoperatively, followed by cefuroxime 750 mg intravenously plus metronidazole 500 mg intravenously eight hours and 16 hours postoperatively.",arbitruary durations,0,0,NA,postoperative prophylaxis after colorectal surgery,Prophylaxis (post-surgery),1,1018,inpatient,UK,high,1 dose,3 doses,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
232,2127268,Five day treatment of pharyngotonsillitis with cefpodoxime proxetil,1990,Journal of Antimicrobial Chemotherapy,adults,Patients were randomly assigned to receive cefpodoxime proxetil 100 mg bd for five days or penicillin V 0-6 g tid for ten days.,arbitruary durations,0,0,NA,pharyngotonsillitis ,Upper respiratory tract infection,0,162,outpatient,France and South Africa,high,5,10,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
233,2258342,Single-dose pefloxacin versus five-days treatment with norfloxacin in uncomplicated cystitis in women,1990,Journal of Antimicrobial Chemotherapy,adults,Patients were randomly assigned to receive either (a) two tablets 400 mg pefloxacin and one placebo capsule followed by twice daily one placebo capsule or (b) two placebo tablets and one capsule norfloxacin 400 mg followed by twice daily one capsule norfloxacin 400 mg.,arbitruary durations,0,0,NA,uncomplicated cystitis,Urinary tract infection,0,227,outpatient,Netherlands,high,1,5,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
234,2286466,Single dose fosfomycin trometamol versus multiple dose norfloxacin over three days for uncomplicated UTI in general practice,1990,Infection,adults,"comparison between a standard therapy with norfloxacin 400 mg twice daily, and fosfomycin trometamol (3 g) in single dose in uncomplicated urinary tract infections (UTI) in women",arbitruary durations,0,0,NA,uncomplicated UTI,Urinary tract infection,0,32,outpatient,Belgium,high,1,2,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
235,2291755,Pivmecillinam treatment in acute cystitis. Three versus seven days study,1990,Arzneimittelforschung.,adults,151 patients were treated for three days with two tablets of pivmecillinam 200 mg t.i.d. and 148 patients for seven days with one tablet t.i.d.,arbitruary durations,0,0,NA,uncomplicated acute cystitis.,Urinary tract infection,0,345,outpatient,Finland,high,3,7,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
236,2766869,"Treatment of childhood bacterial meningitis with ceftriaxone once daily: open, prospective, randomized, comparative study of short-course versus standard-length therapy",1989,Chemotherapy,children,"The duration of the short-course regimens was 4, 6 and 7 days for Neisseria meningitidis, Hemophilus influenzae and Streptococcus pneumoniae, respectively. The standard-length regimens were twice as long. On the basis of a computer-generated randomization list, 26 children were assigned either to the short- or to the standard-treatment regimen.",arbitruary durations,0,0,NA,childhood bacterial meningitis,Meningitis,1,52,inpatient,Greece,high,"4,6,7","8,12,14",NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
237,2570104,Five days versus one day of penicillin as prophylaxis in elective neurosurgical operations,1989,The Journal of Hospital Infection,adults,"Patients were allocated, by reference to a table of random numbers, to receive either benzyl penicillin 600 mg im at premeditation followed by three further doses 6 hourly (regimen A), or benzyl penicillin 600 mg im at premeditation followed by benzyl penicillin im or phenethicillin 500 mg 6 hourly per OS (as soon as the patient could tolerate oral agents) to complete a total of five days therapy (regimen B).",arbitruary durations,0,0,NA,postoperative prophylaxis after elective neurosurgical operations,Prophylaxis (post-surgery),1,450,inpatient,UK,high,1,5,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
238,2644108,"Single-dose cefotetan vs. multiple-dose cefoxitin--antimicrobial prophylaxis in colorectal surgery. Results of a prospective, multicenter, randomized study",1989,Diseases of the Colon & Rectum,adults,"206 received cefoxitin (1 gm intravenously at the beginning of surgery and after 3, 6, and 12 hours, group A) and 197 cefotetan (2 gm intravenously at the beginning of surgery, group B)",arbitruary durations,0,0,NA,postoperative prophylaxis after colorectal surgery,Prophylaxis (post-surgery),0,403,inpatient,Italy,high,1 dose,4 doses,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
239,2678858,"Preoperative cell-mediated immunity and duration of antibiotic prophylaxis in relation to postopertive infectious complications. A controlled trial in biliary, gastroduodenal and colorectal surgery",1989,Acta Chirurgica Scandinavica,adults,not reported,arbitruary durations,0,0,NA,"postoperative prophylaxis after biliary, gastroduodenal and colorectal surgery",Prophylaxis (post-surgery),0,750,inpatient,Denmark,high,not reported,not reported,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
240,2682096,[Duration of the preventive use of antibiotics in colorectal surgery--single administration versus short-term prevention],1989,Langenbeck's Archives of Surgery,adults,The effect of a combination of 4 g mezlocillin and 0.5 g metronidazole for the prophylaxis against infections in a one-shot dose immediately preoperatively compared to a short-time dose of 2 days,arbitruary durations,0,0,NA,postoperative prophylaxis after resection of colorectal carcinoma,Prophylaxis (post-surgery),0,90,inpatient,German,high,1,2,NA,NA,NA,equivalency,not reported,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Full article not available in English
241,2722725,Single-dose cefmetazole versus multiple dose cefoxitin for prophylaxis in abdominal surgery,1989,Journal of Antimicrobial Chemotherapy,adults,"Subjects randomly received one of two regimens in an open-label fashion, either cefmetazole given preoperatively or cefoxitin given preoperatively then every 6 h for two doses.",arbitruary durations,0,0,NA,postoperative prophylaxis after abdominal surgery,Prophylaxis (post-surgery),0,246,inpatient,Georgia,high middle,1 dose,3 doses,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
242,3048935,"Cefoxitin for one day vs. ampicillin and metronidazole for three days in elective colorectal surgery. A prospective, randomized, multicenter study",1988,Diseases of the Colon & Rectum,adults,"Patients were preoperatively allocated to either ampicillin, 1 gm, four times daily, and metronidazole, 0.5 gm, three times daily, for 72 hours, or to cefoxitin, 2 gm, given three times in a period of 10 hours.",arbitruary durations,0,0,NA,postoperative prophylaxis after elective colorectal surgery,Prophylaxis (post-surgery),0,352,inpatient,Denmark,high,1,3,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
243,3277588,Duration of preventive antibiotic administration for open extremity fractures,1988,The Archives of Surgery ,adults,The three study arms were as follows: (1) 2 g of cefonicid sodium intravenously for one day; (2) 2 g of cefonicid sodium intravenously followed by 1 g of cefonicid sodium intravenously every 24 hours for five days; and (3) 2 g of cefamandole nafate intravenously followed by 1 g of cefamandole nafate intravenously every six hours for five days.,arbitruary durations,1,0,NA,postoperative prophylaxis after open extremity fracture surgery,Prophylaxis (post-surgery),1,341,inpatient,US,high,1,5,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
244,3286537,Two-day cefamandole versus five-day cephazolin prophylaxis in 965 total hip replacements. Report of a multicentre double blind randomised trial,1988,International Orthopaedics,adults,compare a 5-day course of cephazolin with a regimen of 2 days of cefamandole in 965 total hip replacements,arbitruary durations,1,0,NA,postoperative prophylaxis after total hip replacements,Prophylaxis (post-surgery),1,965,inpatient,France,high,2,5,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
245,3396485,Optimal duration of cefotaxime prophylaxis in abdominal and vaginal hysterectomy,1988,Drugs,adults,patients were randomly allocated to short course (2g cefotaxime IV at anaesthesia) or long course (2g cefotaxime at anaesthesia plus 7 doses of 1g 12-hourly) prophylaxis.,arbitruary durations,0,0,NA,postoperative prophylaxis after abdominal and vaginal hysterectomy,Prophylaxis (post-surgery),0,293,inpatient,Australia,high,1,4,NA,NA,NA,not reported,NA,ITT,none,1,NA,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
246,3129780,Five versus ten days treatment of group A streptococcal pharyngotonsillitis: a randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil,1988,Scandinavian Journal of Infectious Diseases,adults,"the patients were randomly assigned to 1 of 3 treatment groups. Group I received the potassium salt of phenoxymethylpenicillin (penicillin V) for 5 days and placebo for 5 days, group I1 penicillin V for 10 days and group III cefadroxil for 10 days.",arbitruary durations,1,0,NA,Group A Streptococal Pharyngotonsillitis,Upper respiratory tract infection,0,216,outpatient,Sweden,high,5,10,NA,NA,NA,not reported,NA,ITT,none,1,NA,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
247,3277153,Five vs. ten days of therapy for acute otitis media,1988,The Pediatric Infectious Disease Journal ,children,randomized into 2 treatment groups: 10 days of therapy with cefaclor or 5 days of therapy followed by 5 days of placebo. The dosage of cefaclor was 40 mg/kg/day administered orally in equally divided doses at 12-hour intervals.,arbitruary durations,1,0,NA,acute otitis media,Ear Nose Throat Infection,0,175,outpatient,US,high,5,10,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
248,3056259,"Double-blind, randomized comparison of 24 weeks of norfloxacin and 12 weeks of norfloxacin followed by 12 weeks of placebo in the therapy of complicated urinary tract infection",1988,Antimicrobial Agents and Chemotherapy,adults,Patients who completed 12 weeks of therapy without major adverse effects and without symptomatic persistence of infection were randomized to continue to receive either norfloxacin (400 mg orally twice a day) or an identical placebo twice a day.,arbitruary durations,1,0,NA,complicated UTI,Urinary tract infection,0,15,outpatient,Canada,high,84,168,NA,NA,NA,difference,NA,ITT,none,1,NA,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
249,3287839,"One or three weeks' treatment of acute pyelonephritis? A double-blind comparison, using a fixed combination of pivampicillin plus pivmecillinam",1988,Acta Medica Scandinavica,adults,1 and 3 weeks' pivampicillin plus pivmecillinam treatment were compared,arbitruary durations,1,0,NA,acute pyelonephritis,Urinary tract infection,0,61,outpatient,Sweden,high,7,21,NA,NA,NA,difference,NA,ITT,none,1,NA,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
250,3068098,Comparison of tinidazole given as a single dose and on 2 consecutive days for the treatment of nonspecific bacterial vaginosis,1988,Gynecologic and Obstetric Investigation,adults,"randomized, double-blind study with (1) tinidazole 2 g as a single dose (82 patients), (2) tinidazole 2 g on 2 consecutive days (84 patients), and (3) with placebo (81 patients).",arbitruary durations,1,0,NA,nonspecific bacterial vaginosis,Vaginosis,0,247,outpatient,Norway,high,1,2,NA,NA,NA,not reported,NA,ITT,none,1,NA,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
251,3101484,Five vs ten days of penicillin V therapy for streptococcal pharyngitis,1987,THE AMERICAN JOURNAL OF DISEASES OF CHILDREN,children,randomly assigned to receive 250 mg of penicillin V potassium three times daily for either five or ten days.,arbitruary durations,0,0,NA,group A beta-hemolytic streptococcal (GABHS) pharyngitis ,Upper respiratory tract infection,0,172,outpatient,US,high,5,10,NA,NA,NA,difference,NA,ITT,none,1,NA,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
252,3492950,Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks. A randomized trial,1987,Annals of Internal Medicine,adults,"compared the efficacy of orally administered ampicillin, 2 g/d, with that of trimethoprim-sulfamethoxazole, 320 mg/d-1600 mg/d, given for 2 or 6 weeks for outpatient management",arbitruary durations,0,0,NA,Acute renal infection,Renal Infection,0,60,outpatient,US,high,14,42,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
253,3543037,[Value of short prophylactic antibiotherapy in thoracic and vascular surgery. Comparative randomized double-blind study of 3 and 8 injections of cefamandole],1986,Journal de Chirurgie (J CHIR-PARIS),adults,"Patients were randomly allocated to receive either 3 injections of cefamandole: at induction of anesthesia and after 4 and 10 hours (251 cases) or 8 injections of the same antibiotic: at induction of anesthesia, after 4 hours and then every 6 hours up to 40 hours (256 cases).",arbitruary durations,1,0,NA,postoperative prophylaxis aftert horacic and vascular surgery,Prophylaxis (post-surgery),0,507,inpatient,France,high,1,2,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
254,3514630,Perioperative antimicrobial prophylaxis in cardiovascular surgery. A prospective randomized trial comparing two day cefuroxime prophylaxis with four day cefazolin prophylaxis,1986,THE JOURNAL OF CARDIOVASCULAR SURGERY,adults,four-day cefazolin prophylaxis (Kefzol 0.5 gr every 6 h) compared with two-day cefuroxime administration (Zinacef 1.5 gr every 12 h).,arbitruary durations,0,0,NA,postoperative prophylaxis after cardiovascular surgery.,Prophylaxis (post-surgery),0,566,inpatient,missing,missing,2,4,NA,NA,NA,missing,missing,missing,missing,missing,missing,missing,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,(ABSTRACT TRUNCATED AT 250 WORDS)
255,3893511,A single dose of sulfametopyrazine versus 7 days of ampicillin in acute on chronic bronchitis,1985,British Journal of Diseases of the Chest,adults,"After initial assessment patients received in randomized double-blind fashion either sulfametopyrazine 2 g + one placebo capsule, indistinguishable from ampicillin, followed by one placebo capsule thrice daily, for a total of 7 days or a placebo tablet of sulfametopyrazine + a 250 mg capsule of ampicillin followed by ampicillin 250 mg thrice daily, for 7 days",arbitruary durations,0,0,NA,acute or chronic bronchitis,Lower respiratory tract infection,0,42,inpatient,UK,high,1,7,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
256,3889396,Seven days of ceftriaxone therapy is as effective as ten days' treatment for bacterial meningitis,1985,The Journal of the American Medical Association,children,"All patients with meningitis caused by Neisseria meninffitidis were treated for only seven days because this has been our practice for many years. Those with meningitis caused by Streptococcus pneumoniae, H influenzae, or Streptococcus agalactiae (group B streptococcus) were assigned to receive either seven or ten days of therapy, using a computer-generated randomized number list",arbitruary durations,0,0,NA,bacterial meningitis,Meningitis,1,79,inpatient,US,high,7,10,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
257,3887560,Cefadroxil once daily for three or seven days versus amoxycillin for seven days in uncomplicated urinary tract infections in women,1985,Scandinavian Journal of Infectious Diseases,adults,The patients were randomly allocated to one of 3 treatment regimens: cefadroxil 2 capsules of 500 mg administered once daily for 3 or 7 days and amoxycillin 1 capsule of 375 mg t.i.d. for 7 days.,arbitruary durations,0,0,NA,uncomplicated urinary tract infections,Urinary tract infection,0,230,outpatient,Sweden,high,3,7,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
258,4002410,[Treatment of acute urinary infections. Comparison between pivmecillinam for 3 days and sulfamethizole therapy for 6 days],1985,Ugeskr Laeger,adults,Comparison between pivmecillinam for 3 days and sulfamethizole therapy for 6 days,arbitruary durations,missing,0,NA,uncomplicated acute cystitis ,Urinary tract infection,0,missing,missing,Denmark,high,3,6,NA,NA,NA,missing,missing,missing,missing,missing,missing,missing,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,[Article in Danish] No abstract available
259,6717216,One day vs. two days of prophylactic antibiotics in patients undergoing major head and neck surgery,1984,The Laryngoscope,adults,prospectively randomized to receive moxalactam (30 mg/kg) before surgery and for either 3 or 6 doses total postoperatively.,arbitruary durations,0,0,NA,postoperative prophylaxis after major head and neck surgery,Prophylaxis (post-surgery),0,30,inpatient,US,high,1,2,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
260,6427533,Acute cystitis: a prospective study of laboratory tests and duration of therapy,1984,Mayo Clinic Proceedings,adults,patients were randomly assigned to receive either a single dose or a 10-day multiple-dose course of TMP-SMZ,arbitruary durations,0,0,NA,Acute cystitis,Urinary tract infection,0,136,outpatient,US,high,1,10,NA,NA,NA,not reported,NA,ITT,none,1,NA,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
261,7055433,Duration of preventive antibiotic administration for penetrating abdominal trauma,1982,The Archives of Surgery,adults,randomized to receive either 12 hours or five days of penicillin G potassium and doxycycline hyclate beginning before operation.,arbitruary durations,0,0,NA,penetrating abdominal trauma,Abdominal infection,0,42,inpatient,US,high,1,5,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
262,7271091,Therapy for nongonococcal urethritis: double-blind randomized comparison of two doses and two durations of minocycline,1981,Annals of Internal Medicine,adults,Active drug was given to Groups A and B for 7 days and to groups C and D for 21 days,arbitruary durations,1,0,NA,nongonococcal urethritis,Urinary tract infection,0,289,outpatient,US,high,7,21,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
263,6792379,Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs ten days' therapy,1981,The Journal of the American Medical Association,children,Patients were randomly assigned to either seven or ten days' therapy of penicillin V potassium at a dose of 20 mg/kg/day for children of less than 50-kg body weight and 15 mg/kg/day for children weighing more than 50 kg.,arbitruary durations,0,0,NA,group A streptococcal pharyngotonsillitis,Upper respiratory tract infection,0,191,outpatient,US,high,7,10,NA,NA,NA,not reported,NA,ITT,none,1,NA,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
264,7028636,Short-term treatment of lower urinary tract infections in children with trimethoprim/sulphadiazine,1981,Infection ,children,treated for either three or ten days with 4/16 mg trimethoprim/sulphadiazine/kgBW/day in two doses.,arbitruary durations,0,0,NA,uncomplicated lower urinary tract infections,Urinary tract infection,0,43,outpatient,Sweden,high,3,10,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
265,7005459,Comparison of 4 and 10 days of doxycycline treatment for urinary tract infection,1980,The Journal of Urology,adults,allocated randomly to a 4 or a 10-day course of doxycycline therapy,arbitruary durations,0,0,NA,cystitis ,Urinary tract infection,0,41,outpatient,US,high,4,10,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
266,380336,Duration of empiric antibiotic therapy in granulocytopenic patients with cancer,1979,The American Journal of Medicine,adults,"After seven days of empiric KGC therapy, the 33 patients with fevers of unknown origin who had become afebrile with empiric antibiotics but whose polymorphonuclear leukocytes remained less than 500/mm3 were randomized to either continue or discontinue (Math Eq) to receive KGC.",arbitruary durations,0,0,NA,granulocytopenic in cancer patients,Prophylaxis (immunocompromised),0,143,inpatient,US,high,7,>7,NA,NA,NA,not reported,NA,ITT,none,1,NA,long,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
267,1095132,Duration of treatment for urinary tract infections in children,1975,The BMJ,children,All patients were given co-trimoxazole for two weeks and then allotted at random to one of two groups according to a key held in the pharmacy. At the end of the two weeks one group continued with the active drug for the remainder of six months andthe other with dummytablets of identical appearance.,arbitruary durations,1,0,NA,uncomplicated UTI in children,Urinary tract infection,0,45,outpatient,UK,high,14,180,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
268,4888353,Controlled trial comparing effect of two and six weeks' treatment in recurrent urinary tract infection,1969,The BMJ,adults,Patients were allocated at random to two or six weeks' treatment on the basis of the last digit of their hospital number.,arbitruary durations,0,0,NA,recurrent UTI,Urinary tract infection,0,146,outpatient,Australia,high,14,42,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
269,15119993,"Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens",2004,Current Medical Research and Opinion,adults,"Eligible patients were randomized in a 1:1 ratio to receive 750 mg of levofloxacin for 5 days, or 500 mg of levofloxacin for 10 days.",arbitruary durations,1,0,NA,CAP,Lower respiratory tract infection,0,149,outpatient,US,high,5,10,NA,NA,NA,non-inferiority,10,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
270,9802626,Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children,1998,The Pediatric Infectious Disease Journal,children,"Patients randomized to azithromycin received azithromycin oral suspension 10 mg/kg (maximum, 500 mg) once on Day 1, followed by 5 mg/kg (maximum, 250 mg) once daily on Days 2 through 5 and placebo for conventional therapy three times daily on Days 1 through 10.",arbitruary durations,1,0,NA,community-acquired pneumonia,Lower respiratory tract infection,0,456,outpatient,US,high,5,10,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
271,10378132,Azithromycin: single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome--a randomized study,1999,Infection,adults,Patients were randomized to receive a single 1.5 g dose of azithromycin (single dose group) or 500 mg once daily for 3 days (3-day group).,arbitruary durations,0,0,NA,atypical pneumonia syndrome,Lower respiratory tract infection,0,100,inpatient,Croatia,high,1,3,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
272,18611681,A sequential study of intravenous and oral Fleroxacin for 7 or 14 days in the treatment of complicated urinary tract infections,1995,International Journal of Antimicrobial Agents,adults,"Patients (54) were randomly assigned, after 3 days Fleroxacin 400 mg iv once daily, to receive oral fleroxacin (400 mg OD,) either during 4 (total 7) days (n = 26), or during 11 (total 14) days (n = 28).",arbitruary durations,0,0,NA, complicated urinary tract infections,Urinary tract infection,0,54,inpatient,Netherlands,high,7,14,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
273,12936972,Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis,2003,Antimicrobial Agents and Chemotherapy,adults,"ects received 500-mg tablets of AZM or a placebo administered as one tablet once daily for 6 days, and 250-62.5 mg of AMC per 5 ml of liquid suspension or a placebo administered as two teaspoons (500-125 mg) three times daily for 10 days",arbitruary durations,1,0,NA,acute bacterial sinusitis,Upper respiratory tract infection,0,941,outpatient,US,high,3,6,NA,NA,NA,equivalency,10,ITT,PP,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
273,12936972,Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis,2003,Antimicrobial Agents and Chemotherapy,adults,"ects received 500-mg tablets of AZM or a placebo administered as one tablet once daily for 6 days, and 250-62.5 mg of AMC per 5 ml of liquid suspension or a placebo administered as two teaspoons (500-125 mg) three times daily for 10 days",arbitruary durations,1,0,NA,acute bacterial sinusitis,Upper respiratory tract infection,0,941,outpatient,US,high,3,10,NA,NA,NA,equivalency,10,ITT,PP,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
273,12936972,Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis,2003,Antimicrobial Agents and Chemotherapy,adults,"ects received 500-mg tablets of AZM or a placebo administered as one tablet once daily for 6 days, and 250-62.5 mg of AMC per 5 ml of liquid suspension or a placebo administered as two teaspoons (500-125 mg) three times daily for 10 days",arbitruary durations,1,0,NA,acute bacterial sinusitis,Upper respiratory tract infection,0,941,outpatient,US,high,6,10,NA,NA,NA,equivalency,10,ITT,PP,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
274,11911557,"A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis",2002,Clinical Therapeutics,adults,"eligible patients were randomized to receive gatifloxacin 400 mg once daily for 5 days, gatifloxacin 400 mg once daily for 10 days, or amoxicillin/ clavulanate 875 mg twice daily for 10 days.",arbitruary durations,0,0,NA,acute bacterial sinusitis,Upper respiratory tract infection,0,445,outpatient,US,high,5,10,NA,NA,NA,equivalency,not reported,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
275,9950107,Azithromycin versus amoxicillin/clavulanate in the treatment of acute sinusitis,1999,American Journal of Otolaryngology ,adults,"Patients were randomized to receive azithromytin (500 mg) once daily for 3 days or amoxicillin/ clavulanic acid (625 mg, ie, 500 mg of amoxicillin and 125 mg of clavulanate) every 8 hours for 10 days.",arbitruary durations,0,0,NA,acute sinusitis,Upper respiratory tract infection,0,100,outpatient,Croatia,high,3,10,NA,NA,NA,not reported,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
276,11387706,[Treatment of group A streptococcal tonsillopharyngitis. 5 days cephalosporin is as effective as 10 days penicillin],2001,MMW Fortschritte der Medizin,children,5 days cephalosporin is as effective as 10 days penicillin,arbitruary durations,0,0,NA,group A streptococcal tonsillopharyngitis,Upper respiratory tract infection,0,missing,missing,Germany,high,5,10,NA,NA,NA,missing,missing,missing,missing,missing,missing,missing,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Full article not found
277,11820968,[Urinary infections without complications: comparison of a treatment with norfloxacin for 7 days versus norfloxacin for 3 days],2002,Atención Primaria,adults,treatment with norfloxacin for 7 days versus norfloxacin for 3 days,arbitruary durations,0,0,NA,uncomplicated UTI,Urinary tract infection,0,118,outpatient,Spain,high,3,7,NA,NA,NA,not reported,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,[Article in Spanish] Details were inferred via translation using Google Translate
278,9154538,Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children,1997,Pediatr Infect Dis J,children,"new formulation of amoxicillin/clavulanate potassium (Augmentin) oral suspension providing 45/6.4 mg/kg/day and administered twice daily (bid) for 5 and 10 days, respectively, with the safety and efficacy of the original formulation providing 40/10 mg/kg/day and administered three times daily (tid) for 10 days",arbitruary duration,0,0,NA,Otitis media,Upper respiratory tract infection,0,868,outpatient,"USA, canada",high,5,10,NA,NA,NA,equivalency,30,ITT,PP,0,1,longer,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
279,9821420,"A multicenter, randomized, double-blind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young children",1998,J Paed,children,"amoxicillin/clavulanate in 3 divided doses for 10 days with an identical 5-day regimen, followed by a 5-day placebo period",arbitruary duration,1,0,NA,Otitis media,Upper respiratory tract infection,0,385,outpatient,France,high,5,10,NA,NA,NA,difference,NA,ITT,PP,1,1,longer,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
280,10530579,Short course therapy with cefuroxime axetil for acute otitis media: results of a randomized multicenter comparison with amoxicillin/clavulanate,1999,Pediatr Infect Dis J,children,short 5-day course of cefuroxime axetil (CAE) suspension with that of amoxicillin/clavulanate (A/CA) suspension for 8 or 10 days,arbitruary duration,0,0,NA,Otitis media,Upper respiratory tract infection,0,716,outpatient,European countries,high,5,10,NA,NA,NA,equivalence,20,ITT,PP,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
280,10530579,Short course therapy with cefuroxime axetil for acute otitis media: results of a randomized multicenter comparison with amoxicillin/clavulanate,1999,Pediatr Infect Dis J,children,short 5-day course of cefuroxime axetil (CAE) suspension with that of amoxicillin/clavulanate (A/CA) suspension for 8 or 10 days,arbitruary duration,0,0,NA,Otitis media,Upper respiratory tract infection,0,716,outpatient,European countries,high,5,8,NA,NA,NA,equivalence,20,ITT,PP,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
281,11283494,"A prospective observational study of 5-, 7-, and 10-day antibiotic treatment for acute otitis media",2001,Otolaryngol Head Neck Surg,children,"5-, 7- and 10-day duration of antibiotic therapy",arbitruary duration,0,0,NA,Otitis media,Upper respiratory tract infection,0,2172,outpatient,USA,high,5,7,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
281,11283494,"A prospective observational study of 5-, 7-, and 10-day antibiotic treatment for acute otitis media",2001,Otolaryngol Head Neck Surg,children,"5-, 7- and 10-day duration of antibiotic therapy",arbitruary duration,0,0,NA,Otitis media,Upper respiratory tract infection,0,2172,outpatient,USA,high,5,7,NA,NA,NA,difference,NA,PP,none,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
282,2212918,Seven day metronidazole versus single dose tinidazole as therapy for nonspecific vaginitis,1990,J Med Assoc Thai,adult,"Group I, received oral metronidazole 1 g daily for 7 days. Another 78 patients in Group II, received oral tinidazole 2 g single dose",arbitruary duration,0,0,NA,nonspecific vaginitis,Vaginosis,0,171,outpatient,Thailand,high-middle,1,7,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,
283,2045037,"Treatment of bacterial vaginitis. Multicenter, randomized, open study with tinidazole in comparison with metronidazole",1991,Fortschr Med,adult,"single oral dose of 2 g tinidazole, the other 2 x 1 vaginal tablet of metronidazole 400 mg on five consecutive days",arbitruary duration,0,0,NA,nonspecific vaginitis,Vaginosis,0,75,outpatient,Germany,high,1,5,NA,NA,NA,difference,NA,ITT,none,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,